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Abstract 
 
The overall purpose of this thesis were to explore the impact of hepatocellular 
carcinoma (HCC) on patients’ health-related quality of life (HRQOL), the significant 
predictors of adjustment outcomes, as well as to establish an adjustment model in 
patients with HCC. This thesis included three studies: systematic review, qualitative and 
quantitative study. 
Systematic review. HCC and HRQOL relevant keywords were combined and 36 
articles were recruited in this review. The main finding indicated patients with HCC had 
worse physical, emotional, and functional HRQOL; but better social/family HRQOL 
than the general population. The medical and physical variables associated with 
HRQOL also identified.  
Qualitative study. Thirty-three patients with HCC in Taiwan were recruited, and 
semi-structured interview was used to collect data to explore patients’ experience in 
illness journey. Four themes were identified, including the impact of disease, the illness 
perceptions of HCC, the information needs and the coping strategies. A preliminary 
model of illness adjustment was also developed. 
Quantitative study. Standardized questionnaires were used to measure HRQOL, 
anxiety and depression, illness perceptions, coping, and social support; and 
demographic and physical variables were also collected (n=286). Patients with HCC 
had worse global HRQOL, physical, role, cognitive, social functioning, and more higher 
levels of depression than the general population; and the prevalence of anxiety, 
depression and emotional distress were 11.27%, 25.44%, and 20.14% respectively. 
Physical variables explained a significant amount of variance in all EORTC and HADS 
scores (R2=.17-.62). Illness perceptions explained an additional 4.33%-31.80% of the 
variance in the EORTC and HADS scores after controlling for ECOG and α-FP. 
 ii
Cognitive representations mediated the effects of ECOG on the EORTC and HADS 
scores, and coping mediated the effects of cognitive representations on psychological 
aspects of adjustment outcomes. 
An adjustment model with multiple pathways was developed based on both 
quantitative and qualitative findings. Suggestions are made for improving clinical care 
for patients with HCC and future studies. 
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Chapter 1. Physical Aspects of Hepatocellular Carcinoma 
 
1.1 Abstract 
This chapter covered on the physical aspects of hepatocellular carcinoma (HCC), 
including epidemiology, risk factors, diagnosis and stage, and treatment. In addition, the 
specific characteristics of HCC in Taiwan are also addressed. HCC is one of the major 
cancers in Taiwan, around 7,000 patients die from the disease every year. There are 
demographic and geographic variations in the incidence of HCC. The risk factors 
include biological, chemical and nutritional factors, especially hepatitis B and C viruses 
and cirrhosis. There is a lack of consensus about standard staging system and treatment 
protocols for HCC. In addition, there is a tendency for HCC to be diagnosed at a late 
stage because of invisible symptoms and reserved liver functions. Although surgical 
resection or transplantation are curative treatments, most patients who are not eligible 
for surgery receive local ablative therapy, hepatic artery transcatheter treatment, and 
systemic treatment. 
 
 
1.2 Epidemiology 
Liver cancer is the sixth most common cancer worldwide in terms of numbers of 
cases (626,000 or 5.7% of new cancer cases), and it is the third most common cause of 
death from cancer (598,000) due to the very poor prognosis (Parkin, Bray, Ferlay, & 
Pisani, 2005). Men are two or three times more often affected than women (El-Serag, 
2002). There are geographic variations in HCC (Chen, Yu, & Liaw, 1997), and the 
largest concentration of patients is in Asia and sub-Saharan Africa (El-Serag, 2002; 
Parkin et al., 2005), as well as in Taiwan.  
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In Taiwan, cancer has been the most common cause of death since 1970, and there 
are steady increases in the numbers of newly diagnosed and deaths of all cancer (see 
Figures 1.1 and 1.2). HCC is the second most common cancer in Taiwan, and rising 
incidence and mortality rates of HCC have been reported in last two decades. There 
were approximately 9,900 new HCC cases and approximately 7,000 people died of 
HCC in 2005; the numbers of patients who died from HCC is one-fifth of those who 
died from all cancers (Taiwan Cancer Registry, 2008).  
 
 
Figure 1.1 Numbers of new diagnosis of all cancer and HCC in Taiwan from 1995 to 
2005. Source: Taiwan Cancer Registry, 2008. 
 
 
Figure 1.2 Numbers of death of all cancer and HCC in Taiwan from 1995 to 2005. 
Source: Taiwan Cancer Registry, 2008. 
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1.3 Risk factors 
Hepatic carcinogenesis is a complex process associated with accumulation of genetic 
and epigenetic changes that run through steps of initiation, promotion and progression 
(Dominguez-Malagon & Gaytan-Graham, 2001). Based on epidemiological analyses, 
both ethnic and environmental factors are important determinants of HCC (Chen et al., 
1997).  
 
1.3.1 Hepatitis viruses 
HCC is commonly the result of chronic viral infection. Hepatitis B virus (HBV) is the 
most frequent risk factor for HCC. There is a strong positive relation between the 
prevalence of HBV and HCC, especially in regions with high incidence of HCC (e.g., 
Taiwan, China, and sub-Saharan Africa) (Llovet, Burroughs, & Bruix, 2003). HBV 
carriers have a 5- to 15-fold increased risk of HCC compared with the general 
population (El-Serag, 2002). Hepatitis C virus (HCV) is also associated with a higher 
risk of developing HCC and HCV carriers have a 17-fold increased risk compared with 
the HCV negative controls (Donato, Boffetta, & Puoti, 1998). HCV is also associated 
with increased HCC in the United States and western countries (El-Serag, Davila, 
Petersen, & McGlynn, 2003). In Asia and Africa, 70% of HCC patients have HBV 
infection, but only 10-20% in Europe and North America. In contrast, only 20% of HCC 
patients have HCV infection in Asia and Africa, but 50-70% are affected in Europe and 
North America (Llovet et al., 2003). 
In Taiwan, HBV and HCV are the first and second leading causes of HCC since 1990 
(Chen et al., 1997). Overall, the mean age of patients with HBV-related HCC was 53.3 
years (SD=13.6), and 65.1 years (SD=9.1) for HCV-related HCC patients. The 
male/female ratio was 6.4 for HBV-related HCC, while it was 1.7 for HCV-related HCC 
(Lu et al., 2006). There has been a dramatic decrease in incidence of liver cancer since 
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universal hepatitis B vaccination was introduced in Taiwan (Chang et al., 1997). 
However, there is increasing tendency of HCV-related HCC (Lu et al., 2006). 
 
1.3.2 Cirrhosis 
The most important predisposing factor of HCC is cirrhosis caused by hepatitis 
viruses, alcohol, or inherited metabolic diseases (Cahill, 2005). Cirrhosis from any 
causes is the seed-bed of HCC (Schafer & Sorrell, 1999). Most HBV and HCV-related 
HCC coexist with cirrhosis which is the underlying of the pathologic process of 
hepatocyte necrosis, chronic inflammation, fibrosis, and scarring that leads to the 
malignant transformation within the liver (Kew, 1996).  
 
1.3.3 Alcohol consumption 
Heavy alcohol drinkers have been found to have a significantly increased HCC risk in 
most epidemiological studies (Chen et al., 1997). Alcohol could induce cirrhosis and 
possible malignant change to the hepatocyte (Groen, 1999). Alcohol-related cirrhosis 
has become the major risk factor of HCC in places where the incidence of chronic viral 
hepatitis is low (Schafer & Sorrell, 1999). 
 
1.3.4 Chemical substances 
There are significant correlations between Aflatoxin exposure and HCC mortality or 
morbidity (Chen et al., 1997; El-Serag, 2002). Chemicals such as inorganic arsenic, 
thorotrast, and vinyl chloride increase the risk of HCC. In addition, exogenous and 
endogenous hormones have been reported to be associated with HCC (Chen et al., 
1997). 
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1.3.5 Genetic and familial tendency 
Familial tendency may result from environmental factors such as HBV or genetic 
factors shared by family members. One study indicated the autosomal recessive gene for 
HCC in Taiwan (Chen et al., 1997). 
 
The development of HCC is a multistage process with a multifactorial aetiology. In 
Taiwan, the major pathway of hepatocarinogenesis is through HBV and HCV infection, 
chronic hepatitis, and liver cirrhosis to HCC. In addition, cigarette smoking, the 
traditional Chinese vegetarian habit, low vegetable consumption and heavy alcohol 
drinking may increase the risk of HCC (Chen et al., 1997). 
 
 
1.4 Symptoms, diagnosis and stage 
1.4.1 Symptoms 
HCC is insidious in onset and is typically asymptomatic during the early stage (Cahill, 
2005). There tends to be a delay in diagnosis due to (1) the lack of symptoms in the 
early stage; (2) the large size and position of liver behind the costal cartilages, which 
precludes the tumour from being readily palpable while small; and (3) the large 
functional reserve of the liver, which delays presentation with functional disturbances r 
(Lau, 2000). Consequently, HCC is generally diagnosed in the later stages of the 
disease. 
Table 1.1 summarizes the clinical presentations associated with HCC (Bialecki & Di 
Bisceglie, 2005). Initially, patients present with nonspecific symptoms such as fatigue, 
weight loss, right upper quadrant pain, or dull ache or pain in the epigastric area (Groen, 
1999). When the tumour grows larger, hepatic decompensation becomes common. 
Ascites and jaundice are typical symptoms, and patients develop tremors, confusion, 
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and encephalopathy while hepatic decompensation worsen (Lau, 2000). 
 
Table 1.1 Clinical presentations in HCC (source: Bialecki & Di Bisceglie, 2005) 
Asymptomic 
Liver dysfunction 
   
 
 
Complications of tumour growth 
   
 
 
 
 
Paraneoplastic syndrome 
   
 
 
 
 
Distant metastasis 
   
Ascites 
  Jaundice 
  Hepatic encephalopathy 
  Variceal bleed 
Abdominal pain 
  Weight loss 
  Cachexia 
  Abdominal mass  
Obstructive jaundice 
  Tumour rupture 
hypoglycemia 
  hypercalcemia 
  polycythaemia 
  Feminization syndrome 
  Diarrhoea 
  Cutaneous manifestations 
 
 
1.4.2 Diagnosis 
Percutaneous biopsy provides the definitive diagnosis of hepatic tumours (Groen, 
1999). Serum alpha fetoprotein (α-FP) and imaging studies are major methods to 
diagnose HCC (Cahill & Braccia, 2004). α-FP values that more than 400 ng/ml or a 
progressive increase in α-FP levels are highly suggestive of HCC (Yu & Keeffe, 2003). 
Imaging studies that are used to evaluate the size and location of tumours include 
ultrasonography, computed tomography (CT), magnetic resonance imaging, computed 
tomographic portogram, hepatic arteriorgraphy, and arteriorgraphically enhanced CT 
(Groen, 1999).  
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1.4.3 Stage 
The purpose of staging is to accurately categorise patients in order to inform the 
likely prognosis of disease and most appropriate treatment (Groen, 1999). The most 
widely used staging systems are the Okuda prognostic staging system (Table 1.2) and 
the TNM system (tumour, node, metastasis) (Table 1.3) by The American Joint 
Committee on Cancer (AJCC) (Schafer & Sorrell, 1999).  
 
Table 1.2 Okuda staging system (source: Wildi et al., 2004) 
Positive features Tumour involving >50 per cent of the liver 
 Ascites 
 Albumin <3 g/dl 
 Bilirubin >3 mg/dl 
Stage I: No positive features 
Stage II: 1 or 2 positive features 
Stage III: 3 or 4 positive features 
 
Table 1.3 TNM classification for HCC (source: Wildi et al., 2004) 
Pathological staging (pTNM) 
Stage I  T1     N0     M0 
Stage II  T2     N0     M0 
Stage IIIA  T3     N0     M0 
IIIB  T4     N0     M0 
IIIC  Any T  N1     M0 
Stage IV  Any T  Any N  M1 
  
T definitions T1: Solitary without vascular invasion 
 T2: Solitary tumor with vascular invasion or multinodular >5 cm 
 T3: Multinodular > 5 cm or tumor with major vascular invasion 
 T4: Tumor with invasion of adjacent organs 
N definitions N0: No regional lymph node metastasis 
 N1: Regional lymph node metastasis 
M definitions M0: No distant metastasis 
 M1: Distant metastasis 
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However, there is a lack of consensus in the definition and staging of HCC between 
different systems (Wildi, Pestalozzi, McCormack, & Clavien, 2004). Most systems fail 
to link staging to treatment indication, except for Barcelona Clinic Liver Cancer (BCLC) 
system (Sala, Forner, Varela, & Bruix, 2005) (see Figure 1.3). In Taiwan, AJCC and 
BCLC are the widely used systems. 
 
 
Figure 1.3 Strategy for staging and treatment assignment in patients diagnosed with 
HCC according to the Barcelona Clinic Liver Cancer (BCLC) system. Source: Bruix & 
Sherman, 2005. 
 
 
1.5 Treatment 
There are no standard proven treatments for HCC, and the choice of treatment 
depends on the general condition of the patient, stage of disease, liver function, as well 
as the treatment protocol and availability of expertise in the individual medical center 
(Lau, 2000). Treatment options for HCC include surgical and nonsurgical modalities. 
Surgical therapy is the only potentially curative treatment for HCC, but most patients 
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are not eligible for these procedures by the time of diagnosis. Nonsurgical treatment can 
prolong survival period and palliate symptoms (Cahill & Braccia, 2004). 
Surgical therapy includes resection and liver transplantation. However, only 10-20% 
of patients are eligible for surgical intervention because of large tumour size and 
metastases on diagnosis (Groen, 1999). The overall 5-year survival rate of liver 
resection ranges from 11% to 76% with a median of around 30%; for liver 
transplantation the rates range from 20% to 36% (Lau, 2000). 
For patients with unresectable HCC, treatments include local ablative therapy, hepatic 
artery transcatheter treatment, and systemic treatment. Precutaneous ethanol injection 
(PEI) is the most common method of local ablative therapy; ethanol is injected under 
ultrasound guidance to cause necrosis of tumour (Schafer & Sorrell, 1999). Hepatic 
artery transcatheter treatment involves (1) transarterial embolization (TAE), 
embolization of the hepatic artery to induce ischemia of tumour and slow down tumour 
growth; (2) transaterial chemotherapy (TAC), deliver the chemotherapeutic agents into 
the hepatic artery to tumour in high concentration; (3) transarterial chemoembolization 
(TACE), combine TAE and TAC; and (4) transarterial radioembolization, delivery of 
radioactive isotapes to tumour (Lau, 2000). Systemic treatments that include 
chemotherapy, immunotherapy, chemoimmunotherapy, hormone therapy, and 
somatostatin analog, have not been shown to have a proven treatment effect (Lau, 
2000).  
Based on the BCLC staging system (Figure 1.3), resection is used for patients with 
very early HCC, radical therapies (resection, liver transplantation or percutaneous 
treatments) for early HCC, and chemoembolization for intermediate stage. However, 
patients with advanced HCC may benefit from new agents and patients with terminal 
HCC receive symptomatic treatment to relieve pain and other symptoms (Sala et al., 
2005).  
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Because of the symptoms, various and repeated treatments, HCC might affect 
patients’ life, for example, they experience pain and other suffering symptoms, regular 
treatment might mean they can not go to work, if they are exhausted by treatment they 
will not socialize, and concern about the future may limit what they do, Therefore it is 
necessary to investigate the impact of HCC, especially quality of life. The next chapter 
will focus on the issues of quality of life and health-related quality of life. 
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Chapter 2. Quality of Life and Health-Related Quality of Life 
 
2.1 Abstract 
Modern medicine has made significant progress in the screening, diagnosis, and 
treatments for HCC, but there is debate about the objective of cancer care: should the 
focus be on the quantity vs. quality of survival? (de Haes & van Knippenberg, 1985). 
The medical impact of HCC on patients, families, and Taiwan society was shown in 
Chapter 1. In this chapter, the emphases are on how HCC impacts on quality of life 
(QOL) of patients, and an additional distinction between QOL and health-related quality 
of life (HRQOL) is made. The health care system concentrates on QOL and health 
which are influenced by illness; therefore I used HRQOL through whole thesis. In 
addition, the characteristics in measurement of HRQOL are discussed, including (1) 
objectivity vs. subjectivity, (2) generic vs. specific, (3) unidimensional vs. 
multidimensional, (4) self-report vs. proxy report, (5) reliability, and (6) validity. 
Subsequently the importance of HRQOL is also addressed. 
 
 
2.2 QOL and HRQOL 
2.2.1 QOL 
QOL is taken to refer to amorphous conceptions of the goodness of life (Zautra & 
Goodhart, 1979). It represents a broad range of human experience about the necessities 
of life, such as a safe environment, adequate housing, a guaranteed income, respect, 
love, and freedom that all contribute to an individual’s QOL (Patrick & Erickson, 1993). 
QOL in a broad concept, encompassing satisfaction about housing, employment, 
standard of living, marriage, interpersonal relationship, religion, and environment 
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(Campbell, Converse, & Rogers, 1976). However, the health care system and its 
providers do not assume responsibility for all these global human concerns, and 
therefore a distinction is made with HRQOL (Patrick & Erickson, 1993). 
 
2.2.2 HRQOL 
In a survey asking health people the five most important things in their lives, health is 
among the most important valued states (Bowling, 1995). QOL and HRQOL are often 
used interchangeably to refer the same concept. However, there are differences between 
the two. As described above, QOL is a broad concept covering all aspects of human life 
including the economic and environmental aspects of an individual, whereas HRQOL 
focuses on the effects of illness and treatment (Guyatt et al., 2007). HRQOL is a 
reflection of the way that individuals perceive and react to their health status and 
nonmedical aspects of their lives, which include (1) health-related factors, such as 
physical, functional, emotional, and mental well-being; (2) non-health-related elements, 
such as job, family, friends, and other life circumstances (Gill & Feinstein, 1994). 
Regarding health outcomes, most indicators reflect a disease model, but HRQOL 
provides a comprehensive evaluation encompassing all important aspects of QOL 
related to health. It has generated a new focus on a broader, more positive concept of 
health, rather than a narrow, negative focus (disease-based) (Seedhouse, 1986). 
A concept of HRQOL is based on a concept of health and QOL, which is influenced 
by an individual’s experiences, beliefs, expectations, and perceptions (Testa & 
Simonson, 1996). Health is defined not only the absence of disease or infirmity but also 
a state of complete physical, mental and social well-being (WHO, 1948). HRQOL is a 
double-sided concept including positive and negative aspects. The negative aspect is 
about the disease and dysfunctions, whereas the positive aspect encompasses feelings of 
mental and physical well-being, full functioning, physical fitness, adjustment and 
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efficiency of mind and body (Bowling, 2001). 
HRQOL is a multi-dimensional dynamic concept (Sajid, Tonsi, & Baig, 2008). 
HRQOL includes multiple components, such as an individual’s physical health, 
psychological state, level of independence, social relationships, and their relationships 
to salient features of their environment (WHO, 1995). These are health related to the 
extent they are influenced by illness, injury, and treatment (Patrick & Deyo, 1989). In 
addition, it is a dynamic concept resulting from past experience, present circumstances, 
and expectations for the future (Bowling, 2001). Perception and achievement of 
HRQOL are dependent on not only an individual’s physical condition but also 
preferences and priorities in life (Edlund & Tancredi, 1985). HRQOL can be recognized 
as a dynamic concept representing individual responses to the physical, mental, and 
social effects of illness which influence the extent to which personal satisfaction with 
life circumstances can be achieved, and which allows favourable comparison with 
others according to the selected criteria (Holmes & Dickerson, 1987). The dimensions 
of HRQOL encompass consequences for the daily lives of individuals, including health 
perceptions, functional status, symptoms, and individuals’ preferences and values 
(Clancy & Eisenberg, 1998). 
HRQOL is sometimes confused with health status or functional status (Farquhar, 
1995). Illness has a pervasive effect that seeps into all areas of life, but HRQOL 
depends on more than physical health status alone (Guyatt, Feeny, & Patrick, 1993). 
HRQOL and health status are two distinct constructs. There is no concordance between 
patient ratings of health status and global HRQOL, for example among patients with 
poor physical functioning, 43% nevertheless rated HRQOL to be good (Covinsky et al., 
1999). Furthermore, patient ratings of their health and global HRQOL seem to be 
influenced by different factors. Perceived health status was most affected by physical 
functioning but less by emotional well-being. However, global HRQOL was influenced 
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more by emotional well-being than physical functioning (Smith, Avis, & Assmann, 
1999). HRQOL encompasses not only perceived health status but also wide broad of 
aspects of life. 
 
 
2.3 The measures issues of HRQOL assessment 
In recent years, HRQOL measures have been applied to different diseases, conditions, 
and populations. However, some criticism has arisen, for example lack of conceptual 
clarity and measurement feasibility (Hunt, 1997; Rogerson, 1995). It is essential to 
define and operationalize HRQOL. The field of HRQOL assessment has become more 
sophisticated and methodologically rigorous (Ferrans, 2007). Eiser and Morse (2001) 
reviewed HRQOL relevant literatures and provided the performance characteristics for a 
good measure of HRQOL (see Table 2.1). Although these specifically relate to 
assessment of HRQOL in children, the key demands are relevant to measurement 
generally.  
Fitzpatrick, Davey, Buxton, and Jones (1998) have also developed criteria for 
assessing the quality of HRQOL measures, including reliability, validity, precision 
(measures can distinguish health and illness), responsiveness (measures can detect 
clinically important changes), acceptability (patients are willing to complete measures), 
and feasibility (the timing and cost of measures are reasonable). In this section, the 
important issues of measuring HRQOL were addressed, including (1) objectivity vs. 
subjectivity, (2) generic vs. specific, (3) unidimensional vs. multidimensional, (4) 
self-report vs. proxy report, (5) reliability, and (6) validity. 
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Table 2.1 Performance characteristics for HRQOL measures (Eiser & Morse, 2001) 
Performance characteristic 
Reliable and valid for the groups of patients for whom it is used 
Employ self-report whenever possible 
Allow completions by proxy 
Brief, easy to administer 
Child-centred and developmentally appropriate 
The usability of the instrument must be considered (e.g., the language, reading level, 
and burden to staff); parents and families should be consistent with the stated 
objectives of the study 
Age-corrected, general population norms 
Reflect the agreed upon definition of HRQOL 
Cover the full spectrum of behaviours thought to contribute to HRQOL (e.g., 
psychological, physical, social functioning) 
Include both generic and subjective assessment 
Include a generic core and disease-specific items 
Allow for supranormal performance 
Cross-culturally compatible 
Emphasis health-enhancing aspects of HRQOL 
 
 
2.3.1 Objectivity vs. subjectivity 
HRQOL includes both subjective and objective components (Felce & Perry, 1995; 
Meeberg, 1993; Muldoon, Barger, Flory, & Manuck, 1998; Testa & Simonson, 1996). 
Assessment of objective functioning and subjective well-being involve different 
definitions and methodologies (Muldoon et al., 1998). Subjective well-being has 
multiple facets, which depends on reactions in multiple physiological and psychological 
systems (Diener, Suh, Lucas, & Smith, 1999). Subjective assessment includes the 
individual’s perception or appraisal of HRQOL, such as emotional levels, life 
satisfaction, and well-being (Eiser, 2004b; Testa & Simonson, 1996). Objective 
functioning is important in defining an individual’s degree of health or ability, and 
individual’s subjective perceptions translate the objective functioning into the HRQOL 
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experienced (Testa & Simonson, 1996). Objective assessment focuses on what the 
individual can do, such as walking or self care ability, and the symptoms, such as pain, 
fatigue or weakness.  
The combination of using HRQOL assessment and objective clinical indicators is 
popular in evaluating the effectiveness and appropriateness of medical treatments and 
methods of health services (Enthoven, 2000). HRQOL instruments can be used to assess 
the ripple effects of disease and symptoms on all aspects of life, not only a narrowly 
focused measure of the target symptoms (Ferrans, 2007). HRQOL assessment can 
incorporate these two characteristics. 
 
2.3.2 Generic vs. specific measures 
A generic measure is defined as a broad outcome indicator including physical, mental, 
and social health; but a specific measure is used to assess disease or condition-related 
attributes (Bowling, 2001). Generic instruments include heath profiles and utility 
measures (Guyatt et al., 1993). In general, generic HRQOL measures should contain the 
dimensions of physical, emotional, social functioning, as well as global perceptions of 
health and well-being (Anderson, Aaronson, & Wilkin, 1993). Generic measures can be 
used to compare across different types and severities of disease, treatments or 
interventions, and across demographic and cultural subgroups (Guyatt et al., 1993). 
On the other hand, a specific measure focuses on the special area of primary interest, 
where the instruments may be specific to the disease (e.g., cancer or heart disease), to a 
population of patients (e.g., children or elderly), to a certain function (e.g., sleeping or 
eating), or to a problem (e.g., pain) (Guyatt et al., 1993). Disease-specific measures are 
used to assess a specific population or disease, with the goal of measuring 
responsiveness or clinically important changes (Guyatt, Bombardier, & Tugwell, 1986; 
Patrick & Deyo, 1989). Selection of different measures depends on the research 
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objectives, patients’ characteristics, and applications of measures in clinical research, 
practice, or policy analysis (Patrick & Deyo, 1989). It is recommended that generic 
measures need supplementation with disease-specific measures to address positive and 
negative clinically important changes (Guyatt et al., 1986; Guyatt et al., 1993). 
 
2.3.3 Unidimensional vs. multidimensional 
The results of HRQOL measures can be reported either as a single composite score or 
as a profile score (Gill & Feinstein, 1994). Unidimensional measures use a single global 
question to present an overall HRQOL score (Ferrans, 2007). The single item asks 
patients to evaluate their overall QOL, for example the item in the Functional 
Assessment of Cancer Therapy-Generic (FACT-G; Cella et al., 1993) is “I am content 
with the quality of my life right now” and in the European Organisation for Research 
and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; Aaronson 
et al., 1993) is “How would you rate your overall quality of life during the past week?”. 
  However, HRQOL is inherently multidimensional (Muldoon et al., 1998). A domain 
or dimension refers to the area of behaviours or experience that researchers or 
physicians are trying to measure (Guyatt et al., 1993). Most HRQOL instruments 
measure each domain separately, by asking specific questions pertaining to its most 
important components (Testa & Simonson, 1996). These results can provide a health 
profile, which measures various aspects of health status, for example physical, 
psychological, and social functioning (Aaronson, 1988; Gill & Feinstein, 1994; Testa & 
Simonson, 1996). 
 
2.3.4 Self-report vs. proxy report 
The question arises about who should assess HRQOL. Sometimes researchers and 
physicians obtain HRQOL rating from proxies instead of patients, because of patients’ 
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physical conditions and time available. For example, terminally ill patients may be too 
weak to complete the instrument and children may be too young to understand the 
meaning of items. Therefore, the views from caregivers or relatives are useful to 
understand patients’ HRQOL. However, the debate here is whether proxy ratings can 
represent accurately patients’ HRQOL. 
For example, using the Sickness Impact Profile (Bergner, Bobbitt, Kressel, Pollard, 
Gilson, Morris et al., 1976) only moderate correlation (r=.55) between terminally ill 
patients (who still could complete the questionnaire) and close relatives, was obtained 
(McCusker & Stoddard, 1984). The relations between self and proxy reports varies 
depending on the domains of measurement and the relationships between proxy and 
patient (Guyatt et al., 1993). Typically, higher correlation is found between self and 
proxy report in physical functioning, but less in psychosocial aspects (Rothman, 
Hedrick, Bulcroft, Hickam, & Rubenstein, 1991). In general, it is recommended that 
HRQOL ratings are obtained from patients directly, and researchers and physicians 
should limit the inferences based on the ratings from proxies or caregivers (Guyatt et al., 
1993; Guyatt et al., 2007). 
 
2.3.5 Reliability 
Reliability refers to the stability and equivalence of repeated measures of the same 
concept (Patrick & Erickson, 1993). A reliable questionnaire is accurate over time 
(Davies, 2009). Generally, types of reliability for HRQOL measures include internal 
consistency, test-retest reliability, and inter-rater reliability (Eiser & Morse, 2001). 
Internal consistency refers to homogeneity of items, which is the extent to which the 
items of a domain or scale measure the same concept or construct. Cronbach’s alpha is 
the most widely used statistical test to assess internal consistency (Cronbach, 1951). 
Test-retest reliability refers to the stability of the measure over time, that two sets of 
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scores which are administered on different occasions are positively correlated (Davies, 
2009). Inter-rater reliability refers to the consistency of measures between different 
raters, which is normally assessed using the kappa statistic (Cohen, 1968). The 
minimum level of reliability depends on the type of analysis. In general, reliabilities in 
the .50-.70 range are acceptable for making comparisons between groups (Ware, 1984). 
 
2.3.6 Validity 
Validity is the extent to which a test measures the construct it purports to measure 
(Lohr et al., 1996), for example the questionnaires are measuring HRQOL rather than 
some other concept (Eiser & Morse, 2001). Types of validity include content validity, 
criterion validity, and construct validity. Content validity refers to judgments about the 
extent to which the content of the measure logically includes a full assessment of the 
characteristics or domains it is intended to measure (Eiser & Morse, 2001). Criterion 
validity is the extent to which a score corresponds to an accurate measure or a gold 
standard measure. Construct validity refers to the extent to which a measure is a good 
representation of the construct. The types of construct validity include convergent 
validity (a construct is related to (converges on) other constructs that it should also be 
similar to theoretically) and discriminant validity (a construct is not related to another 
construct which there is no theoretical relationship). Factor analysis, confirmatory factor 
analysis, and multitrait-multimethod modeling are used for establishing construct 
validity (Cronbach & Meehl, 1955). 
 
 
2.4 The importance of HRQOL 
HRQOL measures can be used to evaluate different methods of symptom 
management (Cella et al., 2007) and the effects of treatments (Osoba, 1999), by 
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incorporating with physical indices such as survival rates, response rates, and mortality 
rates. There are three reasons why researchers and physicians should focus on HRQOL. 
First, HRQOL is useful to understand patients’ point of view about disease and 
treatment. Second, there is value to understand the normal process of adjustment to 
cancer and treatment, and by implication, what is abnormal and when intervention is 
necessary. Third, HRQOL is an important consideration when comparing different 
treatments and evaluating interventions (Eiser, 2004a; Sajid et al., 2008).  
HRQOL measures can be one of several endpoints in clinical trials to help 
decision-making about the optimal treatment for patients and families (Feld, 1995; 
Kaasa, 1995; Kiebert, Curran, & Aaronson, 1998; Lipscomb et al., 2004; Roila & 
Cortesi, 2001). HRQOL measures can help to clarify the tradeoffs between treatments 
and interventions with major benefits and health-related outcome costs (Guyatt et al., 
2007). In particular, if the primary goal of treatment is to improve the way patients are 
feeling, it is imperative to measure HRQOL directly and use the results in clinical 
decision-making (Guyatt et al., 2007). More importantly, HRQOL assessment is 
changing medical care from a disease-centered approach to a patient-centered approach 
(Osoba, 1999), as well as addressing positive elements of life (Diener et al., 1999). 
 
In summary, assessment of patients’ experience about disease and treatment is now 
commonly agreed to be a central component of health care and healthcare research 
(Guyatt et al., 2007; Muldoon et al., 1998). HRQOL has become an important endpoint 
in medical care and clinical trials. Researchers should provide conceptual and 
operational definitions of HRQOL, as well as the specific domains of measurement 
(Gill & Feinstein, 1994; Smith, Avis et al., 1999). Moreover, the measures of HRQOL 
should consider the individual’s social and material contexts (Hunt, 1997). The meaning 
of HRQOL is arguably dependent on the user of the term, their understanding of it, and 
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their position and agenda in the social and political structure (Edlund & Tancredi, 1985). 
Based on the literatures reviewed in this chapter, I conclude that HRQOL is an 
integrative index which combines objective functioning and subjective well-being, and 
may be presented in health profile or multi-dimensional format. HRQOL rating should 
be assessed by patients directly. Individuals may simultaneously evaluate all dimensions 
to formulate the overall judgment; therefore, in the context of chronic disease, HRQOL 
is the appraisal outcome based on psychological functioning and to a lesser degree on 
physical functioning (Smith, Avis et al., 1999). It can be used as an outcome measure 
instead of pathology or underlying disease state (Lydick & Epstein, 1993). Measures of 
health outcome should incorporate both physical indices and the individual’s 
perspectives as a consequence of adjustment.  
In the next chapter, I will review the relevant studies about HRQOL in patients with 
HCC with aims to understand the HRQOL in this group and to determine the most 
appropriate measures for my research. 
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Chapter 3. HRQOL in Patients with HCC: A Systematic Review 
 
3.1 Abstract 
Aims: This systematic review was conducted to identify: (1) measures of HRQOL in 
patients with HCC; (2) differences in HRQOL between patients with HCC, chronic liver 
disease, and the general population; (3) effects of treatment (liver surgery; hepatic artery 
transcatheter treatment; and radiotherapy) on HRQOL; (4) relationships between 
physical variables, symptoms and HRQOL; (5) relationships between demographic 
characteristics, psychological variables and HRQOL; and (6) effects of psychological 
interventions on HRQOL.  
Methods: HRQOL and HCC relevant keywords were searched in computerized 
databases, including BNI (1985 to February 2009), CINAHL (1982 to February 2009), 
Cochrane library (1991 to February 2009), PsychoInfo (1806 to February Week 1 2009), 
and Pudmed (1950 to February 2009).  
Results: Thirty-six articles were identified. The results of the review are as follows. (1) 
The disease-specific concerns include pain, fatigue, nausea, jaundice, weight loss, and 
body image. (2) Patients with HCC had worse physical, emotional, and functional 
HRQOL; but better social/family HRQOL compared to the general population. (3) Liver 
surgery, hepatic artery transcatheter treatment and radiotherapy improved HRQOL. (4) 
Better liver function, early stage of disease, and no recurrence were positively correlated 
with better HRQOL; and pain, fatigue, nausea, and performance status were associated 
with worse HRQOL. (5) HRQOL was negatively correlated with depression, uncertainty, 
chance health locus of control, and positively with satisfaction with medical services. (6) 
Psychosocial interventions may reduce negative feelings and enhance HRQOL.  
Conclusions: Future work should explore the effects of psychological variables on 
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HRQOL and the interaction between physical and psychological variables in relation to 
HRQOL. 
 
 
3.2 Introduction  
Compromised HRQOL has been demonstrated in patients with liver disease such as 
cirrhosis or hepatitis virus (Marchesini et al., 2001; Spiegel et al., 2005). Patients with 
HCC would be expected to show impaired HRQOL because of severe symptoms, 
treatment and side effects, and burden of disease. HRQOL concerns in patients with 
HCC include generic domains, such as physical symptoms and psychological issues, 
and others unique to their disease (Heffernan et al., 2002; Weitzner et al., 1995). 
Therefore, the aims of the systematic review were to determine: 
(1) generic, cancer, and liver cancer-specific measures used in current studies to 
assess  HRQOL in patients with HCC;  
(2) differences in HRQOL between patients with HCC, patients with chronic liver 
disease, and the general population;  
(3) effects of treatments on HRQOL: liver surgery, hepatic artery transcatheter 
treatment, and radiotherapy;  
(4) relationships between physical variables, symptoms and HRQOL; 
(5) relationships between demographic characteristics, psychological variables and 
HRQOL; 
(6) effects of psychological interventions on HRQOL. 
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3.3 Methods 
3.3.1 Methods 
The following computerized databases were searched: BNI (British Nursing Index; 
1985 to February 2009), CINAHL (Cumulative Index to Nursing and Allied Health 
Literature; 1982 to February 2009), Cochrane library (1991 to February 2009), 
PsychoInfo (1806 to February Week 1 2009), and Pubmed (US Library of Medicine and 
National Institute of Health, 1950 to February 2009). Text word and Thesaurus terms 
were used to maximize identification of relevant articles. The following keywords were 
searched using Boolean logic: (1) liver cancer, cancer of liver, hepatic cancer, hepatic 
neoplasms, liver neoplasms, hepatocellular carcinoma, hepatoma, HCC; (2) quality of 
life, QOL, health-related quality of life, HRQOL, anxiety, depression, psychological 
well-being. Additional references cited in retrieved articles or relevant review articles 
were also obtained. 
 
3.3.2 Inclusion and exclusion criteria 
Articles were included which were: (1) published in English or Chinese in a peer 
reviewed journal; (2) included adults patients (age>18 years) with HCC; (3) focused on 
HRQOL or relationships between HRQOL and physical or psychological variables; (4) 
either qualitative or quantitative methodology. 
Exclusion criteria were: (1) literature review or case study; (2) samples including 
children or adolescents only; (3) samples involving heterogeneous populations: 
including various cancers or liver disease; (4) studies reporting findings not directly 
relevant to the core concepts of HRQOL; (5) measure of HRQOL based on the 
Karnofsky performance status scale (Schag, Heinrich, & Ganz, 1984) only. 
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3.3.3 Review procedure 
The systematic review was conducted following recommendations of the Center for 
Reviews and Dissemination (CRD) (NHS, 2001). The CRD includes 10 phases in three 
stages, and the details of process are presented in Table 3.1. In Chapter 1 and 2, I 
reviewed the physical aspects of HCC and the concept of HRQOL, which fulfill 
requirements of phase 0 in documenting the need for a review to understand HRQOL in 
patients with HCC. The review processes from phase 1 to 9 are described in Chapter 3. 
 
Table 3.1 The process of systematic review 
Stage Content Chapter 
Stage I Plan of the review  
phase 0 Identification of the need for a review Ch. 1 & 2
phase 1 Preparation of a proposal for a review Ch. 3 
phase 2 Development of a review protocol Ch. 3 
Stage II Conduct of the review  
phase 3 Identification of research Ch. 3 
phase 4 Selection of studies Ch. 3 
phase 5 Study quality assessment: determine methodological quality, 
bias, internal validity, and external validity 
Ch. 3 
phase 6 Data extraction and monitoring progress: extract 
bibliographic details, descriptions of design, study 
population, intervention, outcome measures, and results 
Ch. 3 
phase 7 Data synthesis: integrate results of the target studies, and 
meta-analyses should be conducted if appropriate 
Ch. 3 
Stage III Reporting and dissemination   
phase 8 Recommendations Ch. 3 
phase 9 Evidence into practice Ch. 3 
 
Abstracts were evaluated for relevance and full articles obtained where appropriate. A 
summary sheet was developed for extracting data. This included (1) aims; (2) 
methodology: qualitative or quantitative or mixed; longitudinal or cross-sectional; 
comparison group; randomization; (3) participants; (4) measure of HRQOL, physical 
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and psychological variables; (5) results. 
 
 
3.4 Results 
Two thousand four hundred and twenty-six articles were identified and abstracts 
obtained. Based on the defined eligibility criteria, 36 articles were selected for review 
(34 from electronic database searching and 2 from relevant citation). The key search 
terms are summarized in Table 3.2. 
 
Table 3.2 Key search terms and results 
 BNI CINAHL Cochrane 
library 
PsychoInfo Pubmed Total
1. liver cancer or cancer 
of liver or hepatic 
cancer or hepatic 
neoplasms or liver 
neoplasms or 
hepatocellular 
carcinoma or hepatoma 
or HCC 
13 1956 3129 136 158416  
2. quality of life or QOL 
or health-related quality 
of life or HRQOL or 
anxiety or depression 
or psychological 
well-being 
7791 78370 46331 224482 431249  
1 and 2 2 76 331 24 2182 2426
Target 1 12 5 5 28 34 
    (relevant citation)      2 
 
The 36 articles were conducted in Canada (n=1), China (n=7), France (n=2), Hong 
Kong (n=5), Italy (n=2), Japan (n=3), Nigeria (n=1), Taiwan (n=5), USA (n=9), and one 
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was an international study (Hong Kong, Taiwan, and the UK). Sixteen studies were 
longitudinal in design. Thirty-three used quantitative methods and three used mixed 
quantitative and qualitative methods. Four involved a randomized control trial. Of 36 
studies, 12 included comparison groups [chronic liver disease (n=5), general population 
(n=3), different treatments (n=5), and other cancer groups (n=2)]. In addition, two 
included reports from caregivers and physicians. Summaries of results are presented in 
Table 3.3. 
 
3.4.1 Aim 1: Measures of HRQOL in patients with HCC 
(1) Generic measures 
There were four generic HRQOL measures which were used in six studies, including 
the Short-Form 36 (SF-36; McHorney, Ware, & Raczek, 1993), World Health 
Organization Quality of Life assessment (WHOQOL; WHO group, 1995, 1998a, 1998b), 
Nottingham Health Profile (NHP; Hunt, McKenna, McEwen, Williams, & Papp, 1981), 
and Sickness Impact Profile (SIP; Bergner, Bobbitt, Kressel et al., 1976). The domains 
of HRQOL assessed, reliability/validity, and references are shown in Table 3.4.  
 
(2) Cancer specific measures 
There were five cancer specific HRQOL measures which were used in 24 studies. 
These included the FACT-G (Cella et al., 1993), EORTC QLQ-C30 (Aaronson et al., 
1993), Spitzer QOL index (Spitzer et al., 1981), Interdisciplinary Group for Cancer Care 
Evaluation in Italy (GIVIO) quality of life questionnaire (The GIVIO Investigators, 
1994), and Functional Living Index-Cancer (FLIC; Schipper, Clinch, McMurray, & 
Levitt, 1984) (see Table 3.4).  
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Table 3.3 The summary of studies in the review 
Author 
Year 
Country 
Aims  Research 
design  
1. quantitative, 
qualitative, mixed 
2. longitudinal, 
cross-sectional 
3. randomization 
Measures  Participants Age  
yr (SD 
or 
range) 
Results 
Aim 1: Measures of HRQOL in patients with HCC 
Blazeby 
et al. 
2004 
Hong 
Kong, 
Taiwan 
and the 
UK  
To develop a 
HRQOL 
questionnaire 
module in 
patients with 
HCC form 
Europe, Hong 
Kong and 
Taiwan. 
Mixed 
Cross-sectional
 European 
Organization 
for Research 
and Treatment 
of Cancer: 
EORTC-QLQ-
HCC18 
Phase 1:  
N=10, 
health-care 
professionals 
N=32, 
patients 
 
Phase 3:  
N=158 
patients 
 
 
 
 
60 
(29-77) 
 
 
58 
(35-83) 
 Phase 1: generation of HRQOL issues: 
literature review and semi-structured 
interview. Phase 2: production of the 
provisional questionnaire: consultation of the 
EORTC QOL group item database. Phase 3: 
pre-testing the questionnaire: testing 
acceptability and relevance 
 In phase 1, 29 HRQOL issues were suggested; 
in phase 2, 22 items were developed; in phase 
3, 18 items were formulated. 
 The scale contains fatigue (3 items), body 
image (2 items), jaundice (2 items), nutrition 
(5 items), pain (2 items), fevers (2 items), 
abdominal swelling (1 item), and sexual 
interest (1 item). 
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Heffernan 
et al. 
2002 
USA 
To develop the 
instrument to 
measure 
HRQOL in 
patients with 
hepatobiliary: 
the Functional 
Assessment of 
Cancer 
Therapy- 
hepatobiliary 
(FACT-Hep). 
Quantitative  
Cross-sectional
 
 The Functional 
Assessment of 
Cancer 
Therapy- 
Generic 
(FACT-G) 
 The Functional 
Assessment of 
Cancer 
Therapy- 
hepatobiliary 
(FACT-Hep) 
 The Profile of 
Mood States– 
Short Form 
(POMSSF) 
N=30, sample 
1 item- 
generation 
(HCC: 2) 
 
N=51, sample 
2 validation 
(HCC: 10) 
 
64  
(10.40, 
39-81) 
 
 
61.50 
(9.60, 
40-80) 
 Phase 1: item generation; Phase 2: item 
reduction; Phase 3: scale construction; Phase 
4: initial reliability and validity testing. 
 The FACT-Hep had 18 items to measure 
disease-related symptoms and functioning.  
 The scale had good reliability (Cronbach’ α 
=.72-.93/.82-.94; test-retest=.84-.91) and 
convergent- divergent validity (high 
correlation with FACT-G and trial outcome 
index; no correlation with social desirability) 
Steel & 
Geller et 
al.  
2005a 
USA 
To assess 
consistency of 
ratings of 
HRQOL 
between 
patients with 
HCC, family 
Quantitative  
Longitudinal 
(baseline, 3, 6, 
months) 
 
 
 FACT-G & 
Hep 
 
 
N=82, 
patients, 
caregivers, 
and 
physicians 
59 
(30-86) 
 The patients’ rating of HRQOL improved at 
three months (higher than baseline) but 
decreased at six months (lower than baseline). 
 At baseline, the patients and family were 
consistent on all subscales except for 
emotional well-being, but the patients and 
oncologists were only consistent on physical 
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caregivers, 
and oncologist 
care providers. 
well-being. 
 At three months, the patients, family, and 
oncologists were consistent on all subscale 
except for social/family well-being; at six 
months, the patients and family were 
consistent on physical, functional well-being 
and additional concerns. 
 The proxies tend to agree with patients on 
physical and functional well-being, but 
underestimate on emotional and social/family 
well-being. 
Wan et al. 
1998 
China 
To develop a 
self- 
administered 
HRQOL 
instrument for 
patients with 
liver cancer. 
Quantitative 
Cross-sectional
 
 Quality of life 
for liver cancer 
(QOL-LC) 
N=105 --  Phase 1: generation of HRQOL issues in 
patients with liver cancer. Phase 2: selection of 
items. Phase 3: testing reliability and validity. 
 The scale includes physical, psychological, 
symptom/ side effect, and social domains; the 
test-retest reliability were .76, .96, .71, .80, 
and the Cronbach’α were .78, .81, .75, .68. 
 The criterion validity with the functional 
living index-cancer (FLIC) and SF-36 
were .76 and .65. 
Yount et 
al. 
To develop 
and validate a 
Quantitative 
Cross-sectional
 FACT-G & 
Hep 
N=95, 
hepatobiliary 
 
 
 Phase 1: collection the candidate FHSI item. 
Phase 2: experts selection. Phase 3: 
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2002 
USA 
symptom 
index derived 
from the 
FACT-Hep: 
FACT- 
Hepatobiliary 
Symptom 
Index-8 
(FHSI-8). 
  POMS 
 Eastern 
Cooperative 
Oncology 
Group 
Performance 
Status (ECOG)
cancer experts 
 
N=51, 
hepatobiliary 
cancer 
patients 
(HCC: 10) 
 
 
61.50 
(9.60, 
40-80) 
psychometric testing. 
 The Cronbach’α was .79 and test-retest 
correlation was .86. The FHSI-8 was 
associated with other subscale of FACT and 
mood, and patient differentiation by ECOG 
and treatment. 
 The eight items included 3 pain, 2 fatigue, 
nausea, weight loss, and jaundice. 
Zhu et al. 
2008 
China 
To evaluate 
the 
effectiveness 
of FACT-Hep 
Chinese 
version. 
Quantitative  
Cross-sectional
 
 FACT-G & 
Hep 
N=180 52.34 
(10.73) 
 The Cronbach’s α were .42 (social)-.84 and 
test-retest correlations were .33 (social)-.81. 
 There were significant differences in the 
FACT-Hep between different stages or 
Child-Pugh classes. 
Aim 2: Comparison of HRQOL in HCC, chronic liver disease and the general population 
Bianchi et 
al. 
2003 
Italy 
To assess 
HRQOL in 
cirrhotic 
patients with 
HCC. 
Quantitative  
Cross-sectional
 Short Form-36 
(SF-36) 
 Nottingham 
Health Profile 
(NHP) 
N=101 
 
 
N=202, 
matched 
patients with 
cirrhosis 
66 
(41-87) 
 
66 
(41-86) 
 Compared with normative population, patients 
with HCC had a significant impairment in 
energy, sleep, physical mobility, and pain 
(NHP); and physical functioning, role 
limitation-physical, bodily pain, general 
health, role limitation-emotional, vitality, 
mental health, and social functioning (SF-36). 
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 Compared with patients with cirrhosis, 
patients with HCC had more pain and less 
social isolation (NHP); and more role 
limitation-physical and bodily pain (SF-36). 
Patients with HCC had a main impairment in 
physical component summary instead of 
mental component summary. 
 Sleep disorder was strongly related to poor 
HRQOL, that a third of the patients with HCC 
(34%) had difficulty in falling asleep, 28% had 
woken up very early in the morning, and 39% 
reported waking up several times during the 
night for problems severely disturbing sleep 
(muscle cramps, use of diuretics, etc.). 
Kondo et 
al. 
2007 
Japan 
To evaluate 
the influence 
of HCC on 
HRQOL. 
Quantitative 
Cross-sectional
 
 SF-36, 
Japanese 
version 
 
N=97, treated 
successfully 
with 
percutaneous 
ablation 
therapy 
 
N=97, with 
chronic liver 
68.50 
(7.80) 
 
 
 
 
 
68.20 
(7.40) 
 Both patients with chronic liver disease and 
HCC had low HRQOL than age and 
sex-matched general population in role 
limitation-physical, general health, role 
limitation-emotional, vitality, mental health, 
and social functioning. 
 There was no significant difference in all eight 
subscales of SF-36 between patients with HCC 
and chronic liver disease. However, patients 
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disease 
without HCC, 
matched for 
age and sex 
with HCC had a significantly lower physical 
component summary score than comparison 
group. 
 The significant predictors of impaired physical 
component summary were older age, higher 
serum bilirubin, and lower serum albumin 
level; the predictor of impaired mental 
component summary was lower serum 
albumin level. 
 In HCC, liver function predicted HRQOL 
strongly, but status of HCC (recurrence or not, 
time period of treatment) did not. 
Lee et al. 
2007 
Taiwan 
To evaluate 
HRQOL in 
patients with 
HCC. 
Quantitative 
Cross-sectional
 
 World Health 
Organization 
(WHO) 
QOL-BREF 
Taiwan version
 EORTC-QLQ-
C30 
 Utility: visual 
analogue scale 
and standard 
gamble method
N=161 61.60 
(12.40) 
 Compared with normative population, the 
patients with HCC had significant lower 
HRQOL in physical domain, but higher in 
environmental domain (adjustment for gender 
and age). 
 Duration of HCC more than one year was 
associated with better HRQOL. 
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Steel & 
Chopra et 
al. 
2007a 
USA 
To evaluate 
the differences 
in HRQOL 
between 
patients with 
HCC, patients 
with chronic 
liver cancer 
(CLD), and 
general 
population. 
Quantitative 
Cross-sectional
 
 FACT-G & 
Hep 
N=83, HCC 
 
 
N=51, CLD 
 
 
N=138, 
general 
population 
58 
(18-83) 
 
54 
(32-79) 
 
40 
(18-84) 
 The patients with HCC had worse physical 
well-being and overall HRQOL than the 
patients with CLD, and they reported greater 
weight loss, difficulties digesting food, loss of 
appetite, and decreased ability to perform 
usual activities. 
 The patients with HCC had worse physical, 
emotional, functional well-being, 
hepatobiliary symptoms, and overall HRQOL 
than the general population but they had better 
social/family well-being. 
 The patients with CLD had worse physical, 
functional well-being, hepatobiliary 
symptoms, and overall HRQOL than the 
general population, but they had better 
social/family well-being. 
 The Child’s Pugh score was positively 
associated with HRQOL. 
Aim 3: Effects of treatment on HRQOL 
Boudet et 
al.  
1995 
France 
To assess 
HRQOL of 
cancer 
patients 
Quantitative 
Cross-sectional
 Sickness 
Impact Profile 
(SIP) 
 Side-effects of 
N=29, 
patients 
grafted for 
liver tumours 
45 (10, 
20-62) 
 
 
 The 2-year survival rate of the cancer patients 
was 34%, lower than the comparison group; 
56% of cancer patients retuned to work. 
 Regarding HRQOL, there was no significant 
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receiving 
orthotopic 
liver 
transplantation
. 
immuno- 
suppression, 
constraints of 
follow up 
(frequency of 
outpatient visits 
or 
readmissions), 
return to work. 
 
N=111, 
patients 
grafted for 
nonmalignant 
liver disease  
 difference between two groups, and 70% of 
cancer patients claimed to live a normal life 
after liver transplantation. 
 There was a high rate of tumour recurrence, 
and a high mortality in patients with malignant 
liver disease. However, among the disease-free 
long-term survivors, the HRQOL of patients 
transplanted for cancer was similar to that of 
patients grafted for other indications. 
Chen et 
al. 
2004 
China 
To evaluate 
the pre- and 
postoperative 
HRQOL in 
patients with 
liver cancer. 
Quantitative  
Longitudinal 
(pre-operation, 
2,5,10 weeks, 
4,6,9 months, 
1,1.5,2 years) 
 
 Gastrointestinal 
quality of life 
index (GQLI)  
N=36, liver 
cancer 
patients 
treated 
surgically 
50 
(42-72) 
 The HRQOL was reduced significantly 2-10 
weeks after the liver operation, but it 
recovered gradually. 
 After operation four months, the HRQOL 
increased to the preoperative level, and after 
nine months the HRQOL was higher than that 
before the operation. 
 Major hepatectomy (lobectomy and combined 
segmentectomy) reduced more HRQOL than 
minor hepatectomy (simple segmentectomy). 
Ganageri 
et al. 
2002 
Italy 
To describe 
the 
psychological 
and social 
Mixed  
Cross-sectional
 
 Quantitative: 
the 
Interdisciplinary 
Group for 
N=80, referral 
for liver 
transplantation 
Median:
54 
(inter- 
quartile 
 The candidates had a good level of HRQOL 
assessed by GIVIO and a low prevalence in 
the personality disorder scales detected by the 
MMPI. 
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conditions of 
liver 
transplant 
candidates and 
to explore the 
meaning that 
these patients 
attribute to 
those 
conditions. 
Cancer Care 
Evaluation in 
Italy (GIVIO) 
 The Need 
Evaluation 
Questionnaire 
(NEQ) 
 the Minnesota 
Multiphasic 
Personality 
Inventory 
(MMPI)  
 Structured 
interview 
range: 
46-57) 
 The major need was information about 
patients’ examinations, therapies, and future 
conditions. 
 The main support was form spouse or partner, 
and time spent waiting and possible 
difficulties after the operation may cause a sort 
of physical and psychological dependence. 
 Overall, candidates had more a psychological 
impact than a physical impact, characterized 
by anxiety, worry, and irritability. 
 
Poon et 
al.  
2001 
Hong 
Kong 
To evaluate 
the HRQOL 
of patients 
undergoing 
resection of 
HCC. 
Quantitative 
Longitudinal 
(before surgery 
and at 3, 6, 9, 
12, 18, 24 
months after 
surgery) 
 
 
 FACT-G N=66, 
received 
hepatic 
resection 
 
N=10, with 
unresectable 
HCC and 
received 
52.80 
(11, 
19-75) 
 
 
61.10 
(8.10, 
51-77) 
 After surgery three months, there were 
significant improvements in overall HRQOL, 
physical, emotional, social well-being, and the 
relationship with physician. The most 
remarkable improvement was physical 
well-being. 
 In patients with unresectable HCC, there was 
no significant difference in overall HRQOL 
and sub scales between baseline and three 
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TACE months later. 
 In the baseline, two groups had similar level of 
overall HRQOL, but after three months, 
patients received resection had a significant 
higher overall HRQOL than the control group. 
 All post-resection overall HRQOL scores were 
higher than the scores before resection. The 
patients received resection were divided into 
with and without recurrence groups. There was 
no significant changes in overall HRQOL 
score of patients without recurrence during 
2-years follow up, however, there was a 
significant decrease in patients with 
recurrence. 
Shun et 
al. 
2008 
Taiwan 
To explore the 
changes and 
factors related 
to HRQOL in 
liver cancer 
patients 
receiving 
stereotactic 
radiation 
Quantitative 
Longitudinal 
(1 week before 
SRT and the 
each week 
during the first 
six weeks of 
SRT: T0-T6) 
 
 The functional 
living 
index-cancer 
(FLIC) 
 Symptom 
severity scale 
(SSS)  
 POMSSF- 
depression 
N=99 62.42 
(12.60) 
 The HRQOL increased slightly but not 
significantly during SRT, and depression 
decreased at T3 but increased at T6. However, 
the symptom severity increased and reached 
their peaks at T5. 
 Regarding predictors, patients with poor 
functional status, more severe levels of 
depression or symptoms, lower levels of 
albumin had lower HRQOL. 
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therapy (SRT).  subscale 
 ECOG 
 Furthermore, when controlling for the effects 
of depression, functional status, albumin level, 
and time effect, the most important symptoms 
to predict changes in HRQOL were fatigue, 
pain, and nausea. 
Steel & 
Baum et 
al. 
2004 
USA 
To test the 
differences in 
HRQOL and 
survival 
between 
patients with 
HCC 
receiving 
hepatic 
arterial 
infusion 
(HAI) of 
Cisplatin and 
90-Yttrium 
microspheres. 
Quantitative  
Longitudinal 
(pre-treatment, 
3, 6, 12 
months) 
 
 
 FACT-G & 
Hep 
N=14, 
received 
90-Yttrium 
microspheres 
 
N=14, 
received 
Cisplatin 
56 
(18-80) 
 
 
 
62 
(38-83) 
 At baseline, the patients received Cisplatin had 
significant higher functional well-being and 
HRQOL than the patients received 90-Yttrium 
microspheres. 
 At three months, the patients received 
90-Yttrium microspheres had significant 
higher functional well-being and HRQOL.  
 At six months, the patients received 
90-Yttrium microspheres only had significant 
higher functional well-being. 
 Patients received different treatments had a 
similar survival. 
Steel & 
Eton et al. 
2006 
To test the 
reliability, 
sensitivity to 
Quantitative 
Longitudinal 
(pre-treatment, 
 FACT-G & 
Hep 
 the FACT- 
N=158 64 
(22-90) 
 All the measures at three months’ follow up 
were lower than the baseline measures. 
However, the overall HRQOL, FACT-Hep, 
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USA change in 
biomarkers 
associated 
with disease 
progression 
and response 
to treatment, 
and clinical 
meaningfulness 
of the 
FACT-Hep in 
patients with 
hepatobiliary 
carcinoma. 
3, 6 months 
follow up) 
 
 
Hepatobiliary 
Symptom 
Index (FHSI)  
and trial outcome index at six months were 
significantly higher than these at three months, 
but not return to the baseline. 
 The minimally important differences (MIDs) 
in FACT-Hep for clinically meaningful 
application: FACT-G subscales = 2-3; 
FACT-G = 6-7; Hepatobiliary Cancer 
Subscale = 5-6; FACT-Hep = 8-9; Trial 
Outcome Index = 7-8; and FHSI = 2-3 points. 
Sun et al. 
2008 
Canada 
To describe 
the symptom 
concerns of 
patients with 
HCC and 
pancreatic 
cancer, and to 
explore the 
effect of 
Quantitative  
Longitudinal 
(baseline, 1, 2, 
3 months) 
 
 
 
 FACT-G & 
Hep 
 The functional 
assessment of 
chronic illness 
therapy- 
spirituality 
subscale 
(FACIT-Sp-12)
N=22, HCC 
 
N=23, 
pancreatic 
cancer 
59  Patients with HCC had significantly lower 
scores in overall HRQOL, physical 
well-being, disease-specific symptoms, and 
spiritual well-being than patients with 
pancreatic cancer. 
 Disease-specific symptoms were highly 
correlated with physical well-being, functional 
well-being, and overall FACT-Hep scores. 
 The spiritual well-being in patients with HCC 
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symptoms on 
HRQOL. 
at baseline was significantly higher than the 
other three time points. 
Tanabe et 
al. 
2001 
Japan 
To explore 
prognostic 
factors and 
HRQOL in 
patients with 
tumor 
recurrence 
after hepatic 
resection for 
HCC. 
Quantitative 
Cross-sectional
 
 
 The quality of 
life 
questionnaire, 
Japan version 
N=188, 
received 
curative 
resection 
60.80 
(21-80) 
 65.43% of patients had recurrence. 
Unfavorable predictors after recurrence were 
pTNM Stage III/IV at initial surgery, receiving 
chemotherapy before initial surgery and 
presence of extrahepatic recurrence. 
 The incidence of deteriorated performance 
status in the repeat resection group was lower 
than in the TACE group because of better 
psychological function in patients undergoing 
resection. 
Wang et 
al. 
2005 
China 
To evaluate 
the HRQOL 
of patient with 
HCC treated 
with 
radiofrequency 
ablation 
(RFA), and 
compared 
with that of 
patients 
Quantitative  
Cross-sectional
 
 QOL-LC N=80, RFA 
 
N=40, TACE 
 
N=40, 
TACE-RFA 
50% 
patients 
between 
50-70 
yrs 
 The RFA and TACE-RFA groups had 
significant higher scores in overall HRQOL 
and symptom/side effect domain than the 
TACE group. 
 Age, income, liver function, tumour 
recurrence, and complication were related to 
the HRQOL after treatment. 
 The RFA group had higher 1- 2- 3-years 
survival rates and less liver function damage, 
complications, and recurrences than the TACE 
group. 
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treated with 
TACE or 
TACE-RFA 
Wang et 
al. 
2007 
China 
To examine 
the impact of 
TACE alone 
and that of the 
TACE 
followed by 
RFA on 
HRQOL in 
patients with 
HCC. 
Quantitative 
Longitudinal 
(baseline and 3 
months) 
 
Randomization
 FACT-G N=40, TACE 
 
N=43, 
TACE-RFA 
--  At baseline, there was no difference in 
HRQOL scores between the TACE group and 
the TACE-RFA group. At three months, the 
TACE-RFA group had a significantly higher 
overall HRQOL, functional, and social/family 
score. 
 Child-Pugh Class and tumour recurrence after 
treatment were significant predictors of 
post-treatment HRQOL. 
Aim 4: Relationships between physical variables, symptoms and HRQOL 
Bonnetain 
et al. 
2008 
France 
To assess 
HRQOL as a 
prognostic 
factor of 
overall 
survival and to 
determine 
whether 
HRQOL 
Quantitative 
Cross-sectional
 
 Spitzer QOL 
index 
 
N=538 62.64% 
patients 
≧ 65yr 
 The HRQOL was a strong and independent 
prognostic factor of overall survival time for 
patients with HCC following mainly alcohol 
cirrhosis, and HRQOL can improve the 
discriminating power of the staging systems. 
 In order to improve survival time, the 
therapeutic goal could be to preserve or 
improve HRQOL by controlling impact of 
disease on physical and emotional functioning. 
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improved 
three 
prognostic 
classifications 
among 
patients with 
HCC. 
Fielding 
et al. 
2007 
Hong 
Kong 
To examine 
whether 
HRQOL 
predict 
survival 
among 
Chinese 
patients with 
liver and lung 
cancer.  
Quantitative  
Longitudinal 
(first 
outpatient visit 
and after 1.53 
& 1.95 
months) 
 
 FACT-G  
 Visual 
analogue: 
eating ability, 
eating appetite, 
eating 
enjoyment, 
self-care 
ability, and 
current health 
perception. 
N=176, liver 
cancer 
 
N=358, lung 
cancer 
57.34 
(12.76) 
 
64.81 
(10.28) 
 The HRQOL, overall or subscale, did not 
predict the overall survival in patients with 
liver cancer. 
 Less advanced cancer stage and better eating 
appetite were significantly associated with 
longer survival in patients with liver cancer. 
Lai et al. 
2007 
Taiwan 
To explore the 
relationship 
between 
uncertainty 
and HRQOL, 
Quantitative  
Cross-sectional
 
 FACT-G & 
Hep 
 The Mishel 
Uncertainty in 
Illness Scale 
N=110 62.07  Regarding uncertainty, the first uncertainties 
were about the prognosis, future, and 
symptoms. 
 There was negative correlation between 
uncertainty and HRQOL. 
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and to find the 
predictors of 
HRQOL in 
patients with 
liver cancer. 
  The significant predictors of HRQOL were 
uncertainty, Child-Pugh classification, pain, 
and gender that these factors accounted for 
44% of variance in HRQOL. 
Otegbayo 
et al. 
2005 
Nigeria 
To evaluate 
the HRQOL in 
patients with 
primary liver 
cell carcinoma 
in Nigeria. 
Quantitative  
Cross-sectional 
 
 WHOQOL, 
including body 
pains, energy 
and 
acceptability of 
bodily 
appearance 
N=34 49.60 
(13.40, 
23-74) 
 70% of patients rated their HRQOL as very 
poor, poor, neither poor nor good; and 85% 
were dissatisfied with their health. 
 82% of patients reported pain from moderate 
to extreme extent; and 50% didn’t have 
enough energy to do daily activities; and 
61.7% reported their bodily appearance 
unacceptable to them. 
Steel & 
Hess et 
al. 
2005b 
USA 
To assess the 
rates of sexual 
dysfunction in 
patients with 
HCC and the 
relationships 
between 
sexual 
dysfunction 
and HRQOL. 
Quantitative 
Cross-sectional
 
 FACT-G & 
Hep 
 The Sexual 
Functioning 
Questionnaire 
N=21, HCC 
 
 
N=23, CLD 
65 
(41-82) 
 
54 
(40-79) 
 Regarding the prevalence of sexual 
dysfunction in patients with HCC, the rate for 
hypoactive sexual desire disorder was 5.3%, 
male erectile disorder was 5.6%, premature 
ejaculation was 5.6%, and dyspareunia was 
5.9%. In patients with CLD, 16% was male 
erectile disorder and 5% was premature 
ejaculation and dyspareunia. 
 Compared with general population, patients 
with HCC had higher rates in hypoactive 
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sexual desire disorder and male erectile 
disorder, but a lower rate in premature 
ejaculation. 
 Compared with patients with CLD, patients 
with HCC had higher rates in hypoactive 
sexual desire disorder, sexual aversion 
disorder, male orgasmic disorder, premature 
ejaculation, and dyspareunia; but a lower rate 
in male erectile disorder. 
 Patients with HCC who reported increased 
rates of sexual problems had poorer HRQOL, 
especially in physical well-being. 
Ueno et 
al. 
2002 
Japan 
To explore the 
risk factors 
most affecting 
impaired 
HRQOL after 
partial 
hepatectomy 
in patients 
with HCC 
Quantitative 
Cross-sectional
 
 
 The quality of 
life 
questionnaire, 
Japan version 
N=96, 
received 
curative 
resection 
60.60 
(40-76) 
 The patients were divided by two groups 
based on HRQOL score: those with preserved 
HRQOL and those with impaired HRQOL 
(cut-point: 22). 
 The HRQOL after hepatectomy in patients 
with HCC was impaired in cases of aged 
patients, treatment for recurrence, and change 
of the serum cholinesterase level into 
unfavorable range. 
Wong et 
al. 
To assess the 
impact of 
Quantitative 
Longitudinal 
 FACT-G 
 Eating 
N=235, liver 
caner 
55.94 
(13.53) 
 Patients with liver cancer reported lower 
scores in overall HRQOL, physical, 
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2008 
Hong 
Kong 
eating ability 
on HRQOL in 
Chinese 
patients with 
breast, liver 
lung, or 
nasopharynge
al carcinoma. 
(baseline and 
1.95, 1.57 
months) 
 
 
function: eating 
ability, eating 
appetite, eating 
enjoyment 
 Pain rating 
(Visual 
Analogue) 
 Depression 
(single item) 
 
N=250, breast 
cancer 
 
N=334, lung 
cancer 
 
N=242, 
nasopharynge
al cancer 
functional, emotional, eating appetite, and 
depression than patients with nasopharyngeal 
cancer. 
 After controlling for socio-demographic and 
medical variables, pain, depression, and eating 
function significantly predicted overall 
HRQOL, physical, and functional well-being 
over time (all cancer). 
 Patients with liver cancer had a slight 
decreased score in eating appetite, ability, and 
enjoyment. 
Wong et 
al. 
2008 
Hong 
Kong 
To examine 
the 
longitudinal 
course of the 
relationship 
between 
patients’ 
satisfaction 
and HRQOL 
in Chinese 
patients with 
lung and liver 
Quantitative 
Longitudinal 
(baseline and 
1.95, 1.57 
months) 
 
 
 FACT-G 
 The nine-item 
Chinese patient 
satisfaction 
questionnaire 
(ChPSQ-9) 
 The cognitive 
subscale of 
Medical 
Interview 
Satisfaction 
Scale 
N=235, liver 
cancer 
 
N=334, lung 
cancer 
56.61 
(12.65) 
 
64.66 
(10.60) 
 There were no differences in HRQOL, patient 
satisfaction, and psychosocial measures 
between the two cancer groups. 
 The MISS-cog didn’t predict HRQOL, but all 
psychosocial factors emerged as covariate of 
the ChPSQ-9 in predicting HRQOL. After 
controlling for socio-demographic and 
psychosocial variables, only ChPSQ-9 
predicted HRQOL. 
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cancer. (MISS-cog) 
 The single item 
visual analogue 
to assess eating 
appetite, 
optimism, and 
depression 
Yeo et al. 
2006 
Hong 
Kong 
To evaluate 
whether 
HRQOL is 
predictive of 
survival for 
patients with 
unresectable 
HCC. 
Quantitative  
Cross-sectional
 
 EORTC-QLQ-
C30 
N=233 57 
(16-80) 
 A better score in physical, role, cognitive, 
social functioning and global HRQOL were 
significantly correlated with longer survival; a 
worse score in fatigue, nausea, pain, appetite, 
and constipation were significantly correlated 
with shorter survival. 
 Combining clinical variables and HRQOL in 
multivariate analysis, advanced staging, high 
baseline total bilirubin, and worse appetite 
were independent predictors of shorter 
survival. 
Zhao et 
al. 
2002 
China 
To evaluate 
the HRQOL in 
patients with 
HCC 
undergoing 
Quantitative 
Longitudinal 
(baseline, 1 & 
3 months) 
 
 QOL-LC N=175 51.30 
(16.6) 
 The HRQOL at one and three months were 
significantly higher than that at baseline, 
especially physical and symptom scale. 
 The significant predictors of HRQOL included 
tumour stage, liver function, superselective 
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interventional 
therapy. 
 catheterization or not, chemoembolization or 
not, and number of interventional therapy. 
 Three types of HRQOL change were 
identified: (1) descending to recovering, (2) 
constantly ascending, and (3) ascending to 
descending. 
Aim 5: Relationships between demographic characteristics, psychological variables and HRQOL 
Steel & 
Gamblin 
et al. 
2008 
USA 
To explore the 
post-traumatic 
growth in 
patients with 
primary or 
metastatic 
hepatobiliary 
cancer. 
Mixed  
Longitudinal 
(baseline, 3, 6 
months) 
 
 
 FACT-G & 
Hep 
 The post- 
traumatic 
growth 
inventory 
(PTGI) 
 The Center for 
epidemiological 
studies- 
Depression 
(CES-D) 
 Qualitative 
questions: have 
you changed 
your life in any 
N=120 
 
N=40, 
caregivers at 3 
months 
63 
(30-86) 
 70% of patients reported positive and negative 
changes occurring at the time of diagnosis, and 
19% reported the changes when they 
experienced symptoms. 
 In the qualitative data, patients also reported 
the changes in health behaviours and the 
meaning or philosophy of life. 
 The total and subscale scores of PTGI were 
not associated with the scores of FACT-Hep 
and CES-D. 
 The patients with both positive and negative 
changes reported poor physical well-being, 
poor HRQOL, and higher depression than the 
patients with only negative or no changes. 
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way as a result 
of being 
diagnosed with 
cancer? If yes, 
how? 
Tsai et al. 
2007 
Taiwan 
To explore the 
HRQOL of 
liver cancer 
patients and 
the factors 
correlated 
with the 
HRQOL. 
Quantitative  
Cross-sectional
 The chronic 
liver disease 
quality of life 
questionnaire: 
physical, 
emotional, 
social, and 
sexual 
relationship 
 The chronic 
liver disease 
social support 
questionnaire 
 The 
multidimension
al health locus 
of control scale
(all self-developed) 
N=58 37.9% 
were 
51-60 
yrs 
 The worst aspect of HRQOL was physical 
well-being and the best aspect was social 
well-being. 
 There was a positive correlation between 
health locus control and HRQOL. 
 There was no statistically significant 
correlation between social support and 
HRQOL. 
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Aim 6: Effects of psychological interventions on HRQOL 
Guo. 
2005 
China 
To investigate 
the effects of 
emotional 
intervention 
and Chinese 
medicated diet 
therapy on 
emotion and 
HRQOL in 
patients with 
primary liver 
carcinoma 
after hepatic 
arterial 
chemo- 
embolization 
(HACE). 
Quantitative 
Longitudinal 
(baseline, 2 
months) 
 
Randomization 
 EORTC-QLQ-
C30 
N=47, 
intervention 
group 
 
N=47, control 
group 
53 
(36-69) 
 The intervention included psychoeducational 
course, relaxation training, exercise, and 
Chinese medicated diet. 
 After intervention, the liver biological indexes 
of theintervention group including the levels 
of glutamic pyruvic transaminase, glutamic 
oxalacetic transaminase, alkaline phosphatase, 
lactic dehydrogenase, r-glutamyl 
transpeptidase, total bilirubin in serum and 
bile, and direct bilirubin were significantly 
different from those in the control group.  
 The symptoms such as tiredness, nausea, 
emesis, anorexia and general healthy status 
were significantly improved in the 
intervention group after treatment than before 
treatment. 
Lin et al. 
1998 
Taiwan 
To investigate 
the effect of a 
combination 
of health 
education, 
Quantitative 
Longitudinal 
(baseline, 2, 4, 
6, 7 days) 
 
 The knowledge 
questionnaire 
 The worry 
inventory 
 The physical 
N=20, 
experimental 
group 
 
N=20, control 
57 (12)  Before experiment, there were no differences 
in demographic data, knowledge, worry, 
physical distress, and anxiety.  
 After experiment, the knowledge score 
increased and worry score decreased in the 
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muscle 
relaxation, and 
back massage 
on reducing 
stress in 
patients with 
HCC received 
TAE. 
Randomization distress scale 
 The state-trait 
anxiety 
inventory 
(STAI) 
group experiment group.  
 After TAE, the experimental group decreased 
anxiety level but the control group increased. 
In addition, the experimental group decreased 
physical distress more rapidly than the control 
group. 
Steel & 
Nadeau et 
al. 
2007b 
USA 
To evaluate 
the benefits of 
individually 
tailored 
psychosocial 
intervention 
on patients 
with advanced 
hepatobiliary 
carcinoma. 
Quantitative  
Longitudinal 
(baseline and 3 
months) 
 
Randomization
 FACT-G & 
Hep 
 CES-D 
 STAI 
N=14, 
intervention 
group 
 
N=14, 
attention- 
standard of 
care 
67 
(39-84) 
 The patients in the intervention had clinically, 
but not statistically, significant improvements 
on symptoms of depression and anxiety, 
disease-related symptoms and treatment side 
effects, HRQOL. 
 The patients in the intervention group also 
showed modest improvements in peripheral 
blood leukocytes and survival when compared 
with the standard of care group. 
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Table 3.4 The domains, reliability/validity, and references of the standardized questionnaires used to measure HRQOL in patients with HCC 
Title  No. of 
studies
Domain  Reliability/ validity Reference 
The generic measure 
Short Form 36 
(SF-36) 
2 Physical health: 
Physical functioning 
Role limitation- physical 
Bodily pain 
General health 
Mental health: 
　 Role limitation- emotional 
Vitality 
Mental health 
Social functioning 
 36 items 
 Most reliabilities of all subscale>0.8. 
 Content validity, construct validity (principal 
component factor analysis), and discriminant 
validity (groups with different physical/ mental 
health status and severity) were assessed. 
 http://www.sf-36.org/ 
McHorney, Ware, & 
Raczek, 1993; Ware, 
2000; Ware & 
Sherbourne, 1992 
World Health 
Organization 
Quality of Life 
Assessment 
(WHOQOL) 
2 Physical domain 
Psychological domain 
Social domain 
Environmental domain 
 100 items; BREF: 28 items 
 Cronbach's α= .73 -.85; Test-retest reliabilities 
=.66-.87. 
 Discriminant validity (healthy and unhealthy 
individuals) and construct validity (confirmatory 
factor analysis) were assessed. 
WHO group, 1995, 
1998a, 1998b; 
Skevington, Lotfy, & 
O'Connell, 2004 
Nottingham Health 
Profile (NHP) 
1 Part 1: six domains of distress:  
Energy 
 Test-retest reliabilities = .77-.85. 
 Construct validity and criterion-related validity 
Anderson, Aaronson, 
& Wilkin, 1993; 
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Sleep 
Pain 
Emotional reactions 
Social isolation 
Physical mobility. 
Part 2: disease effects on daily activities:  
Work 
Home maintenance 
Social life 
Home life 
Sexual life 
Hobbies 
Holidays 
(correlation with SF-36 and SIP) were assessed. Hunt, McKenna, 
McEwen, Williams, 
& Papp, 1981 
Sickness Impact 
Profile (SIP) 
1 Social interaction 
Communication 
Alertness 
Emotional behaviour 
Body care 
Mobility 
Ambulation 
Work 
Eating 
Sleep 
 Test-retest reliabilities = .62-.90. 
 Discriminated validity (dysfunction and severity of 
illness) and clinical validity (disease specific 
measures: osteoarthritis, rheumatoid arthritis, and 
hip replacement) were assessed. 
Bergner, Bobbitt, 
Kressel et al., 1976; 
Bergner, Bobbitt, 
Pollard, Martin, & 
Gilson, 1976; 
Pollard, Bobbitt, 
Bergner, Martin, & 
Gilson, 1976 
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Home management 
Reaction 
The cancer specific measures 
Functional 
Assessment of 
Cancer Therapy- 
generic (FACT-G)
17 Physical well-being 
Emotional well-being 
Functional well-being 
Social and family well-being 
 27 items. 
 Test-retest reliabilities=.72-.92.  
 Criterion-related validity (correlation with SF-36 
and ECOG performance status), convergent and 
divergent validity (mood, interpersonal support, and 
social desirability) and discriminant validity 
(different treatment groups) were assessed. 
 http://www.facit.org/ 
Brucker, Yost, Cashy, 
Webster, & Cella, 
2005; Cella et al., 
1993; Heffernan et 
al., 2002; Overcash, 
Extermann, Parr, 
Perry, & Balducci, 
2001 
European 
Organization for 
Research and 
Treatment for 
Cancer Quality of 
Life Questionnaire 
Core-30 
(EORTC-QLQ- 
C30) 
4 Five functional scale: physical, role, social, 
emotional, and cognitive 
Symptoms: pain, fatigue, nausea/ vomiting, 
dyspnea, insomnia, appetite loss, 
constipation, diarrhea 
　 Financial impact 
Global QOL/general health 
 30 items. 
 Cronbach's α =.54-.86. 
 Construct validity (interscale correlations) and 
discriminant validities (between different disease, 
performance status, and health status) were 
assessed. 
 http://groups.eortc.be/qol/index.htm 
Aaronson et al., 
1993; Hjermstad, 
Fayers, Bjordal, & 
Kaasa, 1998; King, 
1996 
Spitzer QOL index 1 Activity 
Daily life 
Health perceptions 
 Observer-based measurement. 
 Cronbach's α =.74-.84. 
 Content validity and construct validity (comparing 
Anderson et al., 
1993; Spitzer et al., 
1981 
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Social support 
Behaviour. 
physician-rated QOL index) were assessed. 
Interdisciplinary 
Group for Cancer 
Care Evaluation in 
Italy (GIVIO) 
quality of life 
questionnaire 
1 Satisfaction with life 
Satisfaction with health 
Emotional state 
Cognitive state 
Functional state 
Social state 
Physical symptoms 
Satisfaction with health care 
Finally work activities. 
 For Italian. 
 Cronbach's α>.70. 
The GIVIO 
Investigators,1994; 
Mosconi et al., 1998 
Functional Living 
Index-Cancer 
(FLIC) 
1 Physical functioning 
Mental functioning 
Social functioning 
General health/well- being 
Treatment- related symptoms. 
 Cronbach's α= .92 -.95. 
 Construct validity (principal components analysis), 
convergent/ discriminant validity (between 
symptoms and anxiety), and criteria- related 
validity (different nature of diseases and treatment) 
were assessed. 
Schipper, Clinch, 
McMurray, & Levitt, 
1984; Spilker, 1995 
The liver cancer specific measures 
FACT- 
Hepatobiliary 
(FACT-Hep)* 
12 Swelling or cramps in my stomach 
Losing weight 
Control of bowels 
Digest food well 
Have diarrhea 
 18 items, and accompany FACT-G. 
 Cronbach’ α =.72-.93/.82-.94; test-retest=.84-.91. 
 Convergent- divergent validities (high correlation 
with FACT-G and trial outcome index; no 
correlation with social desirability) were assessed. 
Heffernan et al., 2002 
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Have good appetite 
Unhappy about change in appearance 
Back pain 
Bothered by constipation 
Fatigued 
Able to do my usual activities 
Bothered by jaundice or yellow skin 
Have fevers 
Have itching 
Have change in food tastes 
Have chills 
Mouth is dry 
Discomfort or pain in stomach 
Quality of life 
scale for patients 
of liver cancer 
(QOL-LC)* 
3 Physical domain 
Psychological domain 
Social domain 
Symptom/side effect domain: pain in stomach, 
loss weight, digestive problem, fever, 
diarrhea 
 22 items. 
 Cronbach's α= .68 -.81; Test-retest 
reliabilities=.71-.86. 
 Construct validity (principle component factor 
analysis) and criteria-related validity (SF-36 and 
FLIC) were assessed. 
Wan et al., 1998 
The quality of life 
questionnaire 
(JAPAN) 
2 Physical function 
Psychological function 
Social function 
Physical sensation 
 14 items. 
 Based on SF-36, NHP, and FLIC. 
Gross et al., 1999; 
Nuruki et al., 1995 
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Recognition of the disease 
EORTC 
QLQ-HCC18* 
1 Thirsty 
Trouble of taste 
Lost the muscle in arms or legs 
Abdominal swelling 
Worry figure of abdomen 
Worry eyes and skin becoming yellow 
Feel itch 
Shoulder pain 
Abdomen pain 
Fever 
Feel cold 
Worry nutrition 
Feel full just beginning eating 
Worry weight too light 
Vitality is not like anticipate 
Difficulty finishing things 
Need to sleep in daytime 
Influences on sexual life 
 18 items, and accompany EORTC QLQ-C30. 
 The detail of questionnaire development was 
provided. 
Blazeby et al., 2004 
FACT 
Hepatobiliary 
Symptom Index 
(FHSI)* 
1 Lack of energy 
Nausea 
Pain 
Losing weight 
 8 items, extracted from FACT-Hep. 
 Cronbach’α = 0.79; test-retest reliability= 0.86.  
 Criteria-related validity (correlation with 
FACT-Hep) and discriminant validity 
Yount et al., 2002 
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Pain in back 
Fatigue 
Jaundice or yellow color to skin 
Discomfort or pain in stomach 
(differentiation by ECOG and treatment) were 
assessed. 
Gastrointestinal 
quality of life 
index (GQLI) 
1 Gastrointestinal Symptoms 
Emotion function 
Physical Function 
Social Function 
Medical Treatment 
 Cronbach's α =.75-.91. 
 Construct validity (factor analysis) and clinical 
validity (detected different treatment) were 
assessed. 
Eypasch et al., 1995 
* the original paper that developed questionnaire was included in the review. 
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(3) Liver cancer specific measures 
There were six liver cancer/disease specific measures shown in Table 3.4. The QOL 
questionnaire developed in Japan by Nuruki (1995) lacked psychometric information. 
The Gastrointestinal quality of life index (GQLI; Eypasch et al., 1995) focused on 
gastrointestinal symptoms instead of HCC symptoms only. Based on this information, it 
was decided not to use either of these measures in work related to my thesis. 
The original articles describing the development of the following four standardized 
questionnaires [the European Organization for Research and Treatment of Cancer 
(EORTC) QLQ-HCC18 (Blazeby et al., 2004), the Functional Assessment of Cancer 
Therapy-Hepatobiliary (FACT-Hep) (Heffernan et al., 2002), the FACT Hepatobiliary 
Symptom Index (FHSI) (Yount et al., 2002), and the quality of life-liver cancer 
(QOL-LC) (Wan, Fang, Zhang, Lin, & Lo, 1998)] were included in the review. EORTC 
QLQ-HCC18 was developed primarily on patients with HCC, assessing fatigue, body 
image, jaundice, nutrition, pain, fever, sexual interest, and abdominal swelling. 
However, the FACT-Hep focused on hepatobiliary cancer such as metastatic colorectal 
cancer, HCC, pancreatic cancer, and cancers of the gallbladder and bile duct. The FHSI 
was a symptom index which was extracted from FACT-Hep including 8 items (3 pain, 2 
fatigue, nausea, weight loss, and jaundice). The QOL-LC was developed for Chinese 
patients with liver cancer, and the ‘symptom/side effect’ subscale included the 
disease-specific items. 
The FACT-Hep was the most widely used liver cancer specific instrument and was 
included in 12 of 36 studies. Steel, Eton, Cella, Olek, and Carr (2006) estimated the 
minimally important difference (MID) for the FACT-Hep to be 8-9 points, and the FHSI 
was 2-3 points. Steel and colleagues assessed the consistency of the FACT-Hep between 
patients, caregivers, and physicians. Caregivers were better proxies than physicians; 
they had adequate estimate of physical, functional, and disease-specific concern, but 
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underestimated emotional and social well-being (Steel, Geller, & Carr, 2005). 
 
 
3.4.2 Aim 2: Differences in HRQOL between patients with HCC, patients with chronic 
liver disease, and general population 
(1) Comparison with patients with chronic liver disease 
Four studies compared HRQOL between patients with HCC and liver disease. 
Patients with HCC had worse physical well-being and overall HRQOL than patients 
with chronic liver disease (Bianchi et al., 2003; Kondo et al., 2007; Steel, Chopra, Olek, 
& Carr, 2007), mainly in pain, loss of appetite and weight, difficulties digesting, and 
decreased ability to perform usual activities (Bianchi et al., 2003; Steel & Chopra et al., 
2007). However, after liver transplantation, there was no significant difference in 
HRQOL between patients with malignant and nonmalignant liver disease (Boudet et al., 
1995). 
 
(2) Comparison with the general population 
Three studies compared HRQOL between patients with HCC and the general 
population. Patients with HCC had lower HRQOL than the general population, 
especially in physical (Kondo et al., 2007; Lee et al., 2007; Steel & Chopra et al., 2007), 
psychological (Kondo et al., 2007; Steel & Chopra et al., 2007), functional well-being 
(Kondo et al., 2007; Steel & Chopra et al., 2007), and hepatobiliary symptoms (This is 
not surprising given that hepatobiliary symptoms would not be expected among on the 
general population) (Steel & Chopra et al., 2007). In contrast, patients reported better 
scores in social/family well-being (Steel & Chopra et al., 2007) and the environment 
domain of QOL (Lee et al., 2007).  
Of 17 studies using the FACT-G & Hep to assess HRQOL, only 10 provided means 
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and standard deviations (Heffernan et al., 2002; Lai, Lin, & Yeh, 2007; Lee et al.,2007; 
Poon et al., 2001; Steel, Eton, Cella, Olek, & Carr, 2006; Steel, Baum, & Carr, 2004; 
Steel, Chopra et al., 2007; Steel, Geller, & Carr, 2005; Sun et al., 2008; Wang et al., 
2007) (see Table 3.5). The means and standard deviations at baseline were pooled 
together and compared with the norms for the general population and cancer patients 
(Brucker, Yost, Cashy, Webster, & Cella, 2005). t-tests were used to examine the 
differences. Patients with HCC had worse physical well-being, t(621.2231)=-3.45, 
p<.001, emotional well-being, t(544.3254)=-17.52, p<.001, functional well-being, 
t(504.3647)=-5.65, p<.001, and overall HRQOL, t(629.2695)=-4.99, p<.001; but had 
better social/family well-being, t(327.6015)=4.19, p<.001, than the general population. 
In addition, patients with HCC had worse emotional well-being, t(766.5188)=-14.46, 
p<.001, functional well-being, t(748.8241)=-8.01, p<.001, social/family well-being 
t(752.8413)=-8.92, p<.001, and overall HRQOL, t(243.2823)=-7.48, p<.001, than 
patients with heterogeneous cancer (Brucker et al., 2005). 
 
Table 3.5 The original and pooled mean (SD) of FACT-G & Hep subscale 
 n PWB EWB FWB SFWB Hep Overall Overall (Hep)
Pooled 798 21.78 
(5.92) 
16.04 
(4.65)
16.79 
(6.23)
20.24 
(4.97)
47.89 
(10.10)
76.49 
(13.00) 
133.55 
(21.78) 
Norma 
(GP) 
1075 22.70 
(5.40) 
19.90 
(4.80)
18.50 
(6.80)
19.10 
(6.80)
-- 
80.10 
(18.10) 
-- 
Norma 
(cancer) 
2236 21.30 
(6.00) 
18.70 
(4.50)
18.90 
(6.80)
22.10 
(5.30)
-- 
80.90 
(17.00) 
-- 
PWB- Physical well-being; EWB- Emotional well-being; FWB- Functional well-being; 
SFWB- Social/family well-being; Hep- Hepatobiliary concerns; Overall- HRQOL 
(PWB+EWB+FWB+SFWB); Overall(Hep)- HRQOL 
(PWB+EWB+FWB+SFWB+Hep); GP- General population. a: data from Brucker et al., 
2005. 
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3.4.3 Aim 3: The effects of treatments on HRQOL: liver surgery, hepatic artery 
transcatheter treatment, and radiotherapy 
(1) Effects of liver surgery on HRQOL 
Four studies investigated the effects of liver surgery. Following hepatic resection, 
HRQOL declined during two-10 week periods after the liver operation, but increased to 
the preoperative level at three-four months, and was higher than the preoperative level 
at nine months (Chen et al., 2004; Poon et al., 2001). Significant improvement was 
found in physical well-being (Poon et al., 2001). Major hepatectomy resulted in more 
reduced HRQOL than minor hepatectomy (Chen et al., 2004). On the other hand, 
patients treated with hepatic resection had better HRQOL and were less depressed than 
patients treated by hepatic arterial infusion (HAI) (Poon et al., 2001; Tanabe et al., 
2001). After liver transplantation, there was no significant difference in HRQOL 
between patients with malignant and nonmalignant liver disease, and 70% of patients 
with liver cancer claimed to ‘live a normal life’ (Boudet et al., 1995). 
 
(2) Effects of hepatic artery transcatheter treatment and radiation therapy on HRQOL 
Seven studies investigated the effects of the TAE or TACE treatment. The HRQOL in 
patients who received TAE or TACE was lower at three months than pre-treatment 
(Steel et al., 2006; Sun et al., 2008), and was higher at six months than at three months, 
but did not return to baseline (Steel et al., 2006). Patients treated with 90-Yttrium 
microspheres had better HRQOL than patients who received Cisplatin through hepatic 
arterial infusion (Steel, Baum, & Carr, 2004). In addition, patients treated with 
radiofrequency ablation (RFA) or TACE-RFA had better HRQOL than those treated 
with only TACE (Wang et al., 2005, 2007). On the other hand, HRQOL increased 
slightly but not significantly during stereotactic radiation therapy (SRT) (Shun et al., 
2008).  
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3.4.4 Aim 4: The relationships between physical variables, symptoms and HRQOL 
(1) The relationships between physical variables and HRQOL 
Eleven studies explored the relationships between HRQOL and physical variables, 
including liver function, tumour stage and recurrence. There were significant positive 
correlations between liver function and HRQOL. Patients with better Child-Pugh 
classification (Lai, Lin, & Yeh, 2007; Steel & Chopra et al., 2007; Wang et al., 2005, 
2007), higher albumin (Kondo et al., 2007; Shun et al., 2008), lower serum bilirubin 
(Kondo et al., 2007), lower serum cholinesterase (Ueno et al., 2002) had better HRQOL. 
Patients with advanced stage (Zhao et al., 2002) or tumour recurrence (Chen et al., 2004; 
Ueno et al., 2002; Wang et al., 2005, 2007) had worse HRQOL. However, there were 
contrary findings in that tumour mass or hepatocellular failure (Bianchi et al., 2003), 
and whether or not patients had a HCC recurrence (Kondo et al., 2007), did not predict 
HRQOL. In addition, patients with duration of HCC more than one year had better 
HRQOL (Lee et al., 2007). 
 
(2) The relationships between symptoms and HRQOL 
Seven studies explored the relationships between HRQOL and symptoms. Severe 
symptoms were associated with patients’ HRQOL including pain (Chen et al., 2004; Lai 
et al., 2007; Shun et al., 2008; Sun et al., 2008; Wong & Fielding, 2008b), sleep disorder 
(Bianchi et al., 2003), fatigue (Shun et al., 2008; Sun et al., 2008), nausea (Shun et al., 
2008), and sexual problems (Steel, Hess, Tunke, Chopra, & Carr, 2005). In addition, 
patients who had better performance status (Shun et al., 2008) and eating ability (Wong 
& Fielding, 2008b) had better HRQOL. 
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3.4.5 Aim 5: The relationships between demographic characteristics, psychological 
variables and HRQOL 
Regarding demographic characteristics, older age (Chen et al., 2004; Kondo et al., 
2007; Ueno et al., 2002), being female (Lai et al., 2007), and lower income (Wang et al., 
2005) were associated with worse HRQOL. In contrast, Wang et al. (2005) showed that 
older patients had better HRQOL.  
Five studies explored the relationships between HRQOL and psychological variables. 
HRQOL was negatively correlated with depression (Shun et al., 2008; Wong & Fielding, 
2008b), uncertainty (Lai et al., 2007), and chance health locus of control (Tsai, Chien, 
Chan, Lin, & Lan, 2007); and was positively correlated with satisfaction about medical 
services (Wong & Fielding, 2008a). 
 
 
3.4.6 Aim 6: effects of psychological interventions on HRQOL 
Three studies used randomization control trials to investigate the effects of 
psychological interventions on HRQOL. Guo (2005) randomized 47 patients with 
primary liver carcinoma to intervention group which received emotional intervention 
and Chinese medicated diet, and 47 patients to control group who received normal 
medical care. After two months, patients in the intervention groups had improved liver 
function and general health status, as well as decreased physical symptoms. Lin, Tsang, 
and Hwang (1998) randomly assigned 40 patients with HCC to the intervention (n=20) 
or control group (n=20). The intervention group received health education, muscle 
relaxation, and back massage; and the control group received routine care. The 
intervention group showed a greater increase in knowledge scores, a greater decrease in 
worry scores, and a smaller increase in physical distress scores than the control group. 
Steel, Nadeau, Olek, and Carr (2007) randomized 14 patients to an intervention group 
  64
who received education, cognitive behavioural therapy, supportive expressive therapy, 
and pharmacological intervention; and 14 patients to the control group who received 
education and attention-standard of care. After three months, the intervention group had 
clinically significant improvements on depression and anxiety, disease-related 
symptoms and treatment side effects compared with the control group. 
 
 
3.5 Discussion 
As a result of the systematic review, four generic measures, five cancer specific 
measures, and six liver cancer specific measures were identified. According to the liver 
cancer specific questionnaires, the disease-specific concerns include pain, fatigue, 
nausea, jaundice, weight loss, and body image. A standard measurement instrument with 
well-established psychometric characteristics and disease specificity is necessary to 
assess HRQOL in patients with HCC (Poon et al., 2001). The cancer-specific instrument 
combines a core questionnaire for use in a particular cancer with a module questionnaire 
which assesses specific issues in cancer patient subgroups (Pallis & Mouzas, 2004). The 
EORTC QLQ-C30 and the FACT-G are the most widely used instruments in assessing 
HRQOL of patients with cancer (Pallis & Mouzas, 2004), but these two only measure 
the general concerns of HRQOL (Aaronson et al., 1993; Cella et al., 1993). They lack 
the specific measure for patients with HCC, therefore the EORTC and the FACT group 
developed the liver cancer specific scale. The EORTC QLQ-HCC18 and the FACT-Hep 
have to accompany the EORTC QLQ-30, FACT-G respectively to measure HRQOL in 
patients with HCC. Furthermore, the FHSI-8 provides a simple and effective symptom 
index for clinical application. Both the EORTC QLQ-HCC18 and the FACT-Hep are 
international instruments and include a Taiwan version, but the EORTC QLQ-HCC18 is 
specifically focused on HCC patients with clear subdimensions of disease concerns. 
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Based on this finding, the most appropriate measure of HRQOL for patients with HCC 
is EORTC QLQ-HCC18 in my thesis. 
HRQOL covers all aspects of health and functional status, and it is more informative 
than medical indices such as survival rate, modality rate, or functional index (Bonnetain 
et al., 2008). Compared with the general population, patients with HCC have worse 
HRQOL in physical, emotional, and functional well-being; but they may have better 
social/family well-being. Compared with heterogeneous adult patients with cancer, they 
have worse HRQOL in emotional, functional, and social/family well-being. Compared 
with patients with chronic liver disease, they have worse physical well-being and 
overall HRQOL. 
The present review revealed that patients with HCC have worse HRQOL in physical 
condition, emotional status, and functional ability, which is consistent with previous 
reviews (Gutteling, de Man, Busschbach, & Darlington, 2007; Martin, Sheridan, & 
Younossi, 2002). Conversely, patients with HCC have better social and family 
relationships, similar to the previous studies (Brucker et al., 2005; Lee et al., 2007; Steel 
& Chopra et al., 2007). It is possible that family and friends provide more assistance 
and support for patients after disease. Moreover, patients with HCC have worse 
HRQOL than patients with chronic liver disease, largely lower in physical aspects. The 
physical well-being may be impaired due to severe symptoms or treatment side effects, 
especially pain, loss of appetite, difficulties digesting, and fatigue. 
Liver surgery, hepatic artery transcatheter treatment, and radiation therapy can 
improve patients’ HRQOL. HRQOL may decrease from pre-treatment to three months 
after treatment and increase from three to six months. Patients with better liver function, 
early stage of disease, and no recurrence have better HRQOL. Severe symptoms such as 
pain, fatigue, and nausea are negatively correlated with HRQOL, whereas performance 
status and eating ability positively correlate with HRQOL. 
  66
There is a trade-off between benefits and drawbacks of treatment for patients with 
cancer, and with the goal of improving patients’ functions to live the best possible life 
within the constraint of HCC, HRQOL can be a good outcome to evaluate the 
cost/benefit of treatment (Wang et al., 2007). Treatment may reduce patients’ HRQOL 
in short-term period but improve HRQOL in longer term. However, the recovery rate 
varies depending on patients’ physical condition and treatment. Various factors may 
influence the change pattern. The recovery rate of patients treated by surgery is better 
than those treated by TAE/TACE. The HRQOL in patients treated by surgery improves 
over that before treatment, but the HRQOL in patients treated with TAE/TACE does not 
return back to the baseline level. The potential explanation is that patients who receive 
surgery are at early stage and have better liver function. Liver function is another 
significant factor associated with HRQOL. Increasing severity of liver disease based on 
the Child-Pugh classification is strongly correlated with decreased physical component 
summary scores on the SF-36 (Arguedas, DeLawrence, & McGuire, 2003). In addition, 
patients with less severe symptoms have better HRQOL. The large-size tumour may 
compress the adjacent stomach, the gross ascite may cause a feeling of abdominal 
swelling, hepatic dysfunction may reduce appetite, and the multiple symptoms may lead 
to poor tolerance to intervention (Yeo et al., 2006). 
  Apart from medical treatment and physical factors, psychosocial variables also 
play an important role in determining HRQOL. HRQOL is negatively correlated with 
depression, uncertainty, chance health locus of control; and positively correlated with 
satisfaction with medical services. In addition, psychosocial interventions may reduce 
negative feelings and enhance HRQOL. Patients who feel uncertainty about disease, 
treatment, and the future, and feel controlled by chance have worse HRQOL (Lai et al., 
2007; Tsai et al., 2007). HCC has a great impact on physical health and psychological 
well-being, even the stigma of death, and patients’ anticipated life trajectory is 
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challenged. In addition, satisfaction, especially about doctors and nurses, is strongly 
related to HRQOL. Satisfaction is based on patients’ expectations, medical care that 
they received, and cultural imperative (Wong & Fielding, 2008a). In the randomization 
control experiments, the psychological interventions involving psychoeducation, 
relaxation, and emotional expression were found to improve patients’ HRQOL. 
In this review, the data pooled together were at baseline in order to minimize the 
effect of treatment, but there were still other confounding factors, such as liver function, 
disease stages, or treatments which may influence the differences in HRQOL between 
patients with HCC and the general population.  
Several limitations of this review should be acknowledged. First, the studies varied in 
terms of the sample (e.g., disease stage, treatment), measurement tool, and country, 
making simple comparisons difficult. Second, not all the studies provided detailed 
information regarding means and standard deviations. Third, the norm of FACT 
(Brucker et al., 2005) is based on the US population and may be different from other 
countries’ norms. Fourth, the dropout rates of some longitudinal studies were high, and 
therefore the improvement in HRQOL may be overestimated. Fifth, the sample size was 
small in some studies, especially psychological intervention studies. 
In summary, HCC has a negative impact on patients’ HRQOL, especially on physical, 
emotional, and functional well-being, but patients may have better social/family 
well-being than norms based on the healthy population. Medical variables, such as 
disease stage, treatment, liver function, and symptoms play an important role in 
determining HRQOL. Further studies are warranted to understand the effects of 
psychological variables on HRQOL, the interaction between physical variables and 
psychological variables, and to explore the factors that may enhance patients’ HRQOL 
and adjustment. However, only a few of the studies focused on the psychosocial 
variables. I propose therefore to explore the influences of both physical and 
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psychosocial variables on HRQOL.  
Although I wanted to recruit either qualitative or quantitative methodology, but no 
qualitative study with good quality was founded. Three studies stated that they used 
both research methods but only used some open-ended questions and lacked a rigid 
qualitative methodology. In addition, the previous studies used the standardized 
questionnaires that may ignore the specific characteristics and cultural differences in 
patients with HCC in Taiwan. Hence, I decided to use a mixed methods approach, 
combining qualitative and quantitative methodology, to gain a broad understanding of 
the HRQOL and adjustment in patients with HCC. In the next chapter, general 
considerations of mixed methods research will be discussed.  
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Chapter 4. Mixed Method Research 
 
4.1 Abstract 
The results of Chapter 3 revealed that most previous studies used standardized 
measures and focused on the effects of physical variables. There were very little studies 
given link to patients’ perceptions and the role of psychological variables; in order to 
gain a broader understanding about the HRQOL and process of adjustment in patients 
with HCC, a mixed methods approach would be most appropriate. At first, I 
concentrated on the definition of mixed methods research and compared the differences 
between qualitative and quantitative methods; and then I described how to conduct a 
mixed methods research, including characteristics and typologies, as well as data 
combination. Finally I described the research design of my thesis. 
 
 
4.2 What is a mixed methods research 
In recent years, mixed methods research has become popular in various fields and 
been accepted as a rigorous and legitimate research design (Tashakkori & Teddie, 2003). 
However, there are major differences in philosophical worldview and rationales of 
proponents of qualitative and quantitative methodology and these need consideration. 
 
4.2.1 Definition 
Mixed methods research began in the 1950s when Campbell developed 
the multitrait and multimethod matrix for validation of psychological traits 
(Campbell & Fisker, 1959); and following two decades of development, 
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mixed methods research has concrete theoretical foundation and practical 
guidelines, and has been accepted as the third research paradigm 
(quantitative approach, qualitative approach, and mixed methods research 
approach) (Creswell & Plano Clark, 2007; Johnson & Onwuegbuzie, 2004). 
It is defined as research which combines elements of qualitative and 
quantitative research methods for the broad purposes of breadth and 
depth of understanding and corroboration (Johnson, Onwuegbuzie, & 
Turner, 2007). The combination of qualitative and quantitative methods may occur at 
different stages of the research process, such as formulation of research questions, 
sampling, data collection, data analysis, and result interpretation (Bryman, 2006). 
Mixed methods research not only expands the research toolbox, but also provides the 
opportunity for synthesis of research traditions and methods which is beyond the scope 
of any single technique (Borkan, 2004). When using both qualitative method and 
quantitative method in a single study, two questions may arise: the first is the conflicts 
between different philosophical assumptions of knowledge, and the other is a technical 
problem (Morgan, 1998). In order to solve the first question, the comparisons between 
qualitative and quantitative methods will be conducted and a theoretical framework will 
be provided. The second problem will be discussed in the next section. 
 
4.2.2 The comparisons between qualitative and quantitative approaches 
Disputes between qualitative and quantitative researchers have been apparent for a 
long period. The basic differences between two methods are summarised in Table 4.1 
and include seven points. 
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Table 4.1 The comparisons between qualitative method, quantitative method, and mixed 
methods research 
 Quantitative method Qualitative method Mixed method 
Philosophical 
worldviews 
Postpositivism Constructivism Pragmatism 
Purposes  To ask for an 
exploration of the 
central phenomenon 
or concept in a 
study 
To find out about the 
relationships among 
variables, ex. 
cause-and-effect or 
predictive 
relationships 
The integrated 
question to answer 
both quantitative 
and qualitative 
questions 
Specific 
methods 
Observation 
Interviews 
Groups 
Documents 
photographic  
Experiment 
Quasi-experiment 
Correlation study 
Survey  
Both qualitative and 
quantitative 
methods 
Data analysis Text or image analysis
To identify the themes 
and meanings 
Numerical statistical 
analysis 
To reject hypothesis or 
not 
Data transformation 
and data integration
The role of 
researcher 
Interpret the meanings 
of data actively, and 
aware personal 
value or status may 
influence the results
Keep objectivity and 
remove bias 
Both qualitative and 
quantitative 
positions 
Quality of 
research 
Reliability 
Validity 
Generalizability  
Credibility 
Dependability 
Transferability 
Confirmability  
Both qualitative and 
quantitative criteria
Strengths  To describe 
phenomenon in rich 
detail, such as 
contextual factors 
and dynamic 
process  
To control the 
confounding factors 
To test hypothesis or 
theory, and to 
generalize the 
results 
To combine numeric 
and narrative data, 
and provide 
qualitative and 
quantitative 
approaches strength
Weaknesses  Difficulties to test 
hypothesis or 
theory, and to 
generalize the 
results 
Researchers’ bias 
Difficulties to 
application for 
specific situation or 
context 
Practical difficulties, 
e.g., Time and 
money consuming 
Methodological 
problems, e.g., 
paradigm mixing, 
data transformation, 
and conflicting data
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(1) Philosophical worldviews 
The philosophical worldview can be seen as a basic set of beliefs that guide action 
(Guba & Lincoln, 2005). It is a general orientation about the world and the nature of 
research and knowledge that researchers hold (Creswell, 2009). The worldview includes 
ontology (view of reality), epistemology (view of knowing and the relationship between 
knower and to-be-known), methodology (view of research process), and axiology (view 
of what is valuable) (Creswell & Plano Clark, 2007; Guba & Lincoln, 2005). 
Post-positivism, which is usually associated with the quantitative method, asserts that 
social science should be objective, and treats social phenomena as determination which 
causes probably determine effects or outcomes (Johnson & Onwuegbuzie, 2004). 
Objective reality exists out there in the world, and numerical measures of study are 
developed in this philosophy (Creswell, 2009). In contrast, constructivism, associated 
with qualitative method, contends that multiple-constructed realities exist whereby 
individuals seek understanding of the world. They then construct subjective meanings of 
their experience, and the individual’s subjective view is the only source of reality 
(Johnson & Onwuegbuzie, 2004). 
 
(2) Research purposes 
Qualitative and quantitative methods deal with different research questions. The 
questions typically employed in a qualitative study are to explore the specific 
phenomenon and to understand the meaning that individuals give to the phenomenon 
inductively. On the other hand, the central questions in quantitative study are to test 
whether the relationship between various factors exists as well as to test a theory 
deductively (Creswell, 2009; Creswell & Plano Clark, 2007). 
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(3) Research methods 
In general, qualitative study asks open-ended questions while quantitative study asks 
closed-ended questions. Qualitative method collects audio-visual materials from 
observation, interview (individual or group), documents, or photographs. Quantitative 
method collects numeric data from various designs such as experiment, 
quasi-experiment, correlation study, or survey.  
 
(4) Data analysis 
Qualitative method is to identify the significant themes and meanings for providing 
depth description of phenomenon. Quantitative method uses statistical analysis to test 
the hypothesis and confirm the numerical relationships (Creswell, 2009).  
 
(5) The role of Researchers 
In qualitative method, researchers play an active role to interpret results and they 
have to aware of the influences of personal values or background on the analysis 
process. However, in quantitative method, researchers have to keep a detached position 
to report results objectively (Creswell & Plano Clark, 2007). 
 
(6) Criteria for assessing the quality of research 
In qualitative method, researchers have to demonstrate the trustworthiness of work, in 
terms of whether the findings represent a credible interpretation from original data 
(credibility), whether similar findings can be identified in similar contexts 
(dependability), whether findings can be produced in different contexts (transferability), 
and whether other similar researchers have similar findings (confirmability) (Denzin & 
Lincoln, 1994; Lyons, 1999). On the other hand, in quantitative method, researchers 
need to provide information concerning the stability of measures (reliability), the 
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accuracy of measures (validity), and the generalizability of findings across different 
settings (generalizability) (Lyons, 1999). 
 
(7) Strength and weaknesses 
Qualitative method provides a rich description about target phenomenon or 
formulates a theory, including contextual factors and dynamic process. But it is difficult 
to test a hypothesis or theory and generalize the results. In addition, the researchers’ bias 
would influence the qualitative results. On the contrary, quantitative method can test a 
hypothesis or theory, but the results may be too general to apply in specific situation 
(Johnson & Onwuegbuzie, 2004). 
 
4.2.3 The philosophical worldview of mixed methods approach 
In spite of the differences between the two research approaches, qualitative and 
quantitative approaches should not be taken as entirely distinct. There can be 
quantitative components in qualitative study, and vice versa. For example, the important 
themes in qualitative study may be based on the frequency of events, and the categories 
of variables in quantitative study should be based on the meaning of the categories. 
Therefore, the approaches can be viewed as a continuum with the qualitative approach 
anchored at one pole and the quantitative anchored at the other pole, and mixed methods 
approach covering the middle area (Johnson et al., 2007).  
Both qualitative and quantitative methods are empirical methods to explore the 
world/truth and to answer research questions. In the research process, both types of 
methodologists carry out studies to describe their data, formulate possible arguments 
from data, and construct theories to explain or predict phenomena (Sechrest & Sidana, 
1995). The commonalities among qualitative and quantitative methods provide the 
foundations for combining two approaches (Reichardt & Rallis, 1994). Thus, qualitative 
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and quantitative methods are not incompatible but should be seen as complementary 
(Malterud, 2001). Mixed methods research should use a philosophy and method which 
fit together the logistic provided by qualitative and quantitative approaches into a 
workable solution (Johnson & Onwuegbuzie, 2004). 
Regarding the philosophical worldview, pragmatism provides a potential foundation 
for mixed methods research (Tashakkori & Teddie, 2003). Pragmatism states truth value 
is to be determined by the experiences or practical consequences of belief in or use of 
the expression in the world (Murphy, 1990). It focuses on the consequences of research, 
as well as on the primary importance of the questions asked rather than the methods. It 
is pluralistic and addressed on practice and “what works” (Creswell & Plano Clark, 
2007). 
 
4.2.4 The rationales of mixed methods approach 
Mixed methods research uses both qualitative and quantitative methods in a study, 
and the philosophical worldview is to get useful and practice knowledge for research 
questions. In spite of this, there are some challenges, such as the time- and 
money-intensive nature of collecting and analyzing both text and numeric data, and 
requirement for researchers to have both qualitative and quantitative skills. However, a 
mixed methods approach has multiple sources of data and integrations of analysis, and 
uses the strengths of one method to enhance the performance of the other (Morgan, 
1998). It can provide a complete picture of phenomena as well as in-depth knowledge of 
participants’ perspectives (see Table 4.1 the strengths and weaknesses of mixed methods 
research) (Creswell, 2009; Creswell & Plano Clark, 2007; Morgan-Ellis et al., 2006). 
There are five major purposes in conducting mixed methods research,: (1) 
triangulation: convergence, corroboration, correspondence of results form the different 
methods; (2) complementary: elaboration, enhancement, illustration, clarification of the 
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results from one method with the other; (3) development: using the result from one 
method to inform the other method; (4) initiation: exploratory discovery of 
contradiction, new perspectives, or recasting of questions; (5) expansion: extends the 
breadth and range of inquiry (Greene, Caracelli, & Graham, 1989). 
 
 
4.3 How to conduct a mixed methods research 
The philosophical worldview and rationales of mixed methods research were 
discussed in the above section. In this section, the characteristics and typologies, and 
data combination will be addressed. 
 
4.3.1 The characteristics and typologies  
  The recognition of characteristics and typologies in mixed methods research can help 
researchers to design their studies. The various types of typologies have been identified 
(Creswell & Plano Clark, 2007). The basic characteristics of typologies include (1) 
timing, (2) weighting, (3) mixing, and (4) theorizing (Creswell, 2009). 
 
(1) Timing: concurrent vs. sequential.  
Timing refers to the order of data collection; whether the qualitative and quantitative 
data are collected sequentially or concurrently (Bryman, 2006; Creswell, Fetters, & 
Ivankova, 2004; Greene et al., 1989; Morgan, 1998). In a sequential design, the data 
from one method serves as a basis for the other data collection and analysis; in a 
concurrent design, both types of data are collected at the same time and are merged 
together in analysis and interpretation stages (Creswell et al., 2004). The key point is 
how to connect the two types of information for maximizing their contributions to the 
overall research (Morgan, 1998). 
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(2) Weighting: equal vs. unequal.  
Weighting refers to the priority of data with the emphasis on quantitative data, 
qualitative data, or an equal priority between the two types (Bryman, 2006; Creswell et 
al., 2004; Greene et al., 1989; Morgan, 1998). It is determined by researchers, the 
research questions, and the audience for the research (Creswell, 2009). The key point is 
how to make the combination of analysis and results in a coherent fashion (Morse, 
1991). 
 
 
Figure 4.1 The ways of mixing (From Creswell & Plano Clark, 2007) 
 
 
(3) Mixing: merging vs. connecting vs. embedding.  
Mixing refers to the ways of combining two types of data (Bryman, 2006; Creswell, 
2009; Creswell & Plano Clark, 2007). Two basic questions need to be considered: when 
Merging 
Qualitative data Quantitative data Results 
Connecting 
Qualitative data 
(or quantitative data) 
Quantitative data 
(or qualitative data) 
Results 
Connecting 
Quantitative data (or qualitative data) 
 
 Qualitative data 
(or quantitative data)
Results 
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and how does mixing occur? (Creswell, 2009) Mixing can occur at data collection, data 
analysis, and data interpretation, or all of three phases (Creswell, 2009). There are three 
ways in which mixing can occur: merging, transforming one set of data into the other 
form and combining both together; connecting, using one type of data in the first phase 
as the basis for the second phase; embedding, using one type of data as a supportive role 
for the other data (see Figure 4.1) (Creswell, 2009; Creswell & Plano Clark, 2007). 
 
(4) Theorizing: explicit vs. implicit.  
Theorizing refers to whether a theoretical perspective or framework guides the 
research design (Creswell, 2009). Generally, researchers have an explicit theory which 
guides their studies. 
  Creswell (2009) combined the purposes and characteristics of mixed methods 
research, to identify the four major types of mixed methods design: (1) the triangulation 
design (convergence model, data transformation model, validating quantitative data 
model, and multilevel model), (2) the embedded design (experimental model and 
embedded correlational model), (3) the explanatory design (follow-up explanations 
model and participants selection model), and (4) the exploratory design (instrument 
development model and taxonomy development model). He suggested researchers 
should select a design which best matches their research questions (Creswell & Plano 
Clark, 2007). 
 
4.3.2 Data combination 
The mixed methods research process includes eight steps: determine the research 
question; determine whether a mixed methods design is appropriate; select the mixed 
method design that matches the research question; collect the data; analyze the data; 
interpret the data; legitimate the data; and draw conclusion and write the report 
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(Johnson & Onwuegbuzie, 2004). It is a complex and dynamic process, after setting 
purposes and research questions, the next steps can vary in order, iteration, or be revised 
when needed (Johnstone, 2004). 
Data combination is based on research questions, research design, and the nature of 
data. Although qualitative and quantitative data can be combined at different stages of 
research, most occur at the analysis and interpretation stages (Niglas, 2004). There are 
three levels of integration: at the lowest level, qualitative and quantitative research are 
conducted separately and the essential components only are combined; at the middle 
level, the two types of research are conducted in the same study but the integration is 
not specified; and at the highest level, the integration occurs throughout the whole 
research process, from design through analysis and integration (Greene et al., 1989; 
Mortenson & Oliffe, 2009). 
Onwuegbuzie and Teddie (2003) described seven basic phases regarding the data 
analysis process, including data reduction, data display, data transformation, data 
correlation, data consolidation, data comparison, and data integration. Researchers 
identify the main dimensions of qualitative data and significant results of quantitative 
data, and describe both results in visual materials, such as matrices, charts, diagrams, 
tables, or graphs. Then the data are transformed into the other form. Quantitative data 
are converted into narrative data which can be analyzed qualitatively (qualitized), and 
qualitative data are converted into numerical data and analyzed in statistics (quantitized) 
(Caracelli & Greene, 1993; Tashakkori & Teddie, 1998). In the next phase, qualitative 
data are correlated with the quantitized data, and quantitative data with qualitized data; 
and consolidated variables or data sets are created based on the combinations. In 
addition, data comparison can be conducted between qualitative and quantitative data 
sources. In the final phase, two types of data are integrated into a coherent whole or two 
separate sets (qualitative and quantitative) of coherent wholes (Onwuegbuzie & Teddie, 
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2003). 
Furthermore, mixed methods research design influences the data analysis. In 
concurrent triangulation design, qualitative and quantitative data are analyzed separately 
and are merged together. Researchers can transform one type of data to make the 
qualitative and quantitative datasets comparable, or compare the data without 
transformation in a discussion or a matrix (Creswell & Plano Clark, 2007). On the other 
hand, in sequential explanatory or exploratory design, researchers have to consider what 
information in the early stage is important and useful for the next stage. When 
qualitative study is conducted first, the codes and themes, significant statements, and 
potential models are important for the next quantitative study; when quantitative study 
is conducted first, the significant-nonsignificant results, demographic characteristics, 
comparison groups, and extreme cases should be considered (Creswell & Plano Clark, 
2007). 
The final issue is about validity. Combining qualitative and quantitative data may 
raise potential validity problems. Researchers should consider the reliability and validity 
issues in qualitative and quantitative approaches, but also assess the trustworthiness of 
both data combinations and interpretations (Onwuegbuzie & Johnson, 2004, 2006). 
Researchers have to ensure consistency among the research purposes, the questions, and 
the methods they use, as well as the legitimacy or applicability of the results (Newman, 
Ridenour, Newman, & DeMarco Jr, 2003). 
 
 
4.4 The research design of thesis 
In the systematic review described in Chapter 3, it was concluded that most previous 
research used quantitative methods with standardized instruments and focused on the 
effects of physical factors on the HRQOL in patients with HCC. However, treatment 
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and physical factors cannot totally explain the HRQOL and quantitative method by 
itself cannot explore the potentially important variables which may influence patients’ 
adjustment. A mixed methods research design may be useful to gain in-depth knowledge 
of the adjustment process from patients’ perspectives and to test the physical and 
psychological factors that influence patients’ HRQOL.  
 
Table 4.2 The characteristics of thesis 
Characteristics Content  
Rationale for mixing Both qualitative and quantitative data are used to gain 
comprehensiveness of phenomenon, and triangulation 
of result 
Forms of data collection  
  Qualitative  Semi-structured interview 
  Quantitative  Standardized instruments 
Analytical procedure  
  Qualitative  Interpretative phenomenological analysis 
  Quantitative  Descriptive statistics, correlations, and regressions 
Characteristics of design   
Timing  Concurrent: qualitative + quantitative 
  Weighting  Equal  
  Mixing  Analysis and reports of results 
Type of design model Triangulation 
 
 
The overall objective of this mixed methods research is to understand the HRQOL 
and adjustment of patients with HCC in Taiwan. The details of the research design 
based on Creswell’s criteria are presented in Table 4.2 (Creswell et al., 2004). A 
concurrent triangulation design will be conducted. Two studies will be conducted. 
In the qualitative study, semi-structured interviews will be used to collect data and be 
analyzed using Interpretative Phenomenological Analysis (Smith, 1996; Smith, Flowers, 
& Larkin, 2009). In a parallel study, standardized instruments will be used to measure 
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the relationships between HRQOL, depression and anxiety, and other psychological 
variables, including illness perceptions, coping strategies, and social support, as well as 
physical variables, including disease stage, treatment, liver function, and performance 
status. Qualitative and quantitative data will first be analyzed separately, and merged 
together including (1) transforming and relating the data, (2) comparing the results in 
discussion. The process of integration is shown in Figure 4.2. 
 
 
Figure 4.2 The process of analysis and integration 
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Chapter 5. Illness Experience in Patients with HCC: An Interpretative 
Phenomenological Analysis Study 
 
5.1 Abstract 
Aims: HCC is common in Asia and previous research shows patients with HCC report 
compromised HRQOL mainly in physical and psychological dimensions. However, 
most past research used standardized instruments to measure HRQOL and lacked 
qualitative in-depth information. In order to determine more precisely the effect of HCC 
in Taiwan we conducted a qualitative study to explore patients’ experience of the illness 
journey, and significant factors which they see may influence their HRQOL and 
adjustment. 
Methods: Patients with HCC in Taiwan (n=33) undergoing one or more of three 
treatments (surgery, TAE/TACE, and chemotherapy). They were classified according to 
one of four stages of disease severity (I to IV). A semi-structured interview was 
developed to collect data. Interview guides included illness experience, the strategies 
used to deal with the disease, and the significant concerns in their current life. Data 
were analyzed using Interpretative Phenomenological Analysis (IPA), and an 
introduction of IPA was also included in this chapter 
Results: Four main themes were identified: (1) the impact of disease: physical 
symptoms, psychological reactions, social relationship, daily activities and life aspect, 
and positive change; (2) the illness perceptions: consequence, timeline, control, and 
perceived causal factor; (3) information needs: medical information and non-medical 
information; and (4) coping strategies: problem-oriented and emotion-oriented coping 
strategies for disease-related and life-related problems. 
Conclusions: A preliminary model of illness adjustment was developed. The findings 
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have clinical implications for future care of patients with HCC and for development of 
culturally sensitive measures. 
 
 
5.2 Introduction 
HCC is common in Asia and has wide impact on patients and families. The results of 
the systematic review (Chapter 3) suggested that a limitation or previous work was the 
reliance on standardized instruments to measure HRQOL and these measures tend to be 
US based and may not be appropriate for work in other cultures. In addition, 
quantitative measures cannot gain a comprehensive picture of patients’ illness journey. 
We therefore conducted a qualitative study. 
In the traditional view, psychology is seen as ‘hard science’ where a positivist 
quantitative research paradigm has a predominant role. In health psychology, the 
quantitative method has considerable strengths, for example to test the impact of disease 
or the effects of intervention. However, it has some limitations, including lack of 
in-depth information and ease of implementation in clinical practice (Jones, 1995). 
Nowadays the qualitative method is important in health psychology to explore the 
meanings of health and illness experience (Chamberlain, Stephens, & Lyons, 1997; 
Mays & Pope, 1995). 
The results of the systematic review tell us little about the illness journey including 
how patients cope with HCC, interpret the illness, and adjust to new life after diagnosis. 
Therefore, the aims of this study were to: (1) describe the impact of HCC on HRQOL, 
(2) explore the adjustment process, and (3) identify the significant factors which help 
patients’ adjustment. 
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5.3 Interpretative phenomenological analysis 
Interpretative phenomenological analysis (IPA) was used as a guide to conduct this 
research. IPA has been developed as a specific technique for qualitative health 
psychology (Smith, 1996; Smith, Flowers, & Larkin, 2009; Smith & Osborn, 2008), and 
the aims of IPA are to explore how individuals are making sense of their personal and 
social world, and how they are gaining meaning from particular experiences or events 
(Smith & Osborn, 2008). In this section the basic components of IPA were introduced 
including theoretical foundations, research questions, sampling, data collection, analysis 
strategies, and quality of research. 
 
5.3.1 Theoretical foundations 
IPA attempts to get close to the individuals’ personal world, an ‘insider’s perspective’ 
(Conrad, 1987). There are two theoretical foundations of IPA: phenomenology and 
symbolic interactionism (Smith, 1996). Phenomenology is a philosophical approach that 
studies human experience. It focuses on the individual’s lived experience, and tries to 
explore the individual’s personal perception or account of an object or event instead of 
to produce an objective statement of the object or event itself (Smith, 1996; Smith & 
Osborn, 2008). Symbolic interactionism, which was influenced by pragmatism, focuses 
on how persons are interpreting and sense-making. It argues that a central concern of 
social scientists is to explore the meanings individuals ascribe to events, but those 
meanings are only obtained through a process of interpretation (Smith, 1996; Smith & 
Osborn, 2008). In other words, meanings are in, and a result of, social interactions 
(Smith, Flowers, & Osborn, 1997). 
Humans, as self-interpreting beings, tend to interpret objects or events actively, and 
make sense of their experiences actively (Smith & Eatough, 2006). IPA draws attention 
to not only individual’s thinking concerning objects or events (outcomes) but also the 
  86
ways of sense-making (processes). It emphasises cognitive, linguistic, affective, and 
physical components; and assumes a chain of connection between people’s talking, their 
thinking, and emotional state (Smith, 1996; Smith & Osborn, 2008). However, there is a 
dual interpretation process. Individuals are trying to interpret and make sense of their 
experiences and world, and the researcher is trying to make sense of participants’ 
process of sense-making (Smith & Osborn, 2008). From this view, IPA assumes that 
research is a dynamic process with an active role for the researcher in the process 
(Smith & Eatough, 2006). 
IPA has been widely applied in health psychology (Brocki & Wearden, 2006). Health 
psychologists are concerned with patients’ perception and interpretation of their illness 
and bodily experience, and how they gain meanings (Leventhal, Nerenz, & Steele, 
1984). Health psychology makes assumptions about (1) the existence of real and 
discrete bodies, and (2) individuals’ thinking about their bodies can be expressed by 
their talk. IPA can realize the gap between objective physical conditions and subjective 
perceptions of their bodies (Smith, 1996). IPA can be used to determine the beliefs that 
patients have about their bodies and illness, the speech that they use to talk about their 
bodies and illness, and their response to their illness (Smith, Jarman, & Osborn, 1999). 
It can explore meanings and contexts to understand the complexity of phenomenon 
(Brocki & Wearden, 2006). 
 
5.3.2 Research questions 
IPA is useful to approach phenomenon with complexity, process, or novelty (Smith & 
Osborn, 2008). It focuses on individuals’ lived experiences and with how they are 
making sense of experiences in a particular context. The key questions are concerned 
with participants’ perceptions or view, and how they formulate perceptions and views 
(Smith & Eatough, 2006; Smith et al., 2009). 
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5.3.3 Sampling 
  IPA tries to find a homogeneous sample, and uses purposive sampling instead of 
theoretical sampling (Brocki & Wearden, 2006; Smith & Osborn, 2008). There is no 
recommended sample size. In past studies, the numbers of participants varied from one 
to 48 (Brocki & Wearden, 2006), but six to eight is often considered appropriate (Smith 
& Eatough, 2006). In general, sample size of an IPA study depends on the degree of 
commitment to the case study level of analysis, the richness of the individual case, and 
the practical restrictions that the researcher is working under (Smith & Osborn, 2008). 
 
5.3.4 Data collection 
Qualitative methods of data collection are appropriate for an IPA study, such as 
interview, focus group, personal accounts, or diaries; but the best and the most popular 
way is through the semi-structured interview. The advantages of the semi-structured 
interview are flexibility in that researchers can follow up novel avenues resulting in 
richness of data (Smith & Osborn, 2008). Semi-structured interviews are guided by the 
following principles: researchers need to establish rapport with participants; the order of 
questions is less important; researchers are free to probe interesting topics that arise; and 
the interview can follow participants’ interests or concerns (Smith, 1995). 
Before starting the interview, researchers should design an interview schedule. The 
steps for producing an interview schedule include: (1) determine the overall issues to be 
tackled in the interview; (2) set up the issues in appropriate sequence, researchers have 
to think what is the most logical order to address these issues and what is the most 
sensitive issue; (3) think of appropriate questions related to each issue; and (4) design 
possible probes and prompts which can facilitate participants to talk more (Smith, 1995). 
In general, the interview starts with general and non-specific questions and moves to 
specific-level and sensitive questions. In addition, audio record is necessary so that 
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researchers can concentrate on the interview and have detailed information of whole 
interview. 
 
5.3.5 Analysis strategies 
Meaning is central and the aim is to understand the content and complexity of those 
meanings in IPA, therefore, researchers have to get inside participants’ psychological 
worlds (Smith & Osborn, 2008). The analysis is an iterative process: (1) Reading and 
re-reading: researchers have to read and re-read the transcripts several times and be 
familiar with the contents. (2) Initial noting: researchers use one margin to write down 
the first impressions, such as descriptive, linguistic, and conceptual comments. (3) 
Developing emergent themes: researchers use the other margin to write down the 
themes which emerge from the original data. The themes have a slightly higher level of 
abstraction and invoke psychological terminology. (4) Searching for connections across 
emergent themes: researchers can explore and innovate in terms of organizing the 
analysis through abstraction, polarization, contextualization, numeration, function, to 
bring themes together. (5) Moving to the next case: researchers can use a master list of 
themes from the first case or create a new list. (6) Looking for patterns across cases: 
after analysis of all cases, the final results can show how themes are nested within 
super-ordinate themes and illustrate the meanings, contents, and examples of each 
theme (Smith et al., 2009). 
The above steps are a suggestion for analysis methods rather than prescriptions. 
Analysis is a cyclical process, the temporary results from each step will force 
researchers to think the focus and directions of study; in addition, IPA involves personal 
interpretative process and researchers have to distinguish what the participants’ said and 
their interpretation (Smith et al., 1999). 
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5.3.6 Quality of research 
Three levels of interpretation (phenomenological, metaphorical, and theoretical) have 
been identified, and IPA should move beyond the text to a more interpretative and 
psychological level, but still contrast a grounded IPA reading which is based on 
participants’ accounts (Smith, 2004). Researchers have to demonstrate the quality of 
research. There are four principles. The first is sensitivity and context, that researchers 
can demonstrate an appreciation of the rationale for adoption of IPA, the interactional 
nature of data collection within the interview situation, and the match of data and 
analysis process. The second is commitment and rigour. Commitment means researchers 
show the degree of attentiveness to participants during data collection. Rigour refers to 
the thoroughness of the research such as the appropriateness of the sample to the 
question, the quality of interview, and the completeness of the analysis. The third is 
transparency and coherence. Transparency refers to the fact that researchers have to 
describe clearly each stage of research process in the write-up, and coherence refers the 
fitness between question, data collection, analysis, and writing. The last is impact and 
importance regarding whether the research tells readers something interesting, important 
or useful (Yardley, 2000). 
 
In summary, IPA pays attention to the cognitive, linguistic, and affective components 
of human beings, and addresses the meanings and the process of interpretation and 
sense-making. It is useful to make a specific statement about individuals rather that a 
general claim for the research group. The IPA method is flexible but also with practical 
guides. It has been widely used in health psychology; therefore IPA was used in my 
thesis. 
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5.4 Methods 
5.4.1 Participants 
Thirty-three adult patients with HCC were recruited. They had undergone at least one 
of three treatments (surgery, TAE/ TACE, and chemotherapy) and were categorized into 
four stages of disease depending on severity (I to IV). These ratings were made by staff 
in two medical teaching hospitals in Taiwan. Inclusion criteria were: (1) diagnosis of 
HCC confirmed by histopathological examination of either surgical samples or needle 
biopsy specimens, by typical image pictures plus a serum level of a-FP higher than 400 
ng/mL, or by more than two typical image pictures; (2) age 18 years or older; (3) speak 
Chinese or Taiwanese. Patients with a history of suicidal ideation or psychosis were 
excluded. 
 
5.4.2 Data collection 
(1) Procedure 
Ethics approvals were obtained from the Department of Psychology, University of 
Sheffield and two participating hospitals in Taiwan (National Taiwan University 
Hospital and Chi-Mei Medical Center, Liou Ying). Medical staff identified the patients 
who met the inclusion criteria, and the researcher approached potential patients to 
provide an oral explanation and give them detailed information sheets. Patients were 
encouraged to ask any questions about the research and reassured about the voluntary 
nature of participation. They were also informed that whether or not they participated 
would not influence their treatment or care, and that they had the right to withdraw at 
any time without any explanations. Patients signed a consent form when they were 
willing to participate in the research. The interviews were conducted in Taiwanese or 
Chinese, and the author translated the results into English when writing the report. 
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(2) Interview 
A semi-structured interview was used to collected data, and the interview guides were 
set up in advance (Smith, 1995). These included: 
(i) Would you please describe your experience about illness briefly, about the 
whole process?  
(Prompts: since feeling uncomfortable, being told the diagnosis, receiving 
treatments, knowing the progress of disease). 
(ii) What are the influences or impact of disease on your life?  
(Prompts: physical, psychological, social, and other domains). 
(iii) How do you deal/cope with the impact? 
(Prompts: specific coping strategies, resources including internal and external, 
which factors are the most important). 
(iv) Are there any significant concerns in current life? 
(v) Are you satisfied with your adjustment to illness? What are other significant 
factors which may influence your adjustment but we didn’t mention above? 
(vi) Is there anything you want to stress or mention? 
 
(3) Measures 
The demographic data included gender and age; and medical data included ECOG 
score (The Eastern Cooperative Oncology Group performance status score) (Oken et al., 
1982), AJCC stage of HCC, time since diagnosis, and the most recent treatment were 
also collected from medical notes. 
 
5.4.3 Analysis 
Interviews were audiotaped and transcribed verbatim, and IPA was used to analyze 
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data (Smith, 1996; Smith et al., 2009; Smith & Osborn, 2008). The transcript was read 
and re-read, the comments and initial themes were written down. Through analytic 
reading, the preliminary themes were identified and the relationships between themes 
were structured. Comparisons across different conditions: disease stages, treatments, 
and time since diagnosis were conducted. A list of master themes was produced. After 
analysis of all transcripts, the final list was shaped. Atlas. ti 5.0 was used to assist the 
process of analysis. 
In order to enhance validity, the second coder who is a senior nurse with a Masters 
degree in oncology analyzed transcripts independently, and the two coders discussed 
their coding to increase the consistency and coherence of the analysis (Yardley, 2008). 
 
 
5.5 Results 
The demographic characteristics of patients are presented in Table 5.1. The mean age 
of patients was 54.24 years (SD=12.73, range from 31 to 76 years). Two thirds were 
male and most patients had good performance status (ECOG=1 & 2). The mean time 
since diagnosis was 31.36 months (SD=29.48, range from 1 to 93 months); 30.30% 
were assessed at stage III, and 39.40% received surgery. The mean time of interview 
was 58.79 minutes (SD=30.40, range from 21 to 127 minutes). 
 
Four main themes were identified from interview data, including (1) the impact of 
disease on patients’ lives, (2) illness perceptions, (3) information needs, and (4) coping 
strategies. A conceptual model of adjustment was then developed. 
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Table 5.1 The demographic and disease characteristics of patients    (n=33) 
Variables  Frequency (%) 
Age (yrs) 
Mean=54.24 (SD=12.73), range=31-76 
 
Gender  
  Male 
  Female 
 
22 (66.66%) 
11 (33.33%) 
ECOG 
  1 
  2 
  3 
4 
 
16 (48.49%) 
10 (30.30%) 
5 (15.15%) 
2 (6.06%) 
AJCC stage 
  1 
2 
3 
4 
Missing 
 
8 (24.24%) 
7 (21.21%) 
10 (30.30%) 
3 (9.10%) 
5 (15.15%) 
Time since diagnosis (months) 
  Mean=31.36 (SD=29.48), range=1-93 
 
Most recent treatment 
  Surgery 
  TAE/TACE 
  Chemotherapy/ drug therapy 
 
13 (39.40%) 
10 (30.30%) 
10 (30.30%) 
 
 
5.5.1 The impact of disease on patient’s life 
The disease had widespread impact for patients’ lives (see Table 5.2). Physical 
symptoms including liver-specific symptoms, such as jaundice, digestive problem, 
flatulence; and general symptoms, such as sleep problems, fatigue, lack of physical 
vigour, and weakness were recorded. Psychological reactions to the disease included 
cognitive, emotional, and behavioural components.  
      Cognition: at beginning I was afraid a lot…in the past cancer is related to death, 
when I will die… people who had such severe disease may have a maggot in their 
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head, I don’t know how many years I can live. (P26) 
      Emotion: ha, three years ago, three years ago I couldn’t laugh at all, everyday I 
was depressed, and my temperament was bad, very bad. (P10) 
      Behaviour: maybe because of hepatic coma, I blamed the nurse, I shouted to my 
wife, but actually I couldn’t recognize anyone. So they moved me to the single 
room. I could remember these, they told me these when I was clear. (P10) 
 
In social relationships, the impact involved patients and family members, caregivers 
and other family members, as well as patients and friends. In addition, caregivers and 
family members were also influenced by the disease. There were tense between patients, 
caregivers, and other family members because of treatment decisions, care responsibility, 
and emotional stress. 
Patients and family members: having such a body, it is very difficult to maintain 
a family, to take care of other families. … and this time the result of examination is 
not clear, I have to come back after 2 weeks, how do I talk to them? If I tell them I 
have to receive examination again, they will definitely worry these 2 weeks. (P17) 
Caregivers and other family members: she (wife) stays here all day and knows 
all situations. But my parents found some Chinese herb that they hear someone 
said it can cure liver cancer, and they wanted me to try. However, she didn’t want 
and worried the Chinese herb may influence the treatment. (P2)  
Patients and friends: I don’t like tell my disease to other people, only some 
close friends know. And I don’t let them come to hospital, I don’t want to cause 
their burden…I don’t want to let them see me... (P1) 
 
There were wide influences on daily activities, for example patients had to stop work 
temporally or quit work, received treatment and came back to hospitals regularly, and 
could not travel far. All of above influences put a halt to patients’ lives or a sense that 
life was totally changed by the disease. 
I never experience three months so longer so slowly. Before the disease, I was 
busy in my job, my studying, but now suddenly my life was stopped and the 
disease changed the direction of my life. (P32) 
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Table 5.2 The impact of disease 
Dimension  Description Example  
Physical 
symptoms 
The uncomfortable 
symptoms which 
caused by disease, 
but there are varieties 
between disease 
stages and 
treatments. 
Liver-specific symptoms: constipation, 
diarrhea, digestive problem, excrete 
problem, feel full just beginning eating, 
flatulence, hepatic coma, internal 
hemorrhage, 
General symptoms: dry mouth, fatigue, fever, 
itch, jaundice, lack of physical vigour, loss 
appetite, loss weight, muscular pain in 
shoulder, pain, pant, sleep, trouble tasting, 
vertigo, vomiting, weakness 
Psychological 
reaction 
The psychological 
responses to illness, 
including cognition, 
emotion, and 
behaviour.  
Cognition: a knot in one's heart, body image, 
can't escape from death, close death, have 
a maggot in my head, loss of faith, loss of 
living willing 
Emotion: anger (to him/herself; medical 
staff), regret, anxiety (in general life and 
before physical examination), bad mood, 
depression/depressive mood, fear, feel 
inferior, frustration, helplessness, 
hopelessness, initial panic, initial shock, 
irritable, numb, sensitive or arousal easily, 
uncertainty, unhappy, uselessness, worry 
Behaviour: move restlessly 
Social 
relationship 
The influences of 
disease on social 
relationships between 
patients, family 
members, and 
friends. 
Patients and family: can't maintain family 
role, conflicts between patient and family, 
worry about family 
Caregivers and family: conflict between 
family members, increase family's burden 
Patients and friends: reduce of social 
activity, withdraw from social interaction 
Daily activities 
and life aspects 
The influences of 
disease on daily 
activities and life 
aspects. 
Daily activities: can't work, economic 
burden, can't go far away, can't stay at 
home, regular follow-up, regular treatment, 
inconvenient in hospital, social stress  
Life aspects: change life direction, collapse 
of life, life stop!, stop or change life plan 
Positive change Positive changes 
induced by the 
disease 
Help others, be a volunteer, be a example for 
others (for quit bad habits), health life style, 
rearrange life priority and schedule, better 
family relationship, be optimism or 
magnanimous or open-minded, accept 
him/herself, live here and now 
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On the other hand, the disease caused some positive changes. For example patients 
may rearrange their priorities in life, develop healthy habits and quit bad habits, want to 
help others (e.g. use themselves as examples for others quitting bad habits), and be 
optimistic or open-minded. 
It is obviously a good transition. Except for less income, but it is good for my 
family, to spend more time with my children, to do a lot of what they like, it is 
positive. (P16) 
 
 
5.5.2 Illness perceptions 
How do patients perceive their disease, HCC? Four components of illness perceptions 
were identified, including consequences, timeline, perceived causal factors, and control 
(see Table 5.3). Consequences were influenced by several factors, including physical 
symptoms, psychological burden, and self-care or working ability. Patients described 
the consequences as various levels, from mild to severe. 
It is a huge stress, I don’t expect it (disease), but I have to stand it. Now I can’t 
stand anymore, so my life becomes collapsed. (P32) 
Because the recovery of surgery is quite good, so far my physical condition is 
okay, so it (disease) is not a big deal. (P15) 
 
Unlike of the different consequences, there was consistency in timeline perception, 
that this disease is a chronic disease and needs long-term treatment. 
I thought everything was done when the tumour was taken by resection at the 
first diagnosis. But now (recurrence), it is not easy to be cured, it will prolong a 
long period. (P4) 
 
Perceived causal factors included early stage liver disease (HBV, HCV, and cirrhosis), 
alcohol, life style (stay up late, irregular life schedule, and overdraft of physical vigour), 
family history, and stress. 
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HBV: I don’t think this question (why I got HCC), but I think why I got HBV, I 
think that. When I got HBV, it is so easy to get HCC. (P4) 
Drinking: why? It is my deserved. When I was young, didn’t know the bad 
influence, just drunk wine frequently. (P11)  
Stress: I thought the cancer is related to our emotion. I lived with my 
parents-in-law, they treated me well, but there is always pressure for me, it is not 
easy. (P26) 
 
Feelings of control centered on two dimensions, curability and controllability. A 
majority of patients did not think their disease could be cured. However, controllable 
feelings related to treatments, physical condition, and personal interpretation. 
Curable: I asked the doctor if this disease can be cured. He said frankly, just 
receiving treatments (TAE) repeatedly until can not do anything, if you take care of 
your liver well, maybe it can prolong your life. (P13) 
Controllable: when it relapsed, I thought: it happens again, now it is bad, it is 
not easy to be treated. (P4) 
Controllable: I am not afraid, because I know there are always treatments, 
surgery, TAE. Even until you cannot receive TAE, there is still liver transplantation. 
(P25) 
 
In addition, knowledge of disease, stereotype of disease, and personal illness 
experience may formulate patients’ illness perceptions.  
Knowledge of disease: At beginning, I was not afraid, but when she (patients’ 
wife who was nurse before) explain the disease to me; I realized it is a critical 
disease, I started to be afraid. (P20)  
Stereotype of disease: I knew, I knew it is HCC at the beginning of diagnosis. It 
is the “national disease” (major disease in our country). And cancer, everyone is 
afraid of cancer. (P7) 
Illness experience: When I had abdominal distention and jaundice, I knew the 
situation got worse. This disease, if the abdomen becomes bigger, it is a bad sign. 
(P13) 
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Table 5.3 Illness perceptions about HCC 
Illness perceptions  Description  Example  
Consequence  An integrative evaluation about 
the level of disease impact on 
life 
Various levels of perceived 
consequences and impact, 
from mild to severe 
Timeline  A perception about the time 
period of disease.  
A majority of patients 
perceived HCC as a long-term 
and chronic disease.    
Causal factor Potential factors that patients 
thought the factors cause the 
disease, mainly early stage liver 
disease (HBV, HCV, cirrhosis), 
alcohol, life style, family history, 
and stress. 
Alcohol drinking, early stage 
liver diseases, chemical 
substance, food, life style, 
family history, working stress, 
life stress, personality 
Control A feeling that whether patients 
can control the disease, 
including curable and 
controllable.  
Curable or not 
Controllable or not 
 
 
5.5.3 Information needs 
When the disease was diagnosed, a series of questions and thoughts arose. These 
involved medical information and non-medical information. The details of questions are 
presented in Table 5.4. 
When the doctor told me this diagnosis…DONG…a lot of thoughts…a lot of 
questions arose, about cancer this problem, what will happen if I receive surgery, 
how many years I can live, and such as and such as. (P26) 
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Table 5.4 Information needs 
Category  Questions  
Medical 
information 
What factors cause HCC? 
What reason causes the specific symptom? How to manage symptom? 
What are the benefits and side effects of treatments, examination, and 
medicine? The effects of medicine on liver (whether increase the 
burden of liver) 
The meaning of medical index, such as GOT (Glutamic Oxaloacetic 
Transaminase), GPT (Glutamic Pyruvic Transaminase), α-FP, 5 years 
survival rate.  
How to take care their liver? Do they need to take medicine? How to 
follow-up? Do they need to take any examination in a certain period?
How about the disease prognosis? Whether recurrence? What will 
happen in the future? 
Non medical 
information 
How to adjust the disease including patients and families, and how to 
make mood stable or happy. 
Life schedule? What they can eat? What can’t eat? What can do, and 
what can’t? 
The interaction between physical and psychological aspects 
When they can return to work and normal life? 
Recovery, and am I normal? 
What resource can help me, such as cancer or disease association 
Want to know other patients’ situation (to make comparisons) 
 
 
5.5.4 Coping strategies 
We identified both problem- and/or emotion-oriented coping strategies. The 
problem-oriented coping involved patients taking direct action to the stressor itself, 
while the emotion-oriented coping involved patients trying to manage their emotional 
responses to the stressor. The disease may raise multiple problems rather than a single 
stressor; the usage of coping strategies depends on different stressors. There were two 
kinds of stressors: disease-focused and life-focused (see Table 5.5). 
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Focusing on disease itself, different problem-oriented coping strategies were used at 
different stages. At the beginning patients would react to disease immediately, for 
example searching information, find a famous/good doctor, make plans for treatment 
and worst situations; after acute stage, patients may rearrange their life, for example do 
exercise, eat healthy and light food, go to bed early, and quit bad habits. 
Coping with the disease? Only life style, eat light food, go to bed early, regular 
life schedule. That’s all, nothing special, but don’t increase liver’s burden. (P2) 
 
Emotion-oriented coping involves a dynamic transition process. Patients illustrated 
the attitude confronting the disease, for example face and deal with the problem, get 
along with tumour, let it be, let nature take its course; or don’t keep it (disease or tumour) 
in mind, distraction, change thoughts using positive thinking, social comparison; or 
stand it, suppression, get used to it. In addition, talking to someone who can understand 
or sharing experience with other patients is also a good coping strategy. 
Get along with tumour: only let it be. Now that it came to my body, just like a 
friend live in my body, no matter it is a good friend or bad friend, let it stay. (P3) 
Let nature take its course: let nature take its course. It means you should do right 
things in the right moment, depend on your physical condition. If the doctor said 
you should receive treatment, then you just receive; if not, then you should let it go. 
(P4) 
Positive thinking: I wouldn’t think that I didn’t drinking, smoking, and staying 
up late, then why I got this disease. I thought just because I didn’t have such bad 
habits, so I still preserved well liver function. In addition the tumour in a good 
location, so I could receive resection. (P30) 
Social comparison: of course I am afraid; however we still have to face this 
problem. So many people get cancer, two of my friends who also got liver cancer 
at the same year as me passed away. It is bonus from God that I live longer. (P13)   
Suppression: no, I don’t have any good way to against this disease, too many 
times (TAE treatments), it breaks down my faith. I only can stand it by myself. 
(P17) 
 
Patients tried to develop a healthy life style, separate disease and life, make simple 
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life, and find something to do (e.g. interesting or habits) as problem-oriented coping. On 
the other hand, patients did not treat themselves as patients and kept life going, separate 
disease and life, found the meaning of life, sought for religious belief, and lived here 
and now.  
As what I told you before, in psychological aspect I don’t treat myself as a 
patient, but in behavioural aspect, eating, sleeping such as, I have to treat myself as 
a patient and take these carefully. (P29) 
 
Table 5.5 Coping strategies 
 Problem-oriented Emotion-oriented 
Focus on 
disease 
 
Accept the fact 
Knowledge is power, understand the 
effects of medicine, search for 
information, health speech 
Rearrange life schedule, diet, 
exercise/chi kung, sit in 
meditation, go to bed early, quit 
bad habits 
Think and make the plan for the 
worst situation, dying preparation 
Treatment, immediately react to 
disease, find a right doctor, 
alternative prescription, new clinical 
trial, search other medical resources
Blog, record illness experience, 
share experience with others 
Crying 
Distraction, don't keep it in mind, let 
it be 
Get along with tumour 
Give hope 
Let nature take its course 
Positive thinking, change thought 
Separate attitude and behaviours, 
separate physical and 
psychological aspects 
Social comparison 
Suppression, stand it, used to it, get 
used to the symptom 
Focus on 
life 
Depend on partner 
Have something to do, interesting 
Keep normal life 
Keep social interaction 
Keep the original role  
Simple life 
To be independent 
Don't give myself too much stress, 
don't have too much desires 
Find the meaning of life 
Humor 
I don't treat myself as a patient 
Keep faith 
Keep going 
Live here and now 
Religious belief, spiritual group 
Separate disease from life 
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5.6 Discussion  
Through integrating the findings, a preliminary model of adjustment was developed 
to summarize the relationships between illness perceptions, coping, and adjustment 
outcomes shown in Figure 5.1. Adjustment to HCC is a dynamic process and many 
variables may influence this process. The variation of physical condition, personal 
characteristics, and social support are important antecedent factors. The above three 
factors may contribute to patients’ illness perceptions and coping strategies. In addition 
the adjustment outcome is constantly changing rather than a fixed result. 
 
 
 
Figure 5.1 The adjustment model in patients with HCC 
 
Previous 
liver disease 
Physical condition: 
(1) disease characteristics: stage, treatment 
(2) current physical condition and symptoms 
(3) disease progress: uptrend vs. downtrend 
Coping strategies: 
(1) problem-oriented 
(2) emotion-oriented
Adjustment outcomes: 
(1) HRQOL 
(2) psychological well-being 
(3) positive changes
Personal 
characteristics 
Social 
support 
Illness perceptions: 
(1) consequences 
(2) timeline 
(3) control 
(4) perceived causal 
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Previous liver disease. Previous liver disease, including hepatitis or cirrhosis, would 
influence the illness experience and perceptions. Some patients realized they were high 
risk patients and anticipated that one day the liver disease would progress to liver cancer. 
In addition, they may have relevant knowledge about liver disease and liver cancer, 
which was helpful for adjustment. Female patients (because of low prevalence) or 
patients without previous liver disease (e.g., HBV, HCV, or cirrhosis) may ask the 
question “why me, why I got HCC?”. 
Physical condition. Physical condition played an important role in formulating 
patients’ adjustment. The components of physical condition included disease 
characteristics, current physical condition and symptoms, and disease progress. Patients 
with different stages and treatments had diverse experience. For example, patients with 
surgery came back to hospitals regularly to receive image and blood examination; 
however patients with TAE/TACE had higher level of threat of recurrence and most of 
them received several TAE/TACE repeatedly, and patients with drug therapy have to 
receive treatment more frequently.  
Based on the time since diagnosis and progress of disease three stages: acute, 
remission, and advanced can be described. Each stage has different tasks. In the acute 
stage when disease was just diagnosed, patients and family tried to find efficacious and 
effective treatment. In the remission stage when physical condition was stable, they had 
to rearrange their life to a new balance. In the advanced stage when the disease 
recurrence and physical condition gets worse, they would receive treatment repeatedly 
and bear more psychological impact than at earlier stages. 
Current physical condition and symptoms also inform illness experience. Patients 
with better performance status, independent self-care ability, and mild symptoms have 
less stress and burden. Patients did not want to increase burden on caregivers or family, 
and rely on others’ help. Furthermore, uptrend or downtrend disease progress also 
  104
influenced illness perceptions and adjustment. If the physical condition was stable or 
progress was uptrend, then patients had positive evaluation of disease outcome and had 
faith to cope with disease. 
Uptrend: in these two years everyone (both patient and family) is relieved, we 
don’t think HCC so much, much better than the first year. Now the physical 
condition is quit stable, and the results of physical examinations are all in the 
normal range. (P15) 
Downtrend: there is no improvement. If you said it can be cured, then I can 
stand the suffering treatment (TAE) and side effect. However, it is impossible (to 
be cued), and becomes worse after each treatment, just like gets close the death… 
(P13) 
 
Physical symptom is the first consideration which can cause suffering experiences 
and formulate illness perceptions. However, physical symptom is only one antecedent 
factor. Patients who had the same physical condition may not have the same illness 
perceptions and adjustment outcomes. Patients integrate information about their current 
physical conditions, personal illness experience, and social stereotype to formulate 
illness perceptions. Patients’ personal characteristics, social support, illness perceptions, 
and coping may contribute to the outcomes of disease adjustment. 
Personal characteristics. When facing disease or other threats, personal 
characteristics can influence their cognitive evaluation (e.g., illness perceptions) or 
behavioural response (e.g., coping behaviours). Personal characteristics can be taken as 
internal resources and may modify patients’ illness perceptions and the choice of coping 
strategies. The important personal characteristics that patients mentioned in the 
interview included optimism, anxiety, and flexibility. Optimistic patients tended to use 
positive thinking or focused on the positive aspects of disease, but anxious patients may 
think the worst situations. Flexibility meant patients can modify their cognitive thoughts 
or behaviours to cope with disease flexibly. However, personal characteristics may be 
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also influenced by the disease; it is a stable rather than constant variable. Long-term 
illness experience may change patients’ personal trait, such as positive changes. 
Optimism: yes, you can say I am an optimism guy, we have to face the problem, 
can’t escape it. Now that you all have to face this, why not choose a happy attitude 
or in a positive way. (P15) 
Anxious: it is like to be sentenced by the doctor when he told me the diagnosis… 
(be sentenced)…yes, I sometimes use words so strongly, maybe it is about my 
personality, I always think the worst situations, negative aspects of events, very 
pessimistic. (P30) 
Flexibility: you have to rearrange your life and your attitude to disease and life. 
Like me, I can’t continue work that time, but 50 years old is the best time, I was in 
manage level, I still had to give up. If you can do that then try your best, if not, you 
only can accept it.  
 
Social support. Social support, for example tangible and emotional support from 
families, was an important resource that helped patients to deal with the disease. . The 
sources of social support included partners, family members, and friends, but mainly the 
first two. Social support, as an external resource, can provide patients with assistance in 
dealing with the demands of disease. However, there were tensions between patients 
and families or friends. Most patients did not want to increase their family’s burden. 
They may reduce their social interactions with unfamiliar friends because of feeling 
inferior or perceiving that they are being judged by others. Whether to supplement 
medical treatment with Chinese herbal medicine was also an important issue about 
treatment decisions. In addition, social relationship is an important motivation for 
patients to overcome the disease. Patients didn’t want to let their relatives or friends 
disappoint, so they tried hard to against the disease.  
Haha, my friends asked me how I could stand up from such a big disease. 
Because I had a lot of support, my sons, their supports, provided information, be 
with me. A lot of relatives and friends encouraged me, supported me. Through 
these, I could face the disease. (P24) 
  Furthermore, cultural background influenced the disease process and had interactions 
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with patients’ adjustment. For example, family members were deeply involved the 
treatment decisions and care plans. In some extreme examples, adult sons or daughters 
would make decisions for elderly parents. However it cannot be denied that this cultural 
background provides strong support, no matter whether tangible or emotional, for 
patients to cope with this severe disease.  
 
Illness perceptions. Illness perceptions and coping reactions can be linked between 
physical condition and adjustment outcome. Physical condition or symptoms, 
knowledge of disease, and social stereotype of disease formulated patients’ illness 
perceptions. A majority of patients perceive HCC as a chronic disease with great threat, 
but the consequence of disease may depend on the disturbance of performance status, 
symptoms, and daily life. 
Coping strategies. Based on illness perceptions, patients tried to make efforts to cope 
with the demands caused by the disease. Focusing on current symptoms, patients found 
suitable doctors and appropriate treatments; focusing on causal factors, patients 
rearrange their life schedule, quit bad habits, and develop healthy habits; focusing on 
timeline, patients learn to accept the disease and get along with the tumour. On the other 
hand, the outcome of coping also regulated their illness perceptions. Successful 
experience enhances the feeling of control. For example, patients maintained healthy 
life style because they realized it could reduce burden on the liver and might be helpful 
for preventing recurrence. Unsuccessful experience made them modify their coping or 
illness experience. They recognized the disease as a chronic and high threatening 
disease because of recurrence and repeatedly treatment, and they might try to use 
emotion-oriented coping to accept the disease and regulate their emotional responses. 
Adjustment outcomes. Regarding the outcome of disease, comprehensive indices were 
necessary to evaluate patients’ adjustment rather than a physical index. HRQOL was a 
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suitable index that combines objective and subjective measures. In addition, 
psychological well-being can focus on psychological aspects only, including negative 
feeling, such as anxiety, depression, or uncertainty; as well as positive feeling, such as 
peaceful, happiness, or satisfaction. Finally, positive change was a potential index which 
can help patients to cope with disease and get along with the tumour.  
 
The disease has wide impact on not only physical symptoms but also psychosocial 
and daily aspects. The findings support that earlier views that the measures of HRQOL 
for patients with HCC should incorporate generic and disease-specific aspects (Blazeby 
et al., 2004; Heffernan et al., 2002), and the assessment should cover multiple aspects of 
life. On the other hand, it is also important to note the positive change in that the disease 
may bring the positive effects on personal growth or family relationships (Steel, 
Gamblin, & Carr, 2008). 
The findings supported previous research in that illness perceptions can play 
important roles in the relationship between illness and adjustment outcome (Hagger & 
Orbell, 2003; Leventhal et al., 1984) and relate to coping strategies. In addition, the use 
of coping strategies depends on illness perceptions, personal characteristics and 
stressors. Patients search relevant information and try to figure out the potential causal 
factors and effective interventions for the disease. For example alcohol drinking, fatty 
food, and staying up late are negative factors which increase liver’s burden, and patients 
will change bad habits and develop healthy habits and life style. However, multiple 
factors cause the disease and most of the time patients cannot recognize which factor is 
the exactly causal factor, and the disease cannot be cured in a short period. 
Emotion-oriented coping is an essential coping strategy that patients have to learn in the 
illness trajectory. Most patients stress that they learn to face the disease and take the 
essential reaction, however if the disease progress worse, they have to accept the 
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situation and let it take the nature course. 
The adjustment outcomes would feedback to illness perceptions and coping strategies, 
and patients would change their illness perceptions and modify coping strategies based 
on the outcome. Patients deal with the demands of disease until achieving a balanced 
status, and when the variation in physical or internal conditions, they will try to achieve 
a new balance status. 
This study used a qualitative method to explore HCC patients’ illness perceptions and 
adjustment process. The impact of disease, illness perceptions, information needs, and 
coping strategies were identified, and a preliminary model of adjustment was developed. 
The findings have some implications for clinical care. First, health professionals should 
deliver appropriate information to meet patients and family’s needs. Second, a family 
can be taken as a unit so that health professionals educate the whole family about how 
to take care of patients, and assist family interaction. Third, health professionals can 
help patients to identify their illness perceptions and find individuals’ coping strategies, 
in addition to amend strategies following different stages and physical conditions. This 
study illustrated a preliminary model of adjustment in patients with HCC based on 
qualitative data, and the future study is to use quantitative technique to establish the 
statistic relationships between illness perceptions, coping, and adjustment.   
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Chapter 6. Quantitative Study. Part I: The Impact of HCC 
 
6.1 Abstract 
Aims: In Chapter 5 the themes developed from qualitative data included the impact of 
HCC, information needs, how patients perceived the illness and how they coped with 
HCC. The aims of this quantitative study were to explore the impact of HCC by 
determining: (1) differences in HRQOL between patients with HCC and the general 
population, and patients with liver cancer; (2) the prevalence of anxiety, depression, and 
emotional distress; and (3) perceptions of HCC using a standardized measure. 
Methods: Participants were 286 patients with HCC, and data collection included (1) 
adjustment outcomes: HRQOL, anxiety and depression; (2) psychological variables: 
illness perceptions, coping, and social support; and (3) demographic and physical 
variables: demographic information, disease and treatment characteristics (stage, 
treatment, Child-Pugh stage, and time since diagnosis), and current physical conditions 
(ECOG, α-FP, T-bilirubin, Albumin, GOT (Glutamate Oxaloacetate Transaminase), GPT 
(Glutamic Pyruvic Transaminase), INR (International Normalized Ratio), and Platelet). 
Results: Patients with HCC had worse global HRQOL, physical, role, cognitive, and 
social functioning; but better emotional functioning than the general population. The 
prevalence of clinical anxiety, depression and emotional distress in patients with HCC 
was 11.27%, 25.44%, and 20.14% respectively. The most severe problems in HRQOL 
included trouble doing strenuous activities, sleeping in daytime, and lack of vitality. The 
perceived causal factors of HCC included HBV and HCV, drinking alcohol, and fatigue.  
  Conclusions: HCC was associated with adverse physical and psychological impact on 
patients’ HRQOL. Based on these findings, an integrative adjustment model will be 
described in the next chapter. 
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6.2 Introduction 
As discussed in Chapters 1 and 3, HCC has a wide impact on society, patients, and 
their families and, as with all cancer patients, issues of adjustment and HRQOL are 
paramount. Improved survival rates and awareness of the potential problems associated 
with treatment means there is a growing emphasis on psychological well-being and 
adaptation when facing cancer or chronic illness (Folkman & Greer, 2000). The results 
of a systematic review (Chapter 3) highlighted that HCC had considerable adverse 
consequences for physical and psychological aspects of HRQOL. Furthermore, this 
review indicated that although treatment and physical variables are important, 
psychological variables also play an important role in determining HRQOL and 
adjustment outcomes (Fan, Eiser, & Ho, 2010). 
Based on patient interviews, the work in Chapter 5 described the range of variables 
that may influence the dynamic process of adjustment between patients’ perceptions of 
the disease, their efforts to cope with the disease and related demands, and adjustment 
outcomes. In this chapter the influences of HCC on HRQOL, illness perceptions, and 
coping strategies will be explored further through quantitative work, using standardized 
measures with a representative sample. 
A key theme identified in the interviews was patients’ perceptions of the illness and 
these ideas have been more formally described previously by Leventhal, Nerenz, and 
Steele (1984). According to the Common Sense Model (see Figure 6.1), patients 
actively process (for example understand and interpret) information related to their 
health status or illness. Patients develop two parallel-processing pathways, involving 
cognitive representations and emotional responses to their illness. Based on these 
representations, patients plan and implement coping behaviours to manage the problems. 
After that, patients evaluate the results of coping in terms of whether the desired goals 
have been achieved. As a result of feedback from illness outcomes or appraisal of 
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coping, patients modify their illness representations and coping behaviours. This 
processing system is hierarchically organized (Leventhal et al., 1984). 
 
 
Figure 6.1 Common Sense Model of illness representations (Source: Hagger & Orbell, 
2003; Leventhal et al., 1984) 
 
Illness representations are important in the process of adjustment to chronic disease 
(Leventhal et al., 1984; Weinman & Petrie, 1997). As originally described, there are five 
components of illness representations, including (1) identity about the label or nature of 
their conditions, (2) causal belief about the causes of their disease, (3) timeline about 
the duration of their disease, (4) consequences about the impact of disease on one’s life, 
and (5) cure beliefs about whether their disease is amenable to cure or control (Skelton 
& Croyle, 1991; Weinman, Petrie, Moss-Morris, & Horne, 1996; Weinman, 1996). 
Illness representations can be assessed with a standardized instrument, the Illness 
Perception Questionnaire (IPQ), which includes five subscales: identity, cause, timeline, 
consequences, and control/cure (Weinman et al., 1996). In order to improve the internal 
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consistency of control/cure and timeline subscales, as well as to address a greater 
construction of illness perceptions, a revised version of IPQ (IPQ-R) was developed. 
This includes 11 scales: timeline acute/chronic, timeline cyclical, consequences, 
personal control, treatment control, illness coherence, emotional representations, and 
causal beliefs about the contribution of psychological factors, behavioural risk factors, 
immunity, and accident or chance (Moss-Morris et al., 2002). For clinical application 
and rapid screening, the brief IPQ was developed incorporating nine items including 
cognitive representation, emotional representation, understanding of illness, and causal 
factors (Broadbent, Petrie, Main, & Weinman, 2006). 
The importance of illness perceptions has been identified in diverse diseases, such as 
chronic fatigue syndrome (Moss-Morris, Petrie, & Weinman, 1996), heart disease 
(Broadbent, Ellis, Gamble, & Petrie, 2006; French, Lewin, Watson, & Thompson, 2005), 
Huntington’s disease (Kaptein et al., 2006), as well as cancers (Rozema, Vollink, & 
Lechner, 2009; Scharloo et al., 2005). A meta-analysis conducted by Hagger and Orbell 
(2003) supported hypothesized relationships between illness cognitions, coping 
behaviours, and psychological outcomes across different diseases. When patients 
perceived their disease as controllable, they tended to use cognitive strategies such as 
re-appraisal and problem-oriented coping. In addition, better adjustment outcomes, for 
example psychological well-being, were related to lower perceived consequences and 
illness identity. 
In addition to these perceptions, coping involves both cognitive and behavioural 
efforts to manage the external or internal demands that are appraised as taxing or 
exceeding the resources of the person (Lazarus & Folkman, 1984). In general, there are 
two kinds of coping behaviours: problem-oriented coping aims to manage the stressor 
or solve the problem, and emotion-oriented coping aims to regulate the emotional 
response which is induced by the stressor. Past studies have shown that coping 
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strategies are related to adjustment in cancer patients. For example, psychosocial 
adaptation has been found to be positively related to support and self-control rather than 
denial (Heim, Valach, & Schaffner, 1997). Emotional coping strategies, such as focusing 
on the positive aspects and distancing were associated with less emotional distress, but 
avoidance was associated with more emotional distress (Dunkel-Schetter, Feinstein, 
Taylor, & Falke, 1992). Positive re-appraisal and actively processing emotions has been 
found to be associated with better adaptation (Stanton, Danoff-Burg, & Huggins, 2002). 
The interaction of problem-oriented coping and perceived control has been found to be 
a significant predictor of lower anxiety/depression that patients perceived high control 
and used problem-oriented coping had lowest anxiety/depression symptoms (Osowiecki 
& Compas, 1998). In addition, patients may use different ways to cope with different 
cancer-related stressors. Future research need to focus on the connection between the 
stress (De Faye, Wilson, Chater, Viola, & Hall, 2006), appraisal, and coping processes 
(Thomsen, Rydahl-Hansen, & Wagner, 2010). 
The main purposes of this quantitative study (Chapter 6 and 7) were to explore the 
HRQOL in patients with HCC and to identify the significant variables that may 
influence their adjustment process, specifically based on the Common Sense Model of 
illness perceptions and coping theory. Adjustment outcomes were HRQOL, anxiety, and 
depression; and predictive variables included demographic and physical variables 
(disease and treatment characteristics, and current physical conditions), and 
psychological variables (illness perceptions, coping, and social support). The details of 
variables are presented in Figure 6.2. 
Specific aims were to explore HRQOL in patients with HCC by determining: (1) 
differences in HRQOL between patients with HCC and the general population, and 
patients with liver cancer; (2) the prevalence of anxiety, depression, and emotional 
distress; and (3) perceptions of HCC. 
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Figure 6.2 The categories of variables in this study 
 
 
6.3 Method 
6.3.1 Participants and procedures 
Adult patients with HCC were recruited from two medical teaching hospitals in 
Taiwan. Inclusion criteria were: (1) diagnosis of HCC stages (I to IV), undergoing 
surgery, TAE/TACE, and chemotherapy; (2) age 18 years or older; and (3) able to speak 
Chinese or Taiwanese. Patients with a history of suicidal ideation or psychosis were 
excluded. 
Ethics approvals were obtained from the Department of Psychology, University of 
Sheffield and both participating hospitals in Taiwan (National Taiwan University 
Hospital and Chi-Mei Medical Center, Liou Ying). Medical staff identified patients who 
met the inclusion criteria, and the researcher approached the potential patients to 
provide a verbal explanation and give them detailed information sheets. Patients signed 
a consent form if they were willing to participate in the research. Questionnaires were 
administered in the clinic or inpatient wards. If participants could not finish 
questionnaires in one session because of their physical condition, data collection was 
administered over more than one session but within one week. 
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6.3.2 Measures 
Three categories of variables in this quantitative study included: (1) Demographic 
and physical variables, (2) adjustment outcomes, and (3) psychological variables (see 
Figure 6.2). 
 
(1) Demographic and physical variables 
Demographic data were obtained from patients’ reports. Disease characteristics and 
current physical conditions were obtained from medical charts. 
(i) Demographic information included gender, age, job, education level, marital 
status, and whether they needed a caregiver and who provided care.  
(ii) Disease characteristics included stage of HCC based on AJCC (Schafer & Sorrell, 
1999) and BCLC (Bruix & Sherman, 2005) stage, most recent treatment, Child-Pugh 
stage, diagnosis date, past treatment history.  
(iii) Current physical conditions included ECOG performance status score (Oken et 
al., 1982), and physical examinations: including α-FP, T-bilirubin, Albumin, GOT 
(Glutamate Oxaloacetate Transaminase), GPT (Glutamic Pyruvic Transaminase), 
Platelet, and INR (International Normalized Ratio). 
 
(2) Adjustment outcomes 
 (i) HRQOL. The EORTC QLQ-C30 was used to evaluate patients’ cancer specific 
HRQOL. This incorporates five functional scales: physical (five items), role (two items), 
emotional (four items), cognitive (two items) and social (two items) functioning; three 
symptoms scales: pain (two items), fatigue (three items), nausea/vomiting (two items); 
and six single items (dyspnoea, insomnia, appetite loss, constipation, diarrhea, and 
financial difficulties); as well as a global HRQOL (two items) assessment. (EORTC 
website: http://groups.eortc.be/qol/) (Aaronson et al., 1993; Fayers et al., 2001). In 
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addition, the EORTC QLQ-HCC18 was used to measure disease-specific HRQOL in 
patients with HCC, including fatigue (three items), body image (two items), jaundice 
(two items), nutrition (five items), pain (two items), fever (two items), sexual interest 
(one item) and abdominal swelling (one item) (Blazeby et al., 2004).  
The EORTC QLQ-C30 and HCC-18 can be scored to yield three scores: 
(1) global HRQOL score: two items concerning global HRQOL; 
(2) functioning score: five subscales: physical, role, emotional, cognitive, and social 
functioning; and 
(3) symptom score: all symptom items in EORTC QLQ-C30 and HCC18 were 
combined to reduce the number of dependent variables. 
A high score on the functional scale or global HRQOL indicates high level of 
functioning and good HRQOL, and high scores on symptom scale indicates worse 
symptoms. The scale has been translated into Chinese, with demonstrated reliability and 
validity (Chie, Yang, Hsu, & Yang, 2004). 
 
(ii) Anxiety and depression. Anxiety and depression were measured by the Hospital 
Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983). The 14 items 
comprise anxiety (7 items; e.g., “I feel tense or wound up”) and depression (7 items; e.g., 
“I can laugh and see the funny side of things”) scales. Responses are made using 4-point 
Likert scales and scored to yield sum scores for each of these two scales. A score of 0 to 
7 for either subscale is regarded as being in the normal range, 8 to 10 being suggestive 
of the presence of the respective state, and 11 or higher indicating probable presence 
('caseness') of the mood disorder. In addition, a total HADS score of 15 or above has 
been defined as emotional distress (Strong et al., 2007). The HADS has been found to 
perform well in assessing the symptom severity and caseness of anxiety disorders and 
depression in primary care patients (Bjelland, Dahl, Haug, & Neckelmann, 2002). 
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(3) Psychological variables 
 (i) Illness perceptions. The Brief Illness Perception Questionnaire is a nine item 
questionnaire (Brief IPQ) (Broadbent, Petrie et al., 2006) yielding three scores: 
cognitive representations (five items: consequences, timeline, personal control, 
treatment control, and identity), emotional representations (two items: concerns and 
emotions), illness comprehensibility (one item: understanding). Responses are made on 
10-point Likert scales; and one item about causal representation is assessed by an 
open-ended question (IPQ website: http://www.uib.no/ipq/). Higher scores indicate 
more negative illness perceptions. The test-retest reliabilities of all items range from .48 
to .70, and the discriminant validity has been found to be good (Broadbent, Petrie et al., 
2006) and Brief IPQ has been translated into Chinese. 
 
(ii) Coping. Coping strategies were assessed using the Jalowiec coping scale, which 
is based on Lazarus and Folkman’s coping theory (Jalowiec & Powers, 1981). It 
contains 40 items to assess emotion-orientation coping (25 items; e.g., “worried about 
the problem”, “seek comfort or help from family or friends”) and problem-orientation 
coping (15 items; e.g., “tried to find out the information about the disease and 
treatment”, “actively try to change the situation”). Patients are asked to rate the 
frequency of using coping strategies on 4-point scales (0=never, 3=always) (Jalowiec, 
Murphy, & Powers, 1984). The questionnaire has been translated into multiple 
languages including Chinese, and has good reliability and validity (Jalowiec, 2003). 
 
(iii) Social support. The 15-item Inventory of Social Support Behaviour (Barrera, 
1981; Barrera & Ainlay, 1983) was used to assess patients’ perceptions of the amount of 
social support, including tangible assistance (six items; e.g., “did some activity together 
to help you get your mind off things”), emotional support (four items; e.g., “listened to 
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you talk about your private feelings”), and informational and appraisal support (five 
items; e.g., “gave you some information on how to cope with disease”). Items are 
scored on 4 point response scales (1=not at all to 4=always) and higher scores indicate 
better social support. In addition, one open-ended item is used to assess the source of 
social support. The Cronbach’s α of the total scale is .88 (Barrera, 1981; Barrera & 
Ainlay, 1983). The questionnaire has been translated into Chinese and has good 
reliability and validity (Tseng, 1999). 
 
6.3.3 Statistical analysis 
Descriptive statistics were used for all variables (frequency, mean, standard deviation, 
and range). Scales were scored according to guidelines in relevant publications or on 
websites. One sample t-tests were used to examine the differences in HRQOL between 
patients with HCC and the general population; as well as patients with liver cancer. The 
Statistical Package for Social Sciences (SPSS) windows version 16.0 was used for all 
statistical analyses. 
 
6.4 Results 
6.4.1 Demographic and medical characteristics 
A total of 298 patients were contacted but 12 refused to participate because they felt 
uncomfortable, did not have time or they did not want to. Thus, 286 patients were 
recruited and details of demographic and medical information are presented in Tables 
6.1 and 6.2. The mean age of patients was 59.85 years (SD=12.16), and 76.22% were 
males. Just over half of the patients (65.38%) stated they could take care of themselves 
without caregivers. Mean time since diagnosis was 28.70 months (SD=26.43). In 
addition, 117 (40.91%) patients received surgery and 108 (37.76%) were in stage 1 of 
AJCC. 
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Table 6.1 Demographic data                                      n=286 
Variables  Frequency (%) 
Age (yrs) 
  Mean=59.85 (SD=12.16), range=25.46-84.81 
 
Gender   
  Male 218(76.22) 
  Female 68(23.78) 
Education   
Elementary school  112(39.16) 
Junior high school 52(18.18) 
Senior high school 54(18.88) 
Undergraduate 59(20.63) 
Postgraduate 9(3.15) 
Marital status  
Single 15(5.24) 
Married/ Living with partner 258(90.21) 
Divorced/ Separated 8(2.80) 
Widowed 5(1.75) 
Religion  
General religion 64(22.38) 
Buddhism   86(30.07) 
Taoism 26(9.09) 
Christian 9(3.15) 
Catholic 2(0.70) 
None  91(31.82) 
Other  8(2.80) 
Job  
Full time 52(18.18) 
Part time 23(8.04) 
None 211(73.78) 
Main caregiver  
  Self  187(65.38) 
Husband/Wife 55(19.23) 
Son/Daughter 35(12.24) 
Father/Mother 3(1.05) 
Other relatives/ Friend 1(0.35) 
Other 5(1.75) 
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Table 6.2 Disease and medical information                          n=286 
Variables  Frequency (%) 
Time since diagnosis (months) 
  Mean=28.70 (SD=26.43), range =0.07-121.20 
 
Most recent treatment   
  Surgery  117(40.91) 
  TAE/TACE 96(33.57) 
Drug therapy 73(25.52) 
ECOG  
  0 147(51.40) 
  1 77(26.92) 
  2 38(13.29) 
  3 20(6.99) 
  4 4(1.40) 
AJCC stage  
  Stage 1 108(37.76) 
Stage 2 65(22.73) 
Stage 3 87(30.42) 
Stage 4 12(4.20) 
  Missing 14(4.90) 
BCLC stage  
Stage A 25(8.74) 
Stage B 34(11.89) 
Stage C 10(3.50) 
Stage D 3(1.05) 
  Missing 214(74.83) 
Child-Pugh stage  
Stage A 224(78.32) 
Stage B 42(14.69) 
Stage C 16(5.59) 
  Missing 4(1.40) 
Chronic disease  
HBV 184(64.34) 
  HCV 85(29.72) 
  Diabetes 48(16.78) 
  Hypertension 81(28.32) 
  Chronic obstructive pulmonary disease 1(0.35) 
  Kidney disease 3(1.05) 
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Medical examination  
α-FP (normal range: <20) Normal: 168(58.74) 
Abnormal: 87(30.42) 
Missing: 31(10.84) 
  T-bilirubin (normal range: 0.2-1.2) Normal: 158(55.24) 
Abnormal: 109(38.11) 
Missing: 19(6.64) 
  Albumin (normal range: 3.5-5.0) Normal: 40(13.99) 
Abnormal: 32(11.19) 
Missing: 214(74.83) 
  GOT (normal range: ♀<31, ♂<37) Normal: 92(32.17) 
Abnormal: 167(58.39) 
Missing: 27(9.44) 
  GPT (normal range: ♀<31, ♂<41) Normal: 113(39.51) 
Abnormal: 170(59.44) 
Missing: 3(1.05) 
  Platelet (normal range: 120-320) Normal: 165(57.69) 
Abnormal: 101(35.31) 
Missing: 20(6.99) 
  INR (normal range: 0.8-1.2) Normal: 48(16.78) 
Abnormal: 10(3.50) 
Missing: 228(79.72) 
 
 
6.4.2 Psychometric characteristics of standardized measures 
  The means, standard deviations, and Cronbach’s α for subscales in EORTC, HADS, 
Brief IPQ, coping scale, and inventory of social support behaviour are presented in 
Table 6.3. These subscales will be used in hierarchical regression analyses in the next 
chapter. 
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Table 6.3 Psychometric characteristics of standardized measures 
Subscales  Mean (SD) Cronbach’s α
EORTC (range: 0-100)   
Global HRQOL 50.76(20.19) .77 
Physical functioning 78.18(21.43) .84 
Role functioning 70.98(32.34) .95 
Emotional functioning 80.97(17.88) .66 
Cognitive functioning 83.97(17.17) .51 
Social functioning 81.29(24.87) .90 
Symptom 16.89(12.53) .88 
HADS   
Anxiety (range: 0-21) 3.64 (2.91) .74 
Depression (range: 0-21) 4.81 (3.99) .84 
Emotional distress (range: 0-42) 8.46 (6.31) .87 
Brief IPQ (range: 0-10)   
Cognitive representation  5.07(3.05) .78 
Emotional representation* 5.76(2.15) .56 
  Understanding 7.95(2.23) -- 
Coping scale   
Problem-oriented coping (range: 0-45) 9.85(7.57) .87 
Emotion-oriented coping (range: 0-75) 13.67(5.31) .52 
Inventory of social support behaviour   
Tangible support (range: 6-24) 15.59(3.73) .85 
Emotional support (range: 4-16) 11.52(2.37) .85 
Informational and appraisal support (range: 5-20) 14.06(2.60) .74 
-- single item 
* only two items 
 
6.4.3 Aim 1: Differences in HRQOL between patients with HCC and the general 
population, and patients with liver cancer 
Student’s t-test was used to compare with a norm of general population (n=5087-7722, 
depended on different scales) (Scott et al., 2008), patients with HCC had worse global 
HRQOL, t(287.8297)=-16.71, p<.001, physical, t(288.2039)=-9.03, p<.001, role, 
t(292.3532)=-7.09, p<.001, cognitive, t(287.0386)=-2.05, p<.05, social, 
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t(289.3312)=-4.16, p<.001, functioning; but better emotional functioning, 
t(287.2006)=4.29, p<.001 than the general population.  
Student’s t-test was used to compare with a norm of patients with liver/bile/pancreas 
cancer (n=244-739, depended on different scales) (Scott et al., 2008), patients with 
HCC had worse global HRQOL, t(254.6401)=-3.40, p<.001; but better physical, 
t(66.51761)=1.96, p<.05, role, t(2758.2318)=2.56, p<.001, emotional, t(230.6749)=7.89, 
p<.001, cognitive, t(241.3337)=3.75, p<.001, and social functioning, t(249.3544)=6.53, 
p<.001. 
 
 
6.4.4 Aim 2: The prevalence of anxiety, depression, and emotional distress in patients 
with HCC 
As shown in Table 6.4, 9.51% patients showed symptoms of mild anxiety and 1.76% 
had severe anxiety; and 13.42 % had mild depression and 12.02% had severe depression. 
In addition, 20.4% patients scored above the cut-off for emotional distress. 
Compared with a norm of general population (n=1792, Crawford, Henry, Crombie, & 
Taylor, 2001), patients with HCC had lower levels of anxiety, t(281.8747)=-12.91, 
p<.01, and emotional distress, t(284.3488)=-3.41, p<.01; but had higher levels of 
depression, t(284.7096)=4.58, p<.01.  
 
Table 6.4 The prevalence of anxiety, depression, and emotional distress 
 Cut-off point % 
Anxiety  Mild: 8 ≦HADS-A≦10 
Severe: 11≦HADS-A 
9.51 
1.76 
Depression Mild: 8 ≦HADS-D≦10 
Severe: 11≦HADS-D 
13.42 
12.02 
Emotional distress 15≦HADS-A +HADS-D 20.14 
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6.4.5 Aim 3: Perceptions of HCC 
The means and standard deviations for each item (range from 0 to 10) in brief IPQ are 
presented in Table 6.5. Highest scores in understanding and timeline indicated that 
patients had high level of illness understanding and thought that the disease would 
continue to a long period. Lowest scores in identity and treatment control indicated that 
patients experienced few symptoms, but treatment could not help their disease. 
 
Table 6.5 The mean (SD) of Brief IPQ items 
Variables Mean (SD) 
Consequences 5.48(3.12) 
Timeline 7.54(2.04) 
Personal control 5.54(2.60) 
Treatment control 3.41(2.00) 
Identity 3.35(2.72) 
Concern 6.73(2.17) 
Understanding 7.95(2.23) 
Emotional response 4.80(2.95) 
 
 
Perceived causal factors are listed in Table 6.6. Patients were most likely to report the 
causes of their disease to be liver diseases especially HBV (36.01%), health-related 
behaviours (drinking, 14.69%; staying up late, 6.64%; irregular life schedule, e.g., 
eating or sleeping not on time, 4.5%; or diet and food, e.g., not fresh or can food, 
4.20%), stress-relevant factors (negative emotion, 3.15%; or heavy-load or high stress 
level of working, 5.24%), fatigue (6.99%), genetic and family tendency (5.94%). 
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Table 6.6 The perceived causes of HCC 
Factors  N(%) Factors  N(%) 
Liver diseases  Health-related behaviours  
  HBV 103(36.01) Drinking 42(14.69)
  HCV 31(10.84) Stay up late/ sleep 19(6.64) 
Hepatitis (non specific)  6 (2.10) Irregular life schedule 13(4.55) 
  Cirrhosis, fatty liver 2 (.70) Diet and food 12(4.20) 
  Bad life habits 6(2.10) 
Stress-relevant factor  Smoking  5(1.75) 
Stress 10(3.50) Didn't take care of body 5(1.75) 
Emotion 9(3.15) No health examination 4(1.40) 
Working 15(5.24)   
  Genetic or family tendency 17(5.94) 
Fatigue  20(6.99) Other  25(8.74) 
 
 
6.5 Discussion 
In this chapter quantitative data were used to explore the impact of HCC, focusing 
on HRQOL and negative emotional feelings; as well as patients’ reactions to HCC, 
focusing on illness perceptions and coping behaviours. Patients in this study had worse 
global HRQOL, physical, role, cognitive, and social functioning; but better emotional 
functioning than the general populations. The disease influenced patients’ daily 
activities, disturbed sleep, the need to take a rest in daytime, as well as decreased 
vitality or feeling tired (Bianchi et al., 2003). The prevalence of anxiety, depression and 
emotional distress in patients with HCC was 11.27%, 25.44%, and 20.14% respectively. 
In addition patients with HCC had higher levels of depression than the general 
population. 
HCC impacted widely on patients’ HRQOL. Similar to previous studies (Kondo et al., 
2007; Lee et al., 2007; Steel, Chopra et al., 2007), patients with HCC had worse 
HRQOL but better emotional functioning than general population. However, HCC may 
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cause negative feelings in patients (Huang & Lin, 2009) as, based on the HADS, more 
than one-fifth of patients with HCC experienced emotional distress. The finding that 
these patients reported better emotional functioning than the general population needs 
careful explanation. Considering the results of the EORTC and HADS scores, the 
inconsistent results might arise for several reasons. First, it is possible that, the 
emotional functioning subscale in EORTC includes only general items (e.g., did you 
worry, did you feel depressed?) but the HADS includes more specific and detailed items 
resulting in more psychological problems being detected. Second, when patients 
adjusted to the disease, they may experience positive growth/changes from the illness 
experience. However, health professionals should focus on a certain groups of patients 
who might have emotional problems, especially depression. 
Patients interpreted the disease as having broad consequences, long-term timeline, 
and low treatment control. In addition, patients reported high level of understanding 
about HCC. They reported that the factors which impaired liver function or increased 
burden on the liver would induce HCC, included HBV, HCV, drinking alcohol, or 
fatigue. There were socio-cultural reasons that patients believed these factors would 
cause their HCC. For example, there is a high prevalence of HBV and HCV in Taiwan, 
and people believed that alcohol and fatigue could damage their liver. 
A limitation should be noted that the norms for EORTC are from Western countries 
(Austria, Denmark, Germany, Norway, and US), and the differences in social-cultural 
background may compromise the comparisons. For example, Taiwan patients may have 
self-report bias that under-response the psychosocial items, especially only few items 
about psychological issues in EORTC.  This chapter only described the physical and 
psychological impact of HCC, illness perceptions, and coping behaviours. Further 
regression analyses will be conducted in the next chapter to test the relationships 
between physical, psychological variables and adjustment outcomes. 
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Chapter 7. Quantitative Study. Part II: The Role of Illness Perceptions and Coping 
in HRQOL and Adjustment in Patients with HCC  
 
7.1 Abstract 
Aims: This quantitative study builds on the data presented in Chapter 6 to establish a 
model of the relationships between illness perceptions, coping, and adjustment 
outcomes derived from the Common Sense Model (Leventhal et al., 1984) in patients 
with HCC. Using the data described in Chapter 6, we aimed to determine: (1) 
relationships between demographic and physical variables and the EORTC and HADS 
scores, as well as illness perceptions; (2) relationships between psychological variables 
and the EORTC and HADS scores; (3) significant physical and psychological predictors 
of the EORTC and HADS scores; and (4) mediation effects of illness perceptions and 
coping. 
Methods: Participants, data collection, measures, and procedures were described in 
Chapter 6. Correlation and hierarchical regression analyses were used to investigate the 
relationships between variables. 
Results: Demographic and physical variables explained significant amounts of 
variance in the EORTC (global HRQOL and all subscales; R2=.17-.62) and HADS 
scores (anxiety, depression, and emotional distress; R2=.26-.36). Psychological variables 
(illness perceptions, coping, and social support) also explained significant amounts of 
variance in the EORTC (R2=.09-.50) and HADS scores (R2=.42-.52). The significant 
physical predictors of EORTC and HADS scores were ECOG and α-FP; and the 
significant psychological predictors were cognitive and emotional representations. In 
addition, illness perceptions explained an additional 2.90%-33.12% of the variance in 
the EORTC and HADS scores after controlling for ECOG and α-FP. In testing 
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mediation, cognitive representations mediated the effects of ECOG on all EORTC and 
HADS scores; and problem-oriented coping only mediated the effects of cognitive 
representations on global HRQOL, depression, and emotional distress. 
  Conclusions: The results suggest that cognitive and emotional illness representations 
mediate the relationships between physical variables and adjustment outcomes. Other 
potential pathways of adjustment are also discussed. 
 
 
7.2 Introduction 
In this chapter, the data described previously are used to test the relationships 
between adjustment outcomes (EORTC: global HRQOL and all subscales; and HADS: 
anxiety, depression, and emotional distress), demographic and physical variables 
(demographic information, disease characteristics, and current physical conditions), and 
psychological variables (illness perceptions, coping, and social support) (see Figure 7.1). 
The aims were to determine:  
(1) relationships between demographic and physical variables and the EORTC and 
HADS scores, as well as illness perceptions;  
(2) relationships between psychological variables and the EORTC and HADS scores;  
(3) significant physical and psychological predictors of the EORTC and HADS scores; 
and  
(4) mediation effects of illness perceptions and coping. 
Based on the Common Sense Model (Leventhal et al., 1984; Weinman & Petrie, 
1997), it was hypothesized that physical variables would influence adjustment outcomes, 
but that their influences may be through illness perceptions and coping. Illness 
perceptions might mediate the effects of physical variables on the EORTC and HADS 
scores, and coping might mediate the effects of illness perceptions on the EORTC and 
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HADS scores.  
 
 
Figure 7.1The categories of variables in this study 
 
 
7.3 Methods 
The participants, standardized questionnaires, and research procedures were the same 
as Chapter 6.  
 
7.3.1 Screening of variables 
 The basic assumptions of multivariate analysis were first examined including normal 
distribution, multicollinearity, and outliers (Field, 2005). The physical examinations 
Physical variables: 
(1) disease and treatment characteristics: stage of HCC, 
most recent treatment, Child-Pugh stage, diagnosis 
date, and past treatment history 
(2) current physical condition: ECOG, α-FP, T-bilirubin, 
Albumin, GOT, GPT, Platelet, and INR 
Adjustment 
outcomes: 
(1) EORTC 
scores: global 
HRQOL; 
physical, role, 
emotional, 
cognitive, 
social 
functioning; 
and symptom 
scales 
(2) HADS scores: 
anxiety, 
depression, and 
emotional 
distress 
Demographic information:  
gender, age, job, education level, marital status, whether 
they need a caregiver and who provided care, and 
whether they know their diagnosis 
Psychological variables: 
(1) illness perceptions: cognitive and emotional 
representations, and understanding 
(2) coping strategies: problem- oriented coping and 
emotion-oriented coping 
(3) social support: tangible assistance, emotional 
support, and information and appraisal support 
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(current physical conditions: α-FP, T-bilirubin, Albumin, GOT, GPT, Platelet, and INR) 
had extreme outliers and were not normally distributed; therefore, dichotomous 
variables (normal vs. abnormal) were used in the regression analyses. Other categorical 
variables (treatments, stages, ECOG, and Child-Pugh) were transformed into dummy 
variables. Descriptive statistics were used for all variables (frequency, mean, standard 
deviation, and correlation). Spearman’s correlation was used to determine the 
relationships between categorical variables and the EORTC, HADS scores; Pearson’s 
correlation was used to test the relationships between the EORTC, HADS scores and 
illness perceptions, coping and social support. Variables (Albumin and INR) that had 
too many missing data were not entered in the regression analysis. 
 
7.3.2 Statistical analysis 
Aim 1. First, MANOVAs were conducted to test differences in the EORTC and 
HADS scores between patients (1) at different stages, and (2) who received different 
treatments. Second, demographic and physical variables were used to predict the 
EORTC and HADS scores, as well as illness perceptions by hierarchical regressions. 
Aim 2. Hierarchical regressions were used to predict the EORTC and HADS scores 
from illness perceptions, coping, and social support. 
Aim 3. Both physical and psychological variables were entered in hierarchical 
regressions to predict the EORTC and HADS scores. We investigated the influences of 
coping and social support on the relationships between illness perceptions and the 
EORTC and HADS scores, when controlling the effects of demographic and physical 
variables. 
Aim 4. The mediation effects of illness perceptions on relationships between the 
physical variables and EORTC, HADS scores; and coping on relationships between 
illness perceptions and EORTC, HADS scores were tested according to the methods by 
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Preacher and Hayes (2008).  
 
 
7.4 Results 
 
Correlations between the EORTC, HADS scores and illness perceptions, coping, and 
social support are presented in Table 7.1. Cognitive and emotional representations were 
negatively correlated with global HRQOL, physical, role, emotional, cognitive, social 
functioning; but positively correlated with symptoms, anxiety, depression, and 
emotional distress. Problem-oriented coping was positively correlated to global 
HRQOL, physical, role, emotional, cognitive, social functioning; but negatively related 
to symptoms, anxiety, depression, and emotional distress. Emotion-oriented coping was 
negatively correlated to global HRQOL and social functioning, but positively correlated 
to symptoms, anxiety, and emotional distress. Considering social support, tangible 
support was positively correlated to global HRQOL and social functioning, but 
negatively correlated with depression and emotional distress. Emotional support, and 
informational and appraisal support were positively correlated with global HRQOL, but 
negatively correlated with depression. 
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Table 7.1 The correlations between EORTC, HADS, illness perceptions, coping, and social support 
 
HRQOL PF RF EF CF SF SY 
HADS_
A 
HADS_
D ED IP_CO IP_EM IP_UN CO_PR CO_EM SS_TA SS_EM 
PF .52**                 
RF .52** .81**                
EF .54** .33** .30**               
CF .27** .38** .34** .24**              
SF .60** .60** .59** .45** .28**             
SY -.63** -.66** -.66** -.55** -.32** -.56**            
HADS_A -.59** -.37** -.38** -.60** -.14* -.49** .54**           
HADS_D -.69** -.53** -.53** -.51** -.31** -.65** .64** .66**          
ED -.71** -.50** -.51** -.60** -.26** -.64** .65** .88** .94**         
IP_CO -.67** -.50** -.56** -.52** -.26** -.60** .65** .53** .65** .66**        
IP_EM -.51** -.26** -.29** -.63** -.12* -.45** .45** .59** .53** .61** .62**       
IP_UN .12* .32** .27** .08 .15* .13* -.16** -.13* -.17** -.17** -.13* -.08      
CO_PR .23** .17** .16* .17** .15* .13* -.11 -.05 -.25** -.18** -.16* -.03 .29**     
CO_EM -.16** -.06 -.08 -.09 .02 -.15* .19** .22** .10 .17** .16* .17** .05 .27**    
SS_TA .19** .01 .05 .11 .09 .14* -.06 -.09 -.21** -.17** -.14* -.02 .05 .34** .16*   
SS_EM .15* .02 .02 .07 .08 .09 -.00 -.01 -.15* -.10 -.05 .03 .01 .36** .19** .80**  
SS_IN .12* .00 .03 .09 .07 .11 -.01 -.03 -.14* -.10 -.08 .03 .05 .33** .13* .81** .80** 
*: p<.05; **: p<.01 
HRQOL: global HRQOL; PF: physical functioning; RF: role functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom; HADS_A: anxiety in HADS; HADS_D: depression in HADS; ED: emotional distress in HADS; IP_CO: cognitive 
representation of illness perceptions; IP_EM: emotional representation of illness perceptions; IP_UN: understanding of illness; CO_PR: 
problem-oriented coping; CO_EM: emotion-oriented coping; SS_TA: tangible assistance of social support; SS_EM: emotional support of social 
support; SS_IN: informational and appraisal support of social support. 
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7.4.1 Aim 1: Relationships between demographic and physical variables and the 
EORTC and HADS scores, as well as illness perceptions 
 (1) Differences in the EORTC and HADS scores by disease stage 
Because of the small sample size in stage 4 (n=12), stages 3 and 4 were combined. 
The overall MANOVA test was significant, F(48, 488)=2.14, p<.001. Patients in stages 
3 & 4 had worse global HRQOL, F(2, 266)=12.28, p<.001, physical functioning, F(2, 
266)=7.76, p=.001, role functioning, F(2, 266)=11.40, p<.001, emotional functioning, 
F(2, 266)=5.70, p=.004, social functioning, F(2, 266)=15.20, p<.001; higher levels of  
anxiety, F(2, 266)=4.37, p=.014, depression, F(2, 266)=13.09, p<.001, and emotional 
distress, F(2, 266)=10.35, p=.001, than patients in stages 1 or 2. Patients in stages 3 & 4 
also had higher symptom score, F(2, 266)=6.14, p=.002, more fatigue, F(2, 266)=5.02, 
p=.007, nausea and vomiting, F(2, 266)=5.33, p=.005, appetite loss, F(2, 266)=4.28, 
p=.015, nutritional problems, F(2, 266)=12.60, p<.001, and abdominal swelling, F(2, 
266)=11.40, p<.001; and worse body image, F(2, 266)=5.40, p=.005, than patients in 
stages 1 or 2. 
 
(2) Differences in the EORTC and HADS scores by treatment 
The overall MANOVA test was significant, F(48, 516)=3.22, p<.001, indicating that 
there were significant differences in the EORTC and HADS scores between the surgery, 
TAE/TACE, and drug therapy groups. Patients who received surgery or TAE/TACE had 
better physical functioning, F(2, 280)=26.08, p<.001, role functioning, F(2, 280)=28.59, 
p<.001, emotional functioning, F(2, 280)=8.72, p<.001, cognitive functioning, F(2, 
280)=8.83, p<.001; and less severe symptoms, F(2, 280)=16.48, p<.001, and anxiety, 
F(2, 280)=3.60, p=.029, than patients who received drug therapy. Patients who received 
surgery had the highest level of global HRQOL, F(2, 280)=28.94, p<.001, social 
functioning, F(2, 280)=25.99, p<.001, as well as the lowest levels of depression, F(2, 
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280)=22.13, p<.001, and emotional distress, F(2, 280)=14.44, p<.001. 
 
(3) Predictors of the EORTC and HADS scores depending on demographic and physical 
variables 
(i) EORTC scores 
Hierarchical regressions were conducted with demographic data (gender and age) 
entered in the first block; disease characteristics (stages, treatments, child-Pugh stages, 
and time since diagnosis) were entered in the second block; and current physical 
conditions (α-FP, T-bilirubin, GOT, GPT, and Platelet) were entered in the third block. 
Again because of small sample size; stages 3 and 4 were combined, as well as ECOG 3 
and 4. The dependent variables were all EORTC scores: global HRQOL, five 
functioning scores, and symptom. 
Demographic characteristics only explained between 0.53%-6.03% of the variance in 
EORTC scores. Entering the disease characteristics at step 2 produced large and 
significant increments in the amounts of variance explained in the EORTC scores, from 
7.95%-24.39%. Current physical conditions entered at step 3 explained an additional 
significant 6.23%-33.57% of the variance in all EORTC scores, except for cognitive 
functioning. The highest amounts of variance were explained in physical functioning 
(R2=.62, p<.001), role functioning (R2=.56, p<.001), and symptom (R2=.45, p<.001), 
which were all relevant to physical components. 
Considering the specific predictors, patients who had better performance status 
(ECOG=0 or 1) had better global HRQOL and five functioning scales, and less 
symptom score than those with poorer performance status (ECOG=3 & 4). In addition, 
patients with normal α-FP level had better physical, role, social functioning, and less 
severe symptoms than those with abnormal α-FP level. A summary of these regression 
analyses is presented in Table 7.2.  
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(ii) HADS scores 
A similar analysis strategy was used to predict the HADS scores: anxiety, depression, 
and emotional distress (see Table 7.3). Demographic characteristics only explained 
between 0.32%-2.70% of the variance in anxiety, depression, and emotional distress. 
Entering the disease characteristics at step 2 produced large and significant increments 
in the amounts of variance explained in anxiety, depression, and emotional distress, 
from 10.66%-21.73%. Current physical conditions entered at step 3 explained an 
additional 11.96%-15.35% of the variance in anxiety, depression, and emotional distress. 
Considering the specific predictors, patients with good performance status or normal 
α-FP level had lower levels of anxiety, depression, and emotional distress. 
 
(4) Predictors of illness perceptions depending on demographic and physical variables  
Demographic characteristics, disease characteristics and current physical conditions 
were entered in hierarchical regressions in a sequence to investigate whether 
demographic and physical variables predicted illness perceptions. Disease 
characteristics significantly explained 22.81% of the variance in cognitive 
representation, 13.99% of the variance in emotional representation, and 8.05% of the 
variance in illness understanding. Current physical conditions explained an additional 
5.97%-16.87% of the variance in three variables. Patients who were older, received 
surgery, had better performance status (ECOG=0) and normal α-FP level perceived 
HCC as less negative cognitive representation. A longer period of disease was 
associated with higher levels of understanding (see Table 7.4).  
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Table 7.2 Summary of regression analyses: demographic and physical variables 
predicting the EORTC scores (standardized beta values, R2, and ΔR2) 
DV HRQOL PF RF EF CF SF SY 
Step 1        
Gender -.06 -.15* -.07 -.13  -.13* .05  .17* 
Age -.03  -.17** -.10  .04 -.09 .12 -.03 
Step 2        
Gender -.07 -.15* -.08 -.12 -.12 .05   .16**
Age -.07  -.21**   -.16**  .02 -.09 .08 .00 
Stage 1 .12* .08  .09  .07  .03 .12 -.03 
Stage 2 .18* .08  .11   .15* -.01  .14* -.12 
Child 1 .23  .26*   .22*  .16  .14  .40**   -.39**
Child 2 .09 .09  .11 -.02  .01 .20* -.14 
Treat 1 .27**   .27**   .27**  .13   .20*  .24** -.18 
Treat 2 .05   .23**   .29**  .09   .22* .09 -.10 
T_diag .15*  .14*   .18**  .03 -.07 .09 -.09 
Step 3        
Gender -.02  -.09* -.01 -.09 -.10 .09  .11* 
Age .04 -.05 .01  .11 -.04  .18**  -.14* 
Stage 1 .04 -.01 -.01  .03  .03 .04  .06 
Stage 2 .11 -.02 .00  .11 -.02 .06 -.02 
Child 1 .06 -.04 -.06  .04  .06  .22* -.11 
Child 2 -.01 -.07 -.04 -.10 -.01 .10  .02 
Treat 1 .08 -.07 -.08  .02  .05 .01  .09 
Treat 2 -.09 -.08 -.01  .01 .09 -.08  .11 
T_diag .06 .01 .03 -.06 -.08 .00 .05 
ECOG 1   .61**  1.23**   1.11**   .37*   .53**  .70**   -.94**
ECOG 2   .35**   .75**    .56**  .15   .36**  .41**   -.49**
ECOG 3 .15   .34**    .23**  .06   .26** .19*   -.27**
α-FP .10  .12*   .14*  -.00 .01  .17**  -.13* 
T-bil -.01 .03  .04  .02 -.07 .02  -.11* 
GOT .13 -.01 -.03   .19* .06 .02 -.05 
GPT  -.02 -.02 -.02 -.06 -.11 .01 -.02 
Plate -.10   -.13** -.07 -.11 .06 -.06   .14* 
        
1 ΔR2(F) .01(.62) .06(7.43)** .02(2.23) .02(1.97) .03(3.50)* .02(2.27) .03(3.33)*
2 ΔR2(F) .24(9.58)** .22(9.56)** .23(9.70)** .10(3.63)** .08(2.88)** .24(10.38)** .19(7.74)**
3 ΔR2(F) .13(4.97)** .34(20.92)** .31(17.46)** .07(2.42)* .06(1.59) .14(5.11)** .23(11.62)**
        
R2(F) .37(6.94)** .62(18.44)** .56(15.06)** .19(2.97)** .17(2.41)** .41(7.69)** .45(10.50)**
*: p<.05; **: p<.01 
Dependent variables: HRQOL: global HRQOL; PF: physical functioning; RF: role 
functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom. 
Independent variables: gender: male (1) vs. female (2); stage 1: stage 1 in AJCC (1) vs. 
other stage (0); stage 2: stage 2 in AJCC (1) vs. other stage (0); child 1: Child-Pugh 
stage A (1) vs. other (0); child 2: Child-Pugh stage B (1) vs. other (0); treat 1: surgery 
(1) vs. other treatments(0); treat 2: TAE/TACE (1) vs. others (0); T_diag: time since 
diagnosis; ECOG 1: ECOG 0 (1) vs. other ECOG (0); ECOG 2: ECOG 1 (1) vs. other 
ECOG (0); ECOG 3: ECOG 2 (1) vs. other ECOG (0); T-bil: T-bilirubin; plate: platelet. 
α-FP, T-bil, GOT, GPT, plate: normal=1 vs. abnormal=0. 
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Table7.3 Summary of regression analyses: demographic and physical variables 
predicting the HADS scores (standardized beta values, R2, and ΔR2) 
DV Anxiety Depression Emotional distress 
Step 1    
Gender  .14* .05 .10 
Age -.12 -.03 -.07 
Step 2    
Gender  .15* .06 .10 
Age -.067 .01 -.02 
Stage 1 -.08 -.15 -.13 
Stage 2  -.17*  -.17*  -.18* 
Child 1  -.30*   -.36**   -.36** 
Child 2 -.13 -.17 -.17 
Treat 1  .07 -.18 -.08 
Treat 2  .14 -.03  .05 
T_diag   -.19** -.12   -.16** 
Step 3    
Gender  .11  .03  .07 
Age  -.15* -.07 -.11 
Stage 1 -.02 -.06 -.04 
Stage 2 -.10 -.10 -.11 
Child 1 -.14 -.16 -.17 
Child 2 -.02 -.06 -.05 
Treat 1   .22*  .03  .12 
Treat 2    .27**  .13   .21* 
T_diag -.09 -.04 -.06 
ECOG 1   -.51**   -.63**   -.64** 
ECOG 2  -.24*   -.38**   -.36** 
ECOG 3 -.15  -.20*  -.20* 
α-FP  -.17*   -.24**   -.23** 
T-bil -.05 -.08 -.07 
GOT -.09 -.06 -.08 
GPT  .04 .08  .07 
Plate   .17* .06  .12 
    
1 ΔR2(F)   .03(3.24)* .00(.37)  .01(1.43) 
2 ΔR2(F)   .11(3.97)**   .22(8.48)**   .19(7.29)** 
3 ΔR2(F)   .12(3.95)**   .14(5.48)**   .15(5.90)** 
    
R2(F)   .26(4.12)**   .36(6.68)**   .35(6.53)** 
*: p<.05; **: p<.01 
Independent variables: gender: male (1) vs. female (2); stage 1: stage 1 in AJCC (1) vs. 
other stage (0); stage 2: stage 2 in AJCC (1) vs. other stage (0); child 1: Child-Pugh 
stage A (1) vs. other (0); child 2: Child-Pugh stage B (1) vs. other (0); treat 1: surgery 
(1) vs. other treatments(0); treat 2: TAE/TACE (1) vs. others (0); T_diag: time since 
diagnosis; ECOG 1: ECOG 0 (1) vs. other ECOG (0); ECOG 2: ECOG 1 (1) vs. other 
ECOG (0); ECOG 3: ECOG 2 (1) vs. other ECOG (0); T-bil: T-bilirubin; plate: 
platelet. α-FP, T-bil, GOT, GPT, plate: normal=1 vs. abnormal=0. 
There was the possibility of suppressor variable effects in this table that age was 
significant related to time since diagnosis (r=.15) and ECOG score (performance 
status, r=-.24), and physical variables may correlated with each other. These effects 
may influence the interpretations of this result. 
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Table 7.4 Summary of regression analyses: demographic and physical variables 
predicting illness perceptions (standardized beta values, R2, and ΔR2) 
DV IP_CO IP_EM IP_UN 
Step 1    
Gender  .02  .07 -.11 
Age -.08 -.06 -.11 
Step 2    
Gender  .03  .09  -.14* 
Age -.06 -.04  -.14* 
Stage 1 -.03 -.07  .06 
Stage 2 -.10 -.08  .02 
Child 1 -.14 -.06 -.15 
Child 2 -.08 -.05 -.13 
Treat 1   -.38**  -.23*  .09 
Treat 2 -.12 -.03  .09 
T_diag   -.20**   -.22**    .23** 
Step 3    
Gender -.02  .06 -.11 
Age  -.15* -.10 -.13 
Stage 1  .09 -.00  .03 
Stage 2  .00 -.02 -.00 
Child 1  .05  .03 -.15 
Child 2  .03  .02 -.15 
Treat 1  -.19* -.14  .02 
Treat 2 -.02 -.01 -.02 
T_diag -.08 -.13   .20** 
ECOG 1   -.44** -.11  .31* 
ECOG 2 -.19  .07  .25* 
ECOG 3 -.02  .10  .22* 
α-FP   -.27** -.10   .20** 
T-bil -.07 -.06 -.13* 
GOT -.07 -.09 .02 
GPT -.01  .01 .00 
Plate  .09  .05  -.15** 
    
1 ΔR2(F)  .01(.66)  .01(.87)  .03(3.93)* 
2 ΔR2(F)   .23(9.50)**    .14(5.21)**   .08(2.91)** 
3 ΔR2(F)   .17(7.85)**   .06(2.13)*   .08(2.21)** 
    
R2(F)   .40(8.68)**    .21(3.35)**   .19(2.73)** 
*: p<.05; **: p<.01 
Dependent variables: IP_CO: cognitive representation of illness perceptions; IP_EM: 
emotional representation of illness perceptions; IP_UN: understanding of illness. 
Independent variables: gender: male (1) vs. female (2); stage 1: stage 1 in AJCC (1) vs. 
other stage (0); stage 2: stage 2 in AJCC (1) vs. other stage (0); child 1: Child-Pugh 
stage A (1) vs. other (0); child 2: Child-Pugh stage B (1) vs. other (0); treat 1: surgery 
(1) vs. other treatments(0); treat 2: TAE/TACE (1) vs. others (0); T_diag: time since 
diagnosis; ECOG 1: ECOG 0 (1) vs. other ECOG (0); ECOG 2: ECOG 1 (1) vs. other 
ECOG (0); ECOG 3: ECOG 2 (1) vs. other ECOG (0); T-bil: T-bilirubin; plate: 
platelet. α-FP, T-bil, GOT, GPT, plate: normal=1 vs. abnormal=0. 
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7.4.2 Aim 2: Relationships between psychological variables and the EORTC and HADS 
scores 
(i) EORTC scores 
The psychological variables included illness perceptions (cognitive representation, 
emotional representation, and understanding) entered at the first step, coping 
(problem-oriented and emotion-oriented) entered at the second step, and social support 
(tangible assistance, emotional support, and informational and appraisal support) 
entered at the third step.  
The three kinds of variables explained significant amounts of variance in all EORTC 
scores from 9.42% to 49.93%. Illness perceptions explained significant amounts of 
variance in all EORTC scores (ΔR2=.09-.42, p<.01); however, only cognitive 
representation was a consistent predictor for all EORTC scores. Coping produced a 
significant increment in the amount of variance explained for global HRQOL (ΔR2=.03, 
p=.002) and emotional functioning (ΔR2=.01, p=.048). Three subscales of social support 
failed to produce significant increments in the variance explained in all EORTC scores 
(see Table 7.5).   
 
(ii) HADS scores 
A similar analysis as described above was used to predict anxiety, depression, and 
emotional distress. Illness perceptions explained significant amounts of variance in 
HADS scores from 39.69% to 50.43%; coping explained amounts of variance from 
1.18% to 2.04%, only significant for depression (ΔR2=.02, p=.009); social support 
explained amounts of variance from 0.46% to 0.975%, all non-significant. Cognitive 
(B=.23-.47, p<.001) and emotional (B=.22-.41, p<.001) representations were always 
significant for anxiety, depression, and emotional distress, even when entering the 
variables of coping and social support (see Table 7.6).  
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Table 7.5 Summary of regression analysis: psychological variables predicting the 
EORTC scores (standardized beta values, R2, and ΔR2) 
DV HRQOL PF RF EF CF SF SY 
Step 1        
IP_CO -.57**  -.51** -.58** -.21** -.29** -.51** .60** 
IP_EM -.16** .07 .08 -.50** .07 -.13* .07 
IP_UN .04  .26**  .20** .01 .12 .05 -.08 
Step 2        
IP_CO -.52** -.51** -.57** -.18** -.28** -.49** .59** 
IP_EM -.16** .07 .08 -.51** .06 -.13* .06 
IP_UN -.00  .26**  .19** -.02 .10 .04 -.08 
CO_PR .17** .02 .02 .13* .07 .05 -.01 
CO_EM -.10* -.01 -.02 -.01 .03 -.07 .09 
Step 3        
IP_CO -.52** -.52** -.58** -.18** -.28** -.48** .59** 
IP_EM -.16** .08 .08 -.52** .06 -.14* .06 
IP_UN .01 .26**  .19** -.02 .11 .05 -.08 
CO_PR .13* .03 .03 .12* .06 .02 -.02 
CO_EM -.11* -.01 -.02 -.01 .02 -.08 .09 
SS_TA .06 -.14 -.07 -.02 .01 .03 -.02 
SS_EM .13 .14 .04 -.03 .06 .01 -.01 
SS_IN -.09 -.06 -.01 .09 -.04 .05 .05 
        
1 ΔR2(F) .46(70.05)** .32(37.94)**.35(43.87)** .43(60.64)** .09(7.74)** .37(47.39)** .44(63.27)**
2 ΔR2(F) .03(6.19)** .00(.04) .00(.12) .01(3.08)* .01(.80) .01(1.00) .01(1.57) 
3 ΔR2(F) .01(1.79) .01(1.37) .00(.31) .00(.47) .00(.15) .00(.75) .00(.15) 
        
R2(F) .50(29.88)** .33(14.70)** .35(16.34)** .44(23.92)* .09(3.12)** .38(18.25)** .45(24.03)**
*: p<.05; **: p<.01 
Dependent variables: HRQOL: global HRQOL; PF: physical functioning; RF: role 
functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom. 
Independent variables: IP_CO: cognitive representation of illness perceptions; IP_EM: 
emotional representation of illness perceptions; IP_UN: understanding of illness; 
CO_PR: problem-oriented coping; CO_EM: emotion-oriented coping; SS_TA: 
tangible assistance of social support; SS_EM: emotional support of social support; 
SS_IN: informational and appraisal support of social support. 
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Table 7.6 Summary of regression analyses: psychological variables predicting the 
HADS scores (standardized beta values, R2, and ΔR2) 
DV Anxiety Depression Emotional distress 
Step 1    
IP_CO .26** .51** .45** 
IP_EM .43** .20** .33** 
IP_UN -.07 -.09 -.09 
Step 2    
IP_CO .25** .48** .42** 
IP_EM .41** .22** .33** 
IP_UN -.07 -.05 -.06 
CO_PR -.01 -.16** -.11* 
CO_EM .12* .03 .08 
Step 3    
IP_CO .23** .47** .40** 
IP_EM .41** .22** .33** 
IP_UN -.07 -.06 -.07 
CO_PR .003 -.12* -.08 
CO_EM .13* .04 .09 
SS_TA -.11 -.08 -.10 
SS_EM .03 -.07 -.03 
SS_IN .02 .04 .04 
    
1 ΔR2(F) .40(53.75)** .46(68.38)** .50(83.07)** 
2 ΔR2(F) .01(2.78) .02(4.72)** .01(2.96) 
3 ΔR2(F) .01(.63) .01(1.52) .01(1.32) 
    
R2(F) .42(21.68)** .49(28.35)** .52(33.01)** 
*: p<.05; **: p<.01 
Independent variables: IP_CO: cognitive representation of illness perceptions; IP_EM: 
emotional representation of illness perceptions; IP_UN: understanding of illness; 
CO_PR: problem-oriented coping; CO_EM: emotion-oriented coping; SS_TA: 
tangible support of social support; SS_EM: emotional support of social support; 
SS_IN: informational and appraisal support of social support. 
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7.4.3 Aim 3: Significant physical and psychological predictors of the EORTC and 
HADS scores 
In order to reduce the number of physical variables to be included in the regression 
analyses, only ECOG and α-FP, which were consistent predictors for all EORTC and 
HADS scores (see Table 7.2 & 7.3), were entered in the first block. Illness perceptions 
were entered in the second block, and coping and social support in the third block. 
 
(i) EORTC scores 
ECOG and α-FP explained 12.56%-58.39% of the variance in all EORTC scores 
(ps<.01). Illness perceptions explained an additional, and significant 4.39%-33.12% of 
the variance in all EORTC scores except for cognitive functioning (ΔR2=.03, p=.054). 
However, coping and social support explained an additional significant 3.64% of the 
variance in global HRQOL, but failed to explain significant additional amounts of 
variance in five functioning scores and symptom (see Table 7.7). 
ECOG, cognitive and emotional representations, and problem-oriented and 
emotion-oriented coping were significant predictors of global HRQOL. Better 
performance status, less negative cognitive and emotional representations, more 
problem-oriented coping and less emotion-oriented coping were associated with better 
global HRQOL. ECOG was still a significant predictor when entering illness 
perceptions, coping, and social support. In addition, cognitive and emotional 
representations were still significant predictors when entering coping and social support. 
It indicated that ECOG and cognitive and emotional representations may play more 
important roles than other predictor variables. 
ECOG and cognitive representations were significant predictors for all EORTC 
scores. In addition, α-FP was associated with emotional functioning; emotional 
representation was associated with global HRQOL, role, emotional, and social 
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functioning negatively; understanding related to physical functioning positively; 
problem-oriented coping was associated with global HRQOL and emotional functioning 
positively; emotion-oriented coping was associated with global HRQOL negatively; and 
emotional support related to physical functioning positively. 
 
(ii) HADS scores 
ECOG and α-FP explained 14.79%-31.43% of the variance in anxiety, depression, 
and emotional distress. Illness perceptions explained an additional, and significant, 
20.19%-26.44% of the variance. Coping and social support only explained an additional 
2.98% of the variance in depression significantly. Patients who had better performance 
status, less negative cognitive and emotional representations, had less anxiety, 
depression, and emotional distress. In addition, emotion-oriented coping was related to 
anxiety positively (see Table 7.8). 
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Table 7.7 Summary of regression analysis: physical and psychological variables 
predicting the EORTC scores (standardized beta values, R2, and ΔR2) 
DV HRQOL PF RF EF CF SF SY 
Step 1        
ECOG 1 .73** 1.18** 1.03**  .50** .65** .76** -.91** 
ECOG 2 .39**  .71** .52** .25* .44** .48** -.50** 
ECOG 3 .15 .31** .20** .09 .29** .23** -.27** 
α-FP .15* .07 .09 .03 .00 .22** -.12* 
Step 2        
ECOG 1 .486** 1.03** .87**  .29** .53** .58** -.68** 
ECOG 2 .31** .63** .43** .23* .38** .43** -.41** 
ECOG 3 .16* .27** .17** .14 .27** .24** -.28** 
α-FP -.02 -.02 -.01 -.11 -.07 .10 .04 
IP_CO -.45** -.23** -.32**  -.20** -.21* -.33** .46** 
IP_EM -.16** .06 .09  -.51** .05 -.15* .08 
IP_UN -.01 .14** .09* .00 .08 -.02 -.01 
Step 3        
ECOG 1 .49** 1.04** .87**  .28** .53** .59** -.68** 
ECOG 2 .31** .65** .44** .21* .38** .43** -.43** 
ECOG 3 .19** .28** .17* .15 .28** .25** -.29** 
α-FP -.02 -.02 -.00 -.12* -.07 .10 .04 
IP_CO -.40** -.25** -.32** -.18* -.20* -.31** .45** 
IP_EM -.17** .07 .09*  -.53** .04 -.15* .07 
IP_UN -.03 .16** .10 -.03 .07 -.02 -.02 
CO_PR .11* -.05 -.04 .12* .05 -.02 .01 
CO_EM -.11* .01 .01 -.02 .01 -.07 .09 
SS_TA .08 -.11 -.03 -.03 .02 .05 -.04 
SS_EM .13 .16* .03 -.01 .08 .03 -.02 
SS_IN -.09 -.05 .02 .09 -.05 .04 .05 
        
1 ΔR2(F) .31(25.80)** .58(79.98)** .54(67.40)** .13(8.19)** .13(8.47)** .33(27.59)** .38(35.10)**
2 ΔR2(F) .21(33.78)** .04(8.84)** .06(10.65)** .33(27.03)** .03(2.59) .14(18.70)** .17(29.21)**
3 ΔR2(F) .04(3.66)** .01(1.07) .00(.16) .02(16.54) .01(.40) .01(1.13) .01(.87) 
        
R2(F) .56(23.51)** .64(32.12)** .60(27.52)** .47(25.12)** .17(3.65)** .47(16.53)** .56(23.64)**
*: p<.05; **: p<.01 
Dependent variables: HRQOL: global HRQOL; PF: physical functioning; RF: role 
functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom. 
Independent variables: ECOG 1: ECOG 0 (1) vs. other ECOG (0); ECOG 2: ECOG 1 (1) 
vs. other ECOG (0); ECOG 3: ECOG 2 (1) vs. other ECOG (0); IP_CO: cognitive 
representation of illness perceptions; IP_EM: emotional representation of illness 
perceptions; IP_UN: understanding of illness; CO_PR: problem-oriented coping; 
CO_EM: emotion-oriented coping; SS_TA: tangible assistance of social support; 
SS_EM: emotional support of social support; SS_IN: informational and appraisal 
support of social support. 
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Table 7.8 Summary of regression analyses: physical and psychological variables 
predicting the HADS scores (standardized beta values, R2, and ΔR2) 
DV Anxiety Depression Emotional distress 
Step 1    
ECOG 1 -.44** -.69** -.65** 
ECOG 2 -.20 -.42** -.36** 
ECOG 3 -.11 -.21* -.19* 
α-FP -.17* -.26** -.24** 
Step 2    
ECOG 1 -.23* -.46** -.40** 
ECOG 2 -.17 -.35** -.31** 
ECOG 3 -.15 -.22** -.21** 
α-FP -.03 -.10 -.08 
IP_CO  .21** .37** .33** 
IP_EM  .43** .22** .34** 
IP_UN -.04 -.03 -.04 
Step 3    
ECOG 1 -.24* -.46** -.41** 
ECOG 2 -.18 -.34** -.31** 
ECOG 3 -.16* -.24** -.23** 
α-FP -.03 -.10 -.08 
IP_CO .18* .33** .29** 
IP_EM  .42** .24** .35** 
IP_UN -.05 -.00 -.02 
CO_PR .01 -.09 -.06 
CO_EM .13* .04 .09 
SS_TA -.12 -.10 -.12 
SS_EM .03 -.08 -.04 
SS_IN .03 .06 .05 
    
1 ΔR2(F) .15(9.89)** .31(26.12)** .29(22.69)** 
2 ΔR2(F) .26(33.53)** .20(31.30)** .26(43.97)** 
3 ΔR2(F) .02(1.54) .03(2.89)* .02(2.14) 
    
R2(F) .43(13.89)* .55(22.05)** .57(24.30)** 
*: p<.05; **: p<.01 
Independent variables: ECOG 1: ECOG 0 (1) vs. other ECOG (0); ECOG 2: ECOG 1 (1) 
vs. other ECOG (0); ECOG 3: ECOG 2 (1) vs. other ECOG (0); IP_CO: cognitive 
representation of illness perceptions; IP_EM: emotional representation of illness 
perceptions; IP_UN: understanding of illness; CO_PR: problem-oriented coping; 
CO_EM: emotion-oriented coping; SS_TA: tangible assistance of social support; 
SS_EM: emotional support of social support; SS_IN: informational and appraisal 
support of social support. 
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7.4.4 Aim 4: Mediation effects of illness perceptions and coping 
In this section, the mediating effects of illness perceptions and coping were tested: (1) 
whether illness perceptions mediated relationships between ECOG and the EORTC and 
HADS scores; (2) whether coping mediated relationships between cognitive 
representation and the EORTC and HADS scores; and (3) whether coping mediated 
relationships between emotional representation and global HRQOL, emotional 
functioning, anxiety, depression, and emotional distress. 
 
(1) The mediation effects of illness perceptions on the relationships between ECOG and 
the EORTC, HADS scores 
(i) EORTC scores 
The mediation analyses described by Preacher and Hayes (2008) were used to test 
whether illness perceptions mediated the relationships between ECOG and the EORTC 
scores. In Tables 7.2 and 7.7, ECOG was a significant predictor across all EORTC 
scores; therefore ECOG was entered as the independent variable. The two illness 
perceptions scores (cognitive and emotional representations) were entered as potential 
mediators, and all EORTC scores were used as dependent variables (see Figure 7.2). 
When global HRQOL was the dependent variable, the paths from ECOG to cognitive 
representation, B=4.65, SE=.50, p<.001, and to emotional representation, B=1.33, 
SE=.26, p<.001, were both significant. The direct effects of cognitive representation, 
B=-.97, SE=.13, p<.001, and emotional representation, B=-.74, SE=.25, p=.003, on 
global HRQOL were also significant. The effect of ECOG on global HRQOL, B=-11.04, 
SE=1.07, p<.001, though reduced, was still significant when controlling for cognitive 
and emotional representations, B=-5.56, SE=1.01, p<.001, suggesting partial mediation. 
Using bootstrapping procedures, the total mediated effect was found to be significant, 
B=-5.52, SE=.71, CI=-4.26 to -7.12. Inspection of the individual mediators showed that 
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both cognitive representation, B=-4.54, SE=.76, CI=-3.09 to -6.10, and emotional 
representation, B=-.98, SE=.44, CI=-.35 to -2.26, mediated the effect of ECOG on 
global HRQOL. 
The same procedure was applied to other EORTC scores, and the results are 
summarized in Table 7.9. The total mediation effects (both cognitive and emotional 
representation) were significant for all EORTC scores. Cognitive representation was a 
significant mediator across all EORTC scores, whereas emotional representation was a 
significant mediator for global HRQOL, emotional functioning, and social functioning. 
 
 
 
Figure 7.2 To test the mediation effects of illness perceptions on the relationships 
between ECOG and the EORTC, HADS scores 
 
 
 
 
 
a2 
b1 
b2 
a1 
c 
c’ 
ECOG 
EORTC scores or 
HADS scores 
ECOG 
EORTC scores or 
HADS scores 
Cognitive representation 
Emotional representation 
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Table 7.9 Summary of mediation testing: illness perceptions on the relationships 
between ECOG and the EORTC scores 
  HRQOL PF RF EF CF SF SY 
Pathway         
c B 
SE
-11.04 
1.07** 
-16.15
.84** 
-23.82
1.39**
-5.84 
1.06**
-5.64 
.99** 
-12.57 
1.28** 
7.38 
.63** 
c’ B 
SE
-5.56 
1.01** 
-14.37
.94** 
-19.46
1.50**
-1.54 
.97 
-4.47 
1.12** 
-7.13 
1.29** 
4.34 
.61** 
Indirect effects       
Total 
(b1+b2) 
B 
SE
CIs
-5.52 
.71 
-7.12 
-4.26* 
-1.77 
.46 
-2.80 
-.96* 
-4.32 
.90 
-6.38 
-2.77*
-4.35 
.71 
-5.84 
-2.92*
-1.16 
.55 
-2.34 
-.06* 
-5.44 
.79 
-7.02  
-3.99* 
3.07 
.43 
2.23 
3.89* 
b1 B 
SE
CIs
-4.54 
.76 
-6.10 
-3.09* 
-2.19 
.60 
-3.58 
-1.21*
-5.10 
1.10 
-7.65 
-3.42*
-1.55 
.65 
-2.85 
-.35* 
-1.50 
.67 
-3.12  
-.30* 
-4.43 
.86 
-6.21  
-2.77* 
2.78 
.49 
1.91 
3.81* 
b2 B 
SE
CIs
-.98 
.44 
-2.26  
-.35* 
.42 
.33 
-.18 
1.19 
.78 
.54 
-.12 
 2.08 
-2.81 
.64 
-4.09 
-1.50*
.34 
.41 
-.44  
1.13 
-1.01 
.50 
-2.13  
-.17* 
.29 
.24 
-.17 
.82 
*p<.05, **p<.01 
Dependent variable: HRQOL: global HRQOL; PF: physical functioning; RF: role 
functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom. 
Pathway: c: the direct effect of ECOG on EORTC scores; c’: the direct effect of ECOG 
on EORTC scores controlling cognitive and emotional representations; b1+b2: the 
indirect effect of ECOG on EORTC scores through cognitive and emotional 
representations; b1: the indirect effect of ECOG on EORTC scores through cognitive 
representation; b2: the indirect effect of ECOG on EORTC scores through emotional 
representations. 
 
 
  (ii) HADS scores 
The same procedure was applied to the HADS scores, ECOG was entered as the 
independent variable; cognitive and emotional representations were potential mediators; 
and anxiety, depression, and emotional distress were dependent variables (Figure 7.2). 
The results are summarized in Table 7.10. The total mediation effects (both cognitive 
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and emotional representations) were significant for anxiety, depression, and emotional 
distress. Considering the individual mediators, both cognitive and emotional 
representations were significant mediators for anxiety, depression, and emotional 
distress. 
 
Table 7.10 Summary of mediation testing: illness perceptions on the relationships 
between ECOG and the HADS scores 
  Anxiety Depression Emotional distress 
Pathway     
c B 
SE
1.01 
.17** 
2.05 
.21** 
3.06 
.34** 
c’ B 
SE
.32 
.16* 
.99 
.20** 
1.30 
.31** 
Indirect effect   
Total 
(b1+b2) 
B 
SE
CIs
.69 
.12 
.47  
.93* 
1.07 
.15 
.76  
1.35* 
1.76 
.26 
1.25  
2.25* 
b1 B 
SE
CIs
.31 
.11 
.13 
.56* 
.81 
.16 
.53  
1.18* 
1.13 
.24 
.71  
1.62* 
b2 B 
SE
CIs
.38 
.09 
.22  
.56* 
.25 
.09 
.10 
.46* 
.62 
.15 
.38  
1.00* 
*p<.05, **p<.01 
Pathway: c: the direct effect of ECOG on HADS scores; c’: the direct effect of ECOG 
on HADS scores controlling cognitive and emotional representations; b1+b2: the 
indirect effect of ECOG on HADS scores through cognitive and emotional 
representations; b1: the indirect effect of ECOG on HADS scores through cognitive 
representation; b2: the indirect effect of ECOG on HADS scores through emotional 
representations. 
 
(2) The mediation effects of coping on the relationships between cognitive 
representation and the EORTC, HADS scores 
  150
(i) EORTC scores 
Cognitive representation was entered as the independent variable, problem-oriented 
and emotion-oriented coping were the potential mediators, and all EORTC scores were 
dependent variables (see Figure 7.3). When global HRQOL was the dependent variable, 
the paths from cognitive representation to problem-oriented coping, B=-.13, SE=.05, 
p=.011, and to emotion-oriented coping, B=.09, SE=.04, p=.013, were both significant. 
The direct effects of problem-oriented coping, B=.43, SE=.13, p=.001, and 
emotion-oriented coping, B=-.42, SE=.19, p=.027, on global HRQOL were also 
significant. The effect of cognitive representation on global HRQOL, B=-1.42, SE=.10, 
p<.001, was reduced, but was still significant when controlling problem-oriented and 
emotion-oriented coping, B=-1.32, SE=.10, p<.001. Using bootstrapping procedures, the 
total mediated effect was found to be significant, B=-.10, SE=.04, CI=-.17 to -.03. 
Inspection of the individual mediator showed that both problem-oriented coping, B=-.06, 
SE=.03, CI=-.13 to -.01, and emotion-oriented coping, B=-.04, SE=.02, CI=-.10 to -.002, 
mediated the effect of cognitive representation on global HRQOL. 
 
 
Figure 7.3 To test the mediation effects of coping on the relationships between cognitive 
representation and the EORTC, HADS scores 
b2 a2 
b1 a1 
c 
c’ 
Cognitive 
representation 
EORTC scores or 
HADS scores 
Cognitive 
representation 
EORTC scores or  
HADS scores 
Problem-oriented coping 
Emotion-oriented coping 
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Further analyses indicated that problem-oriented and emotion-oriented coping did not 
mediate the effects of cognitive representation on the five functioning scores and 
symptom (see Table 7.11). 
 
Table 7.11 Summary of mediation testing: coping strategies on the relationships 
between cognitive representation and the EORTC scores 
  HRQOL PF RF EF CF SF SY 
Pathway         
c B 
SE
-1.42 
.10** 
-1.08 
.11** 
-1.89 
.17** 
-.99 
.10** 
-.48 
.10** 
-1.46 
.12** 
.86 
.06** 
c’ B 
SE
-1.32 
.10** 
-1.05 
.12** 
-1.84 
.18** 
-.95 
.11** 
-.46 
.11** 
-1.41 
.13** 
.84 
.07** 
Indirect effects       
Total 
(b1+b2) 
B 
SE
CIs
-.10 
.04 
-.17 
-.03* 
-.03 
.03 
-.09 
.03 
-.05 
.06 
-.17 
.05 
-.04 
.03 
-.10 
.01 
-.02 
.03 
-.08 
05 
-.05 
.03 
-.12 
.01 
.03 
.02 
-.01 
.07 
b1 B 
SE
CIs
-.06 
.03 
-.13 
-.01* 
-.03 
.02 
-.08 
.01 
-.04 
.03 
-.12 
.01 
-.03 
.02 
-.07 
-.0002
-.03 
.02 
-.07 
.01 
-.02 
.02 
-.06 
.02 
.01 
.01 
-.02 
.03 
b2 B 
SE
CIs
-.04 
.02 
-.10 
-.002* 
.00 
.02 
-.04 
.04 
-.01 
.04 
-.10 
.07 
-.01 
.02 
-.07 
.01 
.01 
.02 
-.02 
.06 
-.03 
.02 
-.11 
.002 
.02 
.01 
.0004 
.06 
*p<.05, **p<.01 
Dependent variable: HRQOL: global HRQOL; PF: physical functioning; RF: role 
functioning; EF: emotional functioning; CF: cognitive functioning; SF: social 
functioning; SY: symptom. 
Pathway: c: the direct effect of cognitive representation on EORTC scores; c’: the direct 
effect of cognitive representation on EORTC scores controlling problem- and 
emotion-oriented coping; b1+b2: the indirect effect of cognitive representation on 
EORTC scores through problem- and emotion-oriented coping; b1: the indirect effect 
of cognitive representation on EORTC scores through problem-oriented coping; b2: 
the indirect effect of cognitive representation on EORTC scores through 
emotion-oriented coping. 
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  (ii) HADS scores 
Cognitive representation was entered as the independent variable; problem-oriented 
and emotion-oriented coping were the potential mediators; and anxiety, depression, and 
emotional distress were dependent variables (Figure 7.3). The analyses indicated that 
problem-oriented coping mediated the effects of cognitive representation on depression 
and emotional distress; and emotion-oriented coping mediated the effects of cognitive 
representation on anxiety (see Table 7.12). 
 
Table 7.12 Summary of mediation testing: coping strategies on the relationships 
between cognitive representation and the HADS scores 
  Anxiety Depression Emotional Distress 
Pathway     
c B 
SE
.16 
.02** 
.27 
.02** 
.43 
.03** 
c’ B 
SE
.15 
.02** 
.26 
.02** 
.41 
.03** 
Indirect effect   
Total 
(b1+b2) 
B 
SE
CIs
.01 
.01 
-.001 
.02 
.01 
.01 
.003 
.03* 
.02 
.01 
.004 
.04* 
b1 B 
SE
CIs
.0006 
.0002 
-.005 
.01 
.01 
.00 
.002 
.02* 
.01 
.01 
.0001  
.03* 
b2 B 
SE
CIs
.01 
.004 
.001 
.02* 
.00 
.00 
-.004  
.01 
.01 
.01 
-.0001  
.03 
*p<.05, **p<.01 
Pathway: c: the direct effect of cognitive representation on HADS scores; c’: the direct 
effect of cognitive representation on HADS scores controlling problem- and 
emotion-oriented coping; b1+b2: the indirect effect of cognitive representation on 
HADS scores through problem- and emotion-oriented coping; b1: the indirect effect 
of cognitive representation on HADS scores through problem-oriented coping; b2: 
the indirect effect of cognitive representation on HADS scores through 
emotion-oriented coping. 
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(3) The mediation effects of coping on the relationships between emotional 
representation and global HRQOL, emotional functioning, anxiety, depression, and 
emotional distress 
Next, the mediation analyses were conducted to test whether coping mediated the 
effects of emotional representation on psychological aspects of adjustment outcomes, 
including global HRQOL, emotional functioning, anxiety, depression, and emotional 
distress. Emotional representation was entered as the independent variable, the potential 
mediators were problem-oriented and emotion-oriented coping, and psychological 
aspects of adjustment outcomes were the dependent variables (Figure 7.4). 
 
 
Figure 7.4 To test the mediation effects of coping on the relationships between 
emotional representation and psychological aspects of adjustment outcomes 
 
When global HRQOL was dependent variable, the path from emotional 
representation to emotion-oriented coping, B=.21, SE=.08, p=.006, was significant, but 
the path to problem-oriented coping, B=-.05, SE=.11, p=.632, was not. The direct effects 
of problem-oriented coping, B=.68, SE=.15, p<.001, and emotion-oriented coping,  
b2 a2 
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representation 
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Table 7.13 Summary of mediation testing: coping strategies on the relationships 
between emotional representation and psychological aspects of adjustment outcomes 
  Global 
HRQOL 
Emotional 
functioning
Anxiety Depression Emotional 
distress 
Pathway       
c B 
SE
-2.28 
.25** 
-2.55 
.19** 
.37 
.03** 
.45 
.05** 
.82 
.07** 
c’ B 
SE
-2.12 
.24** 
-2.52 
.19** 
.35 
.03** 
.44 
.05** 
.79 
.07** 
Indirect effects     
Total 
(b1+b2) 
B 
SE
CIs
-.16 
.09 
-.34 
.004 
-.03 
.05 
-.15 
.06 
.02 
.01 
.01 
.04* 
.02 
.02 
-.01 
.05 
.04 
.02 
.0005 
.09* 
b1 B 
SE
CIs
-.04 
.07 
-.19 
.10 
-.01 
.04 
-.10 
.05 
.00 
.00 
-.004 
.01 
.01 
.01 
-.02 
.03 
.01 
.02 
-.02 
.04 
b2 B 
SE
CIs
-.12 
.06 
-.27 
-.02* 
-.02 
.04 
-.11 
.05 
.02 
.01 
.003 
.04* 
.01 
.01 
-.003 
.04 
.03 
.02 
.01 
.07* 
*p<.05, **p<.01 
Pathway: c: the direct effect of emotional representation on psychological aspects of 
adjustment outcomes; c’: the direct effect of emotional representation on 
psychological aspects of adjustment outcomes controlling problem- and 
emotion-oriented coping; b1+b2: the indirect effect of emotional representation on 
psychological aspects of adjustment outcomes through problem- and 
emotion-oriented coping; b1: the indirect effect of emotional representation on 
psychological aspects of adjustment outcomes through problem-oriented coping; b2: 
the indirect effect of emotional representation on psychological aspects of adjustment 
outcomes through emotion-oriented coping. 
 
B=-.57, SE=.21, p=.007, on global HRQOL were also significant. The effect of 
emotional representation on global HRQOL, B=-2.28, SE=.25, p<.001, was reduced, but 
was still significant when controlling for problem-oriented and emotion-oriented coping, 
B=-2.12, SE=.24, p<.001. Using bootstrapping procedures, the total mediated effect was 
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found to be non-significant, B=-.16, SE=.09, CI=-.34 to .004. However, inspection of 
the individual mediators showed that emotion-oriented coping, B=-.12, SE=.06, CI=-.27 
to -.02, mediated the effect of emotional representation on global HRQOL, but 
problem-oriented coping, B=-.04, SE=.07, CI=-.19 to .10, did not. 
In summary, emotion-oriented coping mediated the effects of emotional 
representation on global HRQOL, B=-.12, SE=.06, CI=-.27 to -.02, anxiety, B=.02, 
SE=.01, CI=.003 to .04, and emotional distress, B=.03, SE=.02, CI=.01 to .07. However, 
problem-oriented coping did not mediate the relationships between emotional 
representation and psychological aspects of adjustment outcomes (see Table 7.13). 
 
 
7.5 Discussion 
 
Table 7.14 The summary of potential pathways of adjustment 
Pathways  
1. Physical variables → EORTC and HADS scores 
2. ECOG → Cognitive representation → EORTC and HADS scores 
3. ECOG → Emotional representation → Global HRQOL, emotional functioning, 
social functioning, anxiety, depression, 
emotional distress 
4. Cognitive representation → Problem-oriented coping → Global HRQOL, 
depression, emotional 
distress 
5. Cognitive representation → Emotion-oriented coping → Global HRQOL, 
anxiety 
6. Emotional representation → Emotion-oriented coping → Global HRQOL, 
anxiety, emotional 
distress 
 
This quantitative study explored the effects of physical variables, illness perceptions, 
coping, and social support on the EORTC and HADS scores in patients with HCC. 
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Multiple pathways and factors are likely to influence the process of adjustment (see 
Table 7.14).  
As shown in pathway 1, physical variables are the first important variables that 
contribute to all components of HRQOL, as well as anxiety and depression. Patients 
who received surgery tended to report the best HRQOL in both physical and 
psychological aspects and, as would be expected, patients with early stage disease also 
had better adjustment outcomes than those in later stages. Patients needed to have better 
physical conditions (e.g., small size of tumour, better liver function) to receive surgery. 
As disease progresses or metastases, patients’ physical conditions get worse.  
Physical variables explained the largest amount of variance in all EORTC and HADS 
scores; and physical variables remained significant after entering psychological 
variables. In addition, mediation testing also revealed the direct effect of performance 
status (ECOG score) on all EORTC and HADS scores. Better physical conditions and 
performance status were associated with better HRQOL, especially physical aspects 
(e.g., physical functioning, role functioning, and symptoms), and less negative feelings.  
In addition, the significant predictors of physical variables were ECOG and α-FP. 
ECOG is an index of performance status that includes the levels of independence and 
activities: patients with better performance status have better self-care, less 
uncomfortable symptoms, and do not need caregivers’ help. Poorer performance status 
indicates worse physical conditions and need for others care, resulting in patients having 
worse adjustment. α-FP is a screening index for HCC. When the index is out of normal 
range, it indicates tumour existence or recurrence and patients tend to have worse 
HRQOL. 
  Furthermore, disease characteristics and current physical conditions also shaped 
patients’ illness perceptions. Patients who were older, had good performance status, 
underwent surgery, and had normal level of α-FP perceived their disease as less negative 
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cognitive representation (e.g., less severe and felt more the disease was more 
controllable). Better physical conditions were associated with a more positive cognitive 
representation and less negative emotional representation of disease. 
  As shown in pathway 2 and 3, illness perceptions are the second important factor that 
contributes to patients’ adjustment outcomes. The results supported previous results that 
illness perceptions could mediate the relationships between physical variables and 
adjustment outcomes (Hagger & Orbell, 2003). Cognitive representation mediated the 
relationships between performance status and all components of HRQOL, as well as 
anxiety and depression. Emotional representation also had mediating effects, but limited 
to the psychological aspects of adjustment outcomes, including global HRQOL, 
emotional functioning, social functioning, anxiety, depression, emotional distress. 
Physical variables may influence patients’ cognitive perceptions about their disease, 
which then influence adjustment outcomes. Patients who perceived more negative 
emotional representation from HCC had worse global HRQOL, emotional, and social 
functioning, and higher levels of anxiety, depression, and emotional distress.  
Pathway 4, 5, and 6 showed that coping mediated the relationships between illness 
perceptions and psychological aspects of adjustment outcomes, rather than physical 
aspects of HRQOL, such as physical, role, cognitive functioning, or symptoms. 
Problem-oriented coping mediated the relationships between cognitive representation 
and global HRQOL, depression, emotional distress. Similar mediation effects for 
emotion-oriented coping were founded on the relationships between cognitive 
representation and global HRQOL and anxiety, and emotion-oriented coping mediated 
the relationships between emotional representation and global HRQOL, anxiety, and 
emotional distress.  
The results revealed that the use of problem-oriented coping strategies was associated 
with increased HRQOL and emotional functioning, and decreased depression. Patients 
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who perceived their disease to be more severe had worse HRQOL and higher levels of 
depression, but using problem-oriented coping strategies buffered this negative effect of 
cognitive representation on global HRQOL and depression. However, the use of 
emotion-oriented coping was associated with higher levels of anxiety that patients who 
used more emotion-oriented coping had higher level of anxiety. 
The present study used quantitative methods to examine multi-components of 
adjustment outcomes, to identify both physical and psychological predictors of 
adjustment outcomes, and to examine the theoretical fitness of the Common Sense 
Model, addressing the importance of illness perceptions and coping. Patients who 
received surgery or who were at early stages of disease had better adjustment outcomes 
than those who received drug therapy or were at advanced stages. In addition, the 
significant physical predictors were performance status and α-FP. The most significant 
psychological predictors were cognitive and emotional representations. The results 
supported the mediation effects of illness perceptions on the relationships between 
physical conditions and adjustment outcomes, as well as the mediation effects of coping 
on the relationships between illness perceptions and psychological aspects of 
adjustment outcomes. In the next chapter, the interpretations, combinations, and 
comparisons of qualitative and quantitative results, as well as methodology 
considerations will be conducted. 
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Chapter 8. Discussion 
 
8.1 Abstract 
Adjustment to cancer is a long-term trajectory, and many factors can influence the 
process. This whole thesis was based on assumptions from the Common Sense Model 
(Leventhal et al., 1984) using both qualitative and quantitative methodology. In this 
final chapter, a summary of findings are presented followed by establishment of an 
adjustment model which integrates quantitative and qualitative results. The adjustment 
model includes multiple pathways predict adjustment outcomes: physical variables had 
a direct effect on adjustment outcomes; and illness perceptions mediated the 
relationships between physical variables and adjustment outcomes, and coping mediated 
the relationships between illness perceptions and adjustment outcomes. Third, 
methodological considerations involving the integration of qualitative and quantitative 
results, and quantitative issues were addressed. Finally, clinical implications based on 
the adjustment model are made for improving the quality of care. 
 
 
8.2 Summary of findings 
The overall purpose of this thesis was to explore the impact of HCC on patients’ 
HRQOL, to identify the significant predictors of HRQOL and adjustment outcomes, and 
to construct an adjustment model for patients with HCC. 
In a systematic review (Chapter 3), patients with HCC were shown to have worse 
physical, psychological, and functional well-being than the general population. This was 
supported by empirical findings in Chapter 6 that showed that patients had worse global 
HRQOL, physical, role, cognitive, social functioning; and more severe symptoms than 
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the general population. In addition, the HADS results showed that patients with HCC 
had higher levels of depression than the general population, and more than one-fifth 
patients had emotional distress. Therefore, HCC is associated with both physical and 
psychological impact on patients’ life  
In Chapter 3, different treatments, liver function, symptoms (e.g., pain, fatigue, and 
nausea), performance status, and negative feelings (e.g., depression, uncertainty, and 
chance health locus of control) were associated with HRQOL. The results of regression 
analyses in Chapter 7 also showed the significant physical predictors were ECOG and 
α-FP; and the psychological predictors were cognitive and emotional illness 
representations. 
Furthermore, the hierarchical regression and mediation analyses showed the multiple 
pathways of adjustment. The qualitative results also provided rich contextual and 
dynamic information about how patients perceived HCC, how they coped with and 
adjusted to the disease, and the significant factors which may influence their adjustment. 
In the next section, both quantitative and qualitative results will be integrated for 
constructing an adjustment model. 
 
 
8.3 Toward an integrated model 
Based on the findings of the research described, an integrated model of adjustment in 
patients with HCC was developed (see Figure 8.1) and is described below. 
 
8.3.1 Role of quantitative findings 
The quantitative results suggested some modification to the Common Sense Model 
and highlighted the multiple pathways of adjustment.  
We found pathways to adjustment outcomes were mediated by Illness perceptions 
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and coping: from physical variables to illness perceptions and then adjustment outcomes 
(not through coping); or from illness perceptions to coping, and then to psychological 
aspects of adjustment outcomes. However, there was still another pathway: from 
physical variables to adjustment outcomes directly. 
 
 
Figure 8.1 Adjustment model in patients with HCC 
 
 
First, physical variables had a direct influence on all adjustment outcomes. Similar to 
previous research, physical conditions and symptoms were the main stressor, and poor 
performance status and greater symptom distress were associated with worse adjustment 
(Ponto, Ellington, Mellon, & Beck, 2010; Shun et al., 2008). In addition, physical 
variables were positively associated with illness perceptions. 
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Second, the influence of physical variables may be mediated by illness perceptions. 
Physical variables may shape a patient’s illness perceptions, which in turn influence 
adjustment outcomes. For example, deteriorating physical conditions made patients 
perceive that their disease became worse, and the perceptions, both cognitive and 
emotional representations, may decrease patients’ HRQOL and increase negative 
feelings. Cognitive representation could moderate the effects of physical variables on 
both physical and psychological components of adjustment outcomes, but emotional 
representation only mediates the influences on psychological components of adjustment 
outcomes. The findings are similar to those made in a previous meta-analytic review 
(Hagger & Orbell, 2003), the importance of illness perceptions were also found in 
various cancers, such as head and neck squamous cell carcinoma (Scharloo et al., 2010), 
breast cancer (Rozema et al., 2009), gynaecological cancer (Gould, Brown, & Bramwell, 
2010), and prostate cancer (Traeger et al., 2009; Wootten et al., 2007). Illness 
perceptions about timeline, identity, or consequences were negatively associated with 
HRQOL or psychological well-being in above studies. The quantitative results in 
Chapter 5 also revealed the process, whereby physical conditions or symptoms shaped 
patients’ interpretations about the disease, and then the interpretations influenced 
adjustment. 
Third, the mediation effects of coping also occurred between illness perceptions and 
psychological aspects of adjustment outcomes, such as emotion functioning in HRQOL, 
anxiety, depression, or emotional distress. Patients who perceived their disease as worse 
used less problem-oriented coping, which in turn related to worse psychological 
outcomes. In addition, perceptions about emotional impact only influenced 
psychological outcomes through emotional-oriented coping instead of problem-oriented 
coping. More emotional impact was associated with more emotional-oriented coping, 
which in turn determined worse psychological outcomes. 
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  In previous studies, coping is one of most important variables. For example, denial 
and avoidant coping mediated the relationships cognitive representations and negative 
mood in gynaecological cancer (Gould et al., 2010); or emotion-oriented coping 
mediated the relationships between dyadic adjustment and mood disturbance in prostate 
cancer (Wootten et al., 2007). However, in women with breast cancer, the role of coping 
was not significantly associated with perceived physical and mental health (Rozema et 
al., 2009). In this thesis, the role of coping was not as important as illness perceptions, 
and the mediation effects occurred partially between illness perceptions and 
psychological aspects of adjustment outcomes. The potential explanations include the 
possibility of multiple components of coping, and various factors may influence the use 
of coping strategies (Thomsen et al., 2010; Wattebot O'Brien & Moorey, 2010), not only 
illness perceptions. The second is the different characteristics of adjustment outcomes. 
For example, coping explained more variance in psychological or emotional functioning 
than physical or cognitive functioning. Coping has the potential to influence the 
psychological well-being rather than physical well-being or symptoms. 
The regression analyses showed the positive effects of problem-oriented coping but 
negative effects of emotion-oriented coping on adjustment outcomes, similar to the 
previous review (Wattebot O'Brien & Moorey, 2010). In addition, some coping 
strategies were found to be associated with better adjustment in cancer patients, such as 
acceptance (Bussell & Naus, 2010; Shapiro, McCue, Heyman, Dey, & Haller, 2010), 
humour (Shapiro et al., 2010), positive reappraisal, and good reengagement (Schroevers, 
Kraaij, & Garnefski, 2010); but self-blame (Bussell & Naus, 2010), avoiding, or 
self-distraction (Schroevers et al., 2010) were related to worse adjustment. However, the 
qualitative results in Chapter 5 highlighted the individual differences and situation 
differences which may influence the use of coping strategies. For example, an elderly 
patient with low education level would rely on their children and doctors to make the 
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treatment decision. Perhaps when the huge stress (e.g., in the early stage of diagnosis) 
was more than patients can tolerate, they would use avoiding strategies. Therefore, more 
evidence is needed to investigate the effects of specific coping on specific situations. 
 
8.3.2 Role of qualitative findings 
The quantitative results (Chapter 5) extended our understanding of illness perceptions. 
Potential factors which contribute to illness perceptions include not only physical 
variables (or stressor/stimuli) but also knowledge of disease, stereotype of disease, and 
illness experience. Knowledge of disease included information about disease and 
treatment, for example causal factors, treatment methods, prognosis, and side effects. 
When they were diagnosed as HCC, most patients find relevant information or ask 
doctors, and it helped them to form a concept of HCC. Stereotype of disease also shaped 
illness perceptions. In this social-cultural background, high prevalence of HBV and 
death stigma of cancer, it was inevitable to be fearful and have worries. Illness 
experience had two phases, first was previous liver disease before diagnosis and the 
other was from diagnosis until now. When patients had previous experience about 
hepatitis or cirrhosis, they may anticipate one day the disease may progress until HCC. 
This helped them dealing with the relevant medical problems. Furthermore, the 
adjustment outcomes since diagnosis until now would feedback to their illness 
perceptions. If they could handle the disease and adjust well, illness perceptions would 
be positive and have less negative impact.  
Personal characteristics influenced cognitive evaluations (e.g., illness perceptions) 
and behavioural responses (e.g., coping behaviours) to the disease. For example, a 
nervous patient might interpret the disease as very severe but an optimistic patient might 
not. Except for evaluation of the stressor (disease), patients may use the coping methods 
which they were familiar with.  
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In contrast to previous studies which showed the positive relationships between social 
support and psychological well-being (Pinquart & Frohlich, 2009; Schroevers, Ranchor, 
& Sanderman, 2003), and the interaction effects of social support and coping on 
emotional well-being (Kim, Han, Shaw, Mctavish, & Gustafson, 2010) in cancer 
patients, regression results in Chapter 7 showed social support was not a significant 
predictor when controlling for physical variables and illness perceptions. Maybe other 
variables (physical variables and illness perceptions) play a more important role than 
social support in the adjustment process. But in qualitative interviews, patients 
expressed that social support could be taken as an external resource to deal with the 
demanding from the disease, and provide emotional support. In addition, support from 
families and friends would change depending on disease progress and physical 
conditions (Pinquart, Hoffken, Silbereisen, & Wedding, 2007). When patients’ 
conditions were stable or did not receive regular treatment, then the tangible support 
would decrease, not as much as the beginning of diagnosis or treatment. 
 
 
8.4 Methodological issues 
8.4.1 Integrating qualitative and quantitative methodologies 
A mixed methods design including quantitative and qualitative studies was used in 
this thesis. The two kinds of data were collected at the same time but analyzed 
separately. The key issue was how to combine or integrate the two kinds of results for 
improving the validity of the study and reducing the weakness of each methodology.  
It is inevitable that there are interferences/interactions between two kinds of 
methodological process. For participants, the sequences of data collection may influence 
patients’ response. Patients’ ratings to items in standardized questionnaires might be 
affected when they received interview first. For researchers, in analysis process, one 
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kind of data would influence the other, especially qualitative analysis. If researchers 
already know the results of quantitative analyses, then the qualitative analysis may be 
biased because of preconceived ideas. 
In order to reduce these possible interferences, patients who participated in both 
studies were asked to complete standardized questionnaires first, and then received an 
interview. In this way we hoped to reduce the influence of the interview on 
questionnaire responses. In analyses, qualitative data were analyzed first and then 
quantitative data. A senior oncology nurse who was not involved in the quantitative data 
collection also helped to analyze qualitative data to enhance the validity of study. 
  The combinations and comparisons of qualitative and quantitative results occurred in 
the interpretation levels. First, the relationships between physical variables, illness 
perceptions, coping, and adjustment outcomes were based on the quantitative results. 
The analyses in section 7.4.4 could clarify and modify the model obtained from 
qualitative results (Figure 5.1), and provide strong statistical evidences to generalize the 
results to other patients with HCC. Second, qualitative results could provide rich 
information about the context, dynamic changes, or specific items. For example, 
quantitative results revealed the importance of illness perceptions in adjustment process, 
and qualitative results highlighted which factors shaped illness perceptions and how 
illness perceptions influenced adjustment outcomes. In addition, qualitative results 
provided disease-specific and cultural-specific coping strategies in Taiwan society. 
Third, it is essential to investigate the differences between qualitative and quantitative 
results. For example, quantitative results showed that social support was not a 
significant predictors when physical variables, illness perceptions, and coping entering 
in the regression analyses. In contrast, qualitative results highlighted social support was 
an important resource in coping with the disease. The role of social support in 
adjustment process needs further studies to identify. 
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8.4.2 Specific method issues in quantitative study 
Some methodological considerations about the quantitative study should be noticed 
and future studies need to be addressed.  
First is the choice of standardized measures. From the initial literature review 
(Chapter 2), it was concluded that any comprehensive assessment of HRQOL should 
incorporate both generic and disease-specific measures. In Chapter 3, both FACT and 
EORTC groups provide cancer-specific and Hepatobiliary/HCC specific measures 
which are widely used and have good psychometric characteristics, and were translated 
into Chinese. Especially the development of EORTC HCC18 also recruited Taiwan 
patients with HCC, and it is appropriate for this thesis.  
Second, the norms of EORTC QLQ-C30 and HADS (Chapter 6) which were used to 
compare the differences in HRQOL between patients with HCC and the general 
population are from western countries, but the patients in this study were from Taiwan. 
The socio-cultural background is a potential confounding factor, and the norm from the 
same country or society is necessary. 
  Third, in order to reduce patient burden, the short form Brief IPQ and coping 
questionnaire were used in this study. The Cronbach’s α of emotional representation in 
Brief IPQ and emotion-oriented coping were not good enough. The possible 
explanations were that emotional representation only has two items and 
emotion-oriented coping includes various meanings of items. For example, seeking 
family support and blaming others are categorized in emotion-oriented coping, but may 
cause different effects. The detailed measure of coping behaviours would facilitate 
measurement of additional coping behaviours such as escape-avoidance, distancing, 
self-controlling, seeking social support, accepting responsibility, planful 
problem-solving, or positive reappraisal (Jalowiec, 2003). However the greater burden 
  168
on patients in completing longer questionnaires needs to be considered.  
On the other hand, qualitative results showed that the disease-specific or 
cultural-specific coping (e.g., diet, quit bad habits, develop health life style, or seek 
religious belief), which were not measured in standardized questionnaire, may be 
important for patients’ adjustment. It is possible that coping questionnaires could be 
developed that included these disease-specific or cultural-specific items. 
Fourth, the sample size was big enough to run regression analyses in quantitative 
study. The author also rechecked after patients completed the standardized measures for 
reducing the missing data. However, there were a lot of missing data in physical 
variables which were obtained form medical charts, for example Albumin and INR. 
Therefore these data could not be entered in the regression analyses.  
Fifth, a cross-sectional correlation design was used to investigate the HRQOL and 
adjustment in patients with HCC; a longitudinal design is essential to investigate the 
long-term changes in adjustment outcomes and psychological variables, such as illness 
perceptions, coping, and social support. The variations of these variables may depend 
on the changes of physical conditions or life events.  
In addition, the relationships between illness perceptions, coping, and adjustment 
outcomes were based on regression analyses. Although the relationships implied the 
directions between variables, it still lacks consolidated evidence to support 
cause-and-effect relationships. Experimental or quasi-experimental designs are essential 
to establish the cause-and-effect relationships. For example, interventions focusing on 
illness perceptions and coping using randomized controlled trial could be conducted to 
test whether these interventions can improve patients’ HRQOL and psychological 
well-being. 
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8.5 Clinical implications 
Some suggestions about clinical services can be made based on the adjustment model 
(Figure 8.1) which could potentially improve patients’ care. First the results emphasise 
the importance of conducting a comprehensive assessment about patients’ HRQOL, 
including physical functioning, psychological well-being, as well as positive changes 
after disease. Focus on medical outcomes alone does not reflect the whole way in which 
HCC affects the individual. Second it is important to consider the effectiveness of 
treatment to remove tumour and reduce uncomfortable symptoms. The data suggest that 
recovery/uptrend of physical conditions may have direct effects to improve HRQOL and 
psychological well-being. Patients in qualitative interviews mentioned that 
improvement of physical conditions made them have hope and believe they can 
overcome the disease. 
Third the results suggest healthcare professionals should provide appropriate 
information for patients and families to satisfy their needs (see Table 5.4). It is clear 
from analyses of interviews that patients and families wanted to find out what happened 
and what was wrong with their body, and whether any factors caused or precipitated the 
disease, especially in the early stages of diagnosis. However, the data also suggested 
there are individual differences in information needs. Some patients tried to gain a 
feeling of control through understanding all situations, but others may just find a doctor 
who can be trusted and follow the doctor’s treatments and suggestions. 
Fourth, assessment of patients’ illness perceptions about their disease and conditions 
may be useful in clinical care. This will enable decisions to be made about the accuracy 
of their illness perceptions and importance of modifying the perceptions. Through 
assessment of illness perceptions, patients and healthcare professionals can work 
together to find out the effective ways to promote adjustment to the disease. 
 Fifth, patients applied the coping strategies, both problem-oriented and 
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emotion-oriented coping, to overcome the demands of the disease. Based on feedback 
from the coping strategies, they can continue to use or modify the strategies. More 
emotional impact was associated with more use of emotional-oriented coping, which in 
turn determined worse psychological outcomes (Table 7.9). However, in the analyses 
there was no evidence to suggest the use of emotion-oriented coping resulted in 
decreased psychological components of HRQOL or psychological well-being. Health 
professionals can help patients to evaluate multiple factors, such as the stressor, 
resources, and the expectancy of effect, for finding the better strategies.  
  Sixth, although the role of social support is not clear, it is still likely that family 
support is crucial in helping patients’ adjustment, particularly in the transition phases of 
disease, such as diagnosis, disease deterioration, and terminal stage. More culturally 
sensitive measures of social support may be needed for further work in this area.  
 
The strengths of this thesis were incorporation of both physical and psychological 
variables, as well as both qualitative and quantitative methodology. In addition, multiple 
variables, all subcomponents of HRQOL, anxiety, depression, and emotional distress, 
were used as adjustment outcomes. Despite the huge amount of work that has 
considered cancer patients experiences, it has almost all been based in the US or 
Western Europe. This research described here has made a very significant contribution 
to our understanding of how cancer affects patients in Taiwan. Also of significance was 
the focus on HCC, in contrast to much previous work that has focused on cancers more 
prevalent in the west (e.g., breast, lung cancer). For the future, more work that looks at 
both the similarities and differences in how patients cope with cancer in different health 
care systems may contribute to a broader understanding of the patient experience 
generally. 
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Appendix 1: Questionnaires (English and Chinese versions) 
 
Demographic information 
1. Chart No.: 
2. Sex: □○1 Male  □○2 Female              
3. Date of birth: □□□□/□□/□□ 
4. Education: □○1 Elementary school  □○2 Junior high school   
□○3 Senior high school  □○4 Undergraduate  □○5 Postgraduate 
5. Marital status: □○1 Single  □○2 Married/Living with partner  
□○3 Divorced/Separated  □○4 Widowed 
6. Religion: □○1 Buddhism  □○2 Taoism  □○3 Christian  □○4 Catholic   
□○5 General religion  □○6 None 
7. Job: □○1 Full time  □○2 Part time  □○3 None 
8. Do you need other’s care: □○1 Yes □○2 No 
9. If yes, the main caregiver is: □○1 Father/Mother  □○2 Husband/Wife   
□○3 Son/Daughter  □○4 Friend  □○5 Other 
 
Medical information 
1. Date of diagnosis：□□□□/□□/□□ 
2. Chronic disease：□○1 none      □○2 HBV   □○3 HCV  □○4 Diabetes 
 □○5 Hypertension  □○6 COPD  □○7 Kidney disease 
3. ECOG: □○1 1 □○2 2 □○3 3 □○4 4 
4. AJCC stage：□○1 stage 1 □○2 stage 2 □○3 stage 3 □○4 stage 4 
5. BCLC stage：□○1 stage A □○2 stage B □○3 stage C □○4 stage D 
6. Child-Pugh stage：□○1 stage A □○2 stage B □○3 stage C 
7. Exam ：□○1 α-FP:          ng/mL    □○2 T-bilirubin:          mg/dL    
        □○3 Albumin:          g/dL    □○4 GOT:          U/L 
        □○5 GPT:          U/L        □○6 Platelet:          /L   
        □○7 INR:           
8. Most recent treatment: □○1  Surgery □○2 TAE/TACE □○3 Drug therapy 
9. Date of most recent treatment: □□□□/□□/□□ 
10. Past treatment (Multiple choice) 
□○1 None 
□○2 Surgery: □□□□/□□/□□  
□○3 TAE/TACE: □□□□/□□/□□ 
□○4 Drug therapy: □□□□/□□/□□ 
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Section A. Brief Illness Perception Questionnaire 
For the following questions, please circle the number that best corresponds to your 
views: 
 
How much does your illness affect your life 
Not affect at all 0 1 2 3 4 5 6 7 8 9 10 Severely affects 
my life 
 
How long do you think your illness will continue? 
a very short time 0 1 2 3 4 5 6 7 8 9 10 forever 
 
How much control do you feel you have over your illness? 
Absolutely no 
control 
0 1 2 3 4 5 6 7 8 9 10 extreme amount 
of control 
 
How much do you think your treatment can help your illness? 
not at all 0 1 2 3 4 5 6 7 8 9 10 Extremely helpful
 
How much do you experience symptoms from your illness? 
no symptoms at 
all 
0 1 2 3 4 5 6 7 8 9 10 many severe 
symptoms 
 
How concerned are you about your illness? 
not at all 
concerned 
0 1 2 3 4 5 6 7 8 9 10 Extremely 
concerned 
 
How well do you feel you understand your illness? 
don’t understand 
at all 
0 1 2 3 4 5 6 7 8 9 10 Understand very 
clearly 
 
How much does your illness affect you emotionally? (e.g. does it make you angry, 
scared, upset or depressed?) 
not at all affected 
emotionally 
0 1 2 3 4 5 6 7 8 9 10 Extremely affected 
emotionally 
 
Please list in rank-order the three most important factors that you believe caused your 
illness.  The most important causes for me:- 
(1)                      (2)                    (3)                    
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Section B. EORTC-QLQ-C30 & HCC-18 
We are interested in some things about you and your health. Please answer all of the 
questions yourself by circling the number that best applies to you. There are no “right” 
or “wrong” answers. The information that you provide will remain strictly confidential. 
 
 Not 
at all 
A 
little 
Quit 
a bit
Very 
much
1. 1. Do you have any trouble doing strenuous activities, 
like carrying a heavy shopping bag or a suitcase? 
1 2 3 4 
2. Do you have any trouble taking a long walk? 1 2 3 4 
3. Do you have any trouble taking a short walk outside of 
the house? 
1 2 3 4 
4. Do you need to stay in bed or a chair during the day? 1 2 3 4 
5. Do you need help with eating, dressing, washing yourself 
or using the toilet? 
1 2 3 4 
During the past week     
6. Were you limited in doing either your work or other 
daily activities? 
1 2 3 4 
7. Were you limited in pursuing your hobbies or other 
leisure time activities? 
1 2 3 4 
8. Were you short of breath? 1 2 3 4 
9. Have you had pain? 1 2 3 4 
10. Did you need to rest? 1 2 3 4 
11. Have you had trouble sleeping? 1 2 3 4 
12. Have you felt weak? 1 2 3 4 
13. Have you lacked appetite? 1 2 3 4 
14. Have you felt nauseated? 1 2 3 4 
15. Have you vomited? 1 2 3 4 
16. Have you been constipated? 1 2 3 4 
17. Have you had diarrhea? 1 2 3 4 
18. Were you tired? 1 2 3 4 
19. Did pain interfere with your daily activities? 1 2 3 4 
20. Have you had difficulty in concentrating on things, like 
reading a newspaper or watching television? 
1 2 3 4 
21. Did you feel tense? 1 2 3 4 
22. Did you worry? 1 2 3 4 
23. Did you feel irritable? 1 2 3 4 
24. Did you feel depressed? 1 2 3 4 
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25. Have you had difficulty remembering things? 1 2 3 4 
26. Has your physical condition or medical treatment 
interfered with your family life? 
1 2 3 4 
27. Has your physical condition or medical treatment 
interfered with your social activities? 
1 2 3 4 
28. Has your physical condition or medical treatment caused 
you financial difficulties? 
1 2 3 4 
For the following questions please circle the number between 1 and 7 that best 
applies to you 
29.  How would you rate your overall health during the past week? 
Very poor  1   2   3   4   5   6   7  Excellent 
30.  How would you rate your overall quality of life during the past week? 
Very poor  1   2   3   4   5   6   7  Excellent 
 
EORTC-HCC-18 
 
 
During the past week 
Not 
at all 
A 
little 
Quit 
a bit
Very 
much
31. Did you feel thirsty? 1 2 3 4 
32. Have you had trouble of taste? 1 2 3 4 
33. Have you had lost the muscle of arms or legs? 1 2 3 4 
34. Have you had abdomen swelling? 1 2 3 4 
35. Have you worried about the figure of abdomen? 1 2 3 4 
36. Have you worried the eyes and skin becoming yellow? 1 2 3 4 
37. Did you feel itch? 1 2 3 4 
38. Did you have shoulder pain? 1 2 3 4 
39. Did you have abdomen pain? 1 2 3 4 
40. Did you have fever? 1 2 3 4 
41. Did you feel cold? 1 2 3 4 
42. Did you worry to get enough nutrition? 1 2 3 4 
43. Did you feel full just beginning eating? 1 2 3 4 
44. Did you worry your weight too light? 1 2 3 4 
45. Did you feel the vitality which is not like what you anticipate? 1 2 3 4 
46. Have you had difficulty finishing things? 1 2 3 4 
47. Did you need to sleep in daytime? 1 2 3 4 
During the past four weeks 
48. Did disease or treatment have influences on your sexual life? 
 
1 
 
2 
 
3 
 
4 
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Section C. Hospital Anxiety and Depression Scale 
Doctors are aware that emotions play an important part in most illnesses. If your 
doctor knows about these feelings he will be able to help you more. This questionnaire 
is designed to help your doctor to know you feel. Read each item and underline the 
reply which comes closest to how you have been feeling in the past week. Don’t take 
too long over your replies; your immediate reaction to each item will probably be nore 
accurate than a long thought out response. 
 
1. I feel tense or wound up 
□○1 Most of the time  □○2 A lot of the time   
□○3 From time to time, occasionally  □○4 Not at all 
2. I still enjoy the things I used to enjoy 
□○1 Definitely as much  □○2 Not quite so much  □○3 Only a little   
□○4 Hardly at all 
3. I get a sort of frightened feeling as if something awful is about to happen 
□○1 Very definitely and quite badly  □○2 Yes, but not too badly   
□○3 A little, but it doesn’t worry me  □○4 Not at all 
4. I can laugh and see the funny side of things 
□○1 As much as I always could  □○2 Not quite so much now   
□○3 Definitely not so much now  □○4 Not at all 
5. Worrying thoughts go through my mind 
□○1 A great deal of the time  □○2 A lot of time   
□○3 From time to time but not too often  □○4 Only occasionally 
6. I feel cheerful 
□○1 Not at all  □○2 Not often  □○3 Sometimes  □○4 Most of time 
7. I can sit at ease and feel relaxed 
□○1 Definitely  □○2 Usually  □○3 Not often  □○4 Not at all 
8. I feel as if I am slowed down 
□○1 Nearly all the time  □○2 Very often  □○3 Sometimes  □○4 Not at all 
9. I get a sort of frightened feeling like ‘butterflies’ in the stomach 
□○1 Not at all  □○2 Occasionally  □○3 Quite often  □○4 Very often 
10. I have lost interest in my appearance 
□○1 Definitely  □○2 I don’t take so much care as I should   
□○3 I may not take quite as much care  □○4 I take just as much as ever 
11. I feel restless as if I have to be on the move 
□○1 Very much indeed  □○2 Quite a lot  □○3 Not very much  □○4 Not at all
12. I look forward with enjoyment to things 
□○1 As much as ever I did  □○2 Rather less than I used to /  
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□○3 Definitely less than I used to  □○4 Hardly at all 
13. I get sudden feelings of panic 
□○1 Very often indeed  □○2 Quite often  □○3 Not very often  □○4 Not at all
14. I can enjoy a good book or radio or TV program 
□○1 Often  □○2 Sometimes  □○3 Not often  □○4 Very seldom 
 
 
 
Section D. Coping scale 
 
The Jaloweic coping scale includes 40 items and yields two scores: problem-oriented 
coping and emotion-oriented coping. The author does not permit to put the full text of 
scale on thesis; therefore I do not show this scale. 
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Section E. Social support inventory 
The frequency of getting support from others in past one month. 
 
 N
ot at all 
som
etim
es 
often 
alw
ays 
1. Listened to you talk about your private feeling 1 2 3 4 
2. Expressed interest and concern in your well-being 1 2 3 4 
3. Let you know that he/she will always be around if you 
need assistance 
1 2 3 4 
4. Joked and kidded to try to cheer you up 1 2 3 4 
5. Agreed that what you want to do is right 1 2 3 4 
6. Someone encouraged you when physical condition 
improved 
1 2 3 4 
7. Expressed esteem or respect for a competency or personal 
quality of yours 
1 2 3 4 
8. Gave you information about disease 1 2 3 4 
9. Gave you information and provided assistance about daily 
care 
1 2 3 4 
10. Reminded me to take medicine and come back to hospital 1 2 3 4 
11. Assisted you in setting a goal for future 1 2 3 4 
12. Suggested some action that you can take to release stress 1 2 3 4 
13. Took care of you and helped you to deal with daily life 
events 
1 2 3 4 
14. Did some activity together to help you get your mind off 
things 
1 2 3 4 
15. Provided financial support 1 2 3 4 
16. Please give the two person who help most: 
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Section A. 疾病知覺 Brief Illness Perception Questionnaire 
請在標度的某個數字上畫圈，以表明您同意或不同意下列每個說法的堅決程度： 
1. 您的疾病對您生活的影響有多大？ 
毫無影響 0 1 2 3 4 5 6 7 8 9 10 嚴重影響我的生活
2. 您認為您的疾病將持續多長時間？ 
很短時間 0 1 2 3 4 5 6 7 8 9 10 永遠 
3. 您感覺您能在多大程度上控制住您的疾病？ 
絕對不能控制 0 1 2 3 4 5 6 7 8 9 10 極大的控制力 
4. 您認為您接受的治療（藥丸等）能在多大程度上對疾病有所幫助？ 
毫無幫助 0 1 2 3 4 5 6 7 8 9 10 極其有幫助 
5. 您經受疾病引起的症狀的程度有多大？ 
毫無症狀 0 1 2 3 4 5 6 7 8 9 10 許多嚴重的症狀 
6. 您有多關切您的疾病？ 
毫不關切 0 1 2 3 4 5 6 7 8 9 10 極其關切 
7. 您感覺您在多大程度上瞭解自己的疾病？ 
毫不瞭解 0 1 2 3 4 5 6 7 8 9 10 很清楚地瞭解 
8. 疾病在多大程度上影響您的情緒？比如它是否讓您生氣、害怕、沮喪或憂鬱？）
毫無情緒上的影響 0 1 2 3 4 5 6 7 8 9 10 情緒上極其受影響
9. 請按照次序列出三個最重要的因素，您相信這三個因素導致了您的疾病。 
  對我來說最重要的病因是： 
(1)                      (2)                    (3)                    
 
 
Section B.生活品質 EORTC-QLQ-C30 & HCC-18 
我們很希望瞭解有關您和您的健康狀況。請您親自回答以下所有的問題，圈選最合適
於您的答案。 
 完
全
沒
有 
有
一
點 
相
當
多
非
常
多
29. 您從事一些費力的活動，如攜帶重的購物袋或手提箱，是否
有困難？ 
1 2 3 4
30. 您從事長距離步行，是否有困難？ 1 2 3 4
31. 您在戶外從事短距離步行，是否有困難？ 1 2 3 4
32. 您在白天是否需要待在床上或椅子上？ 1 2 3 4
33. 您進食、穿衣、洗澡或上廁所需要別人幫助嗎？ 1 2 3 4
在過去一星期內（過去七天內）     
34. 您在從事工作或日常活動上是否受到限制？ 1 2 3 4
35. 您在從事嗜好或休閒活動上是否受到限制？ 1 2 3 4
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36. 您呼吸會喘嗎？ 1 2 3 4
37. 您曾感到疼痛嗎？ 1 2 3 4
38. 您需要休息嗎？ 1 2 3 4
39. 您睡眠曾有困難嗎？ 1 2 3 4
40. 您曾感到虛弱嗎？ 1 2 3 4
41. 您曾缺乏食慾嗎？ 1 2 3 4
42. 您曾感到噁心嗎？ 1 2 3 4
43. 您曾嘔吐嗎？ 1 2 3 4
44. 您曾便秘嗎？ 1 2 3 4
45. 您曾腹瀉嗎？ 1 2 3 4
46. 您疲倦嗎？ 1 2 3 4
47. 疼痛干擾您的日常活動嗎？ 1 2 3 4
48. 您曾否難將注意力集中在一些事情上，如看報紙或看電視？ 1 2 3 4
49. 您覺得緊張嗎？ 1 2 3 4
50. 您感到憂慮嗎？ 1 2 3 4
51. 您覺得容易發怒嗎？ 1 2 3 4
52. 您覺得情緒低落嗎？ 1 2 3 4
53. 您曾感到記憶困難嗎？ 1 2 3 4
54. 您的身體狀況或醫療過程是否曾干擾您的家庭生活？ 1 2 3 4
55. 您的身體狀況或醫療過程是否曾干擾您的社交活動？ 1 2 3 4
56. 您的身體狀況或醫療過程是否曾造成您財務上的困難？ 1 2 3 4
以下問題，請在1 到7 之間圈選最適合您的答案。 
29. 您如何評定過去一星期內（過去七天內）您整體的健康？ 
非常差  1   2   3   4   5   6   7  極好 
30. 您如何評定過去一星期內（過去七天內）您整體的生活品質？ 
非常差  1   2   3   4   5   6   7  極好 
 
 
 
 
在過去一星期內（過去七天內） 
完
全
沒
有 
有
一
點 
相
當
多
非
常
多
49. 您覺得口渴嗎？ 1 2 3 4
50. 您曾有味覺方面的問題嗎？ 1 2 3 4
51. 您曾有手臂或腿部肌肉消瘦的情形嗎？ 1 2 3 4
52. 您曾有腹部腫脹嗎？ 1 2 3 4
53. 您曾為您腹部的外觀而煩惱嗎？ 1 2 3 4
54. 您曾為您皮膚或眼睛變黃（黃疸）而煩惱嗎？ 1 2 3 4
55. 您曾覺得癢嗎？ 1 2 3 4
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56. 您曾有肩膀疼痛嗎？ 1 2 3 4
57. 您曾有腹部疼痛嗎？ 1 2 3 4
58. 您曾發燒嗎？ 1 2 3 4
59. 您曾畏寒嗎？ 1 2 3 4
60. 您曾為能否得到足夠的營養而擔心嗎？ 1 2 3 4
61. 您曾經剛剛進食很快就覺得飽了嗎？ 1 2 3 4
62. 您曾擔心自己體重過輕嗎？ 1 2 3 4
63. 您曾感到不如預期的有活力嗎？ 1 2 3 4
64. 您曾發覺要完成所做的事會有困難嗎？ 1 2 3 4
65. 您曾需要在白天睡覺嗎？ 1 2 3 4
在過去四星期內 
66. 疾病或治療曾對您的性生活有任何影響嗎？ 
1 2 3 4
 
 
Section C.焦慮與憂鬱 Hospital Anxiety and Depression Scale 
此部分主要了解您的感受，包括 14 個感受敘述，每個敘述有 4 個選擇，請仔
細閱讀每個敘述並勾選最能表示您過去一週的感受之選項，請不要花太多時間思
考，您的立即反應可能比長時間思考後的反應來得正確。 
1.      我覺得緊張或神經緊繃 
  (1)總是如此  (2)經常如此  (3)偶爾如此  (4)一點也不會 
2.      我仍喜歡過去我喜歡的事物 
  (1)和過去一樣喜歡  (2)不像過去那樣喜歡  (3)只有一點喜歡  (4)幾乎都不喜歡 
3.      我有一種可怕的感覺，好像有什麼不好的事情即將發生 
  (1)這感覺很確定且很強烈  (2)有這感覺但不是很強烈  (3)有一點但不令我擔心   
  (4)一點也沒有 
4.      我可以大笑並感受到事情有趣的一面 
  (1)如同過去一樣  (2)不像過去那樣  (3)確實比過去少  (4)一點也沒辦法 
5.      我心裡有些擔憂的想法 
  (1)總是如此  (2)經常如此  (3)有時會有，但並不頻繁  (4)只是偶爾會有 
6.      我覺得開心或愉快 
  (1)經常覺得  (2)有時覺得  (3)不常覺得  (4)一點也不覺得 
7.      我可以舒服的坐著並覺得很放鬆 
  (1)的確如此  (2)經常如此  (3)不常如此  (4)一點也沒辦法 
8.      我覺得自己的生活步調好像慢了下來 
  (1)總是如此  (2)經常如此  (3)有時如此  (4)一點也不會 
9.      我有一種可怕的感覺，就好像胃裡有東西在動 
  (1)總是覺得  (2)經常覺得  (3)偶爾覺得  (4)一點也不會 
10.     我已不在關心自己的外表 
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  (1)的確如此  (2)我沒有應該有的關心  (3)我不太關心  (4)我和過去一樣關心 
11.     我覺得坐立不安，好像我非得不停的動不可 
  (1)的確總是如此  (2)經常如此  (3)不太會這樣  (4)一點也不會 
12.     我對事物感到期待或有希望 
  (1)和過去一樣  (2)比過去少些  (3)比過去少多了  (4)幾乎沒有這種期待 
13.     我突然覺得恐慌 
  (1)總是如此  (2)經常如此  (3)不常如此  (4)一點也不會 
14.     我可以欣賞或沉浸於一本書或好的廣播/電視節目 
  (1)總是如此  (2)有時如此  (3)不常如此  (4)極少如此 
 
 
Section E.社會支持 Social support inventory 
本量表是想要了解您目前生活中，來自週圍他人所提供給您的支持與協助的
情形，根據您平時的感覺、想法，每個問題勾選最適合的選項。 
      1 分：沒有獲得支持  2 分：偶爾獲得支持   
      3 分：經常獲得支持  4 分：總是獲得支持 
 沒
有
獲
得
支
持 
偶
爾
獲
得
支
持 
經
常
獲
得
支
持
總
是
獲
得
支
持
17. 有人可以傾聽我訴說心中的想法及感受 1 2 3 4 
18. 有人會關心我的健康狀態 1 2 3 4 
19. 在不如意的情況下，有人可以安慰陪伴我、度過困境 1 2 3 4 
20. 沮喪時，有人會鼓勵我，振作起來繼續生活下去 1 2 3 4 
21. 有人可以支持我所做的決定 1 2 3 4 
22. 身體狀況改善時，有人會稱讚、鼓勵我 1 2 3 4 
23. 有人能重視我或尊重我的意見 1 2 3 4 
24. 有關疾病方面的問題，有人會與我討論並提供我意見 1 2 3 4 
25. 有關生活方面的照顧，有人會提供我意見並實際幫助我 1 2 3 4 
26. 有人會提醒我按時服藥，定期到醫院檢查 1 2 3 4 
27. 有人可以和我一起討論並擬定未來的目標計劃 1 2 3 4 
28. 有人可以提供我一些壓力紓解的方式 1 2 3 4 
29. 生病時，有人可以照顧我或幫助我處理日常事務 1 2 3 4 
30. 有人可以陪伴我一起做活動，使我不去想自己的困境 1 2 3 4 
31. 如果我需要經濟支援，有人可以提供 1 2 3 4 
32. 請針對以上題目至少列出兩位幫助您最多的人： (1) 
(2) 
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Appendix 2: Consent Form 
 
Dear Sir/Madam: 
The study is to explore HCC patients’ quality of life and the significant factors. The 
questionnaires assess the factors that impact on your illness experiences, quality of life 
and coping strategies. The results may be used to help medical staff understand your 
needs and improve clinical care. 
Please read the following questions and tick the answer that best describes your 
experiences. Remember there are no right or wrong answer. Please try not to leave out 
any questions. Thank you. 
 
Data Protection Act 
In accordance with the Data Protection Act, we have to ask you to sign the following 
declaration. You can be quite sure that all the information we collect will be used only 
for the purposes of research and kept confidential to the research team itself: it will not 
be released to anybody else. 
I agree to allow the university to provide the research team with my name, contact 
details, grades and other information about my course of study. I also agree that 
this information, and the data collected from me, may be held and processed by the 
team for the purposes of research. 
 
Sign:                                           Date:              
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